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SUMMARY 
The placenta is a highly organised and effective 
'barrier' interposed between maternal and foetal circulat-
ions. Multiple functions normally requiring separate organs 
are condensed in this one organ and transport of various 
metabolites is of selective nature. Transfer of plasma 
proteins across the placenta is complex and has received 
little attention so far; this thesis sets out to establish 
existence of receptor molecules responsible for initial 
recognition and selective transfer of the following protein 
molecules; o( 1antitrypsin, haptoglobin, c( 2HS-glycoprotein, 
prealbumin, Gc-specific components, o( 1acid glycoprotein, 
thrombin, fibrinogen, in addition to IgG and transferrin. 
Firstly, isolated syncytiotrophoblastic membranes were 
used to establish the topographical distribution of binding 
of these protein ligands by immunocytochemical methods, 
All proteins studied showed marked positive fluorescence but 
for immunoperoxidase method, prior aggregation of these 
protein ligands was necessary to elicit positive reactions. 
Secondly, an in-vitro placental perfusion system was utilised 
to monitor uptake of tritium radiolabelled derivatives of 
these proteins and uptake profiles in all cases showed 
saturable characteristics, Mathematical application of 
equations for describing assymetric carriers linearised all 
these curves, a fact which was very suggestive of receptor 
mediated uptake as the main mechanism for placental protein 
transfer. Furthermore, uptake curves were very similar in 
nature to Michaelis-Menten type of kinetics; additional 
(iii) 
evidence for 'carrier' mediated uptake. 
The IgG antibody transfer which is also selectively trans-
ferred was studied in some detail. It was necessary to 
re-establish the kinetic association and dissociation characte-
ristics of the IgG-receptor binding as well as any evidence 
of heterogeneity of receptor sites. Ka = 2.2 x 108M-! with 
binding sites of :1:5 x 1014 fmg membrane were obtained with an 
7 -1 . -1 
average rate constant of 2.29 x 10 M m1n Dissociation 
was heterogeneous at high displacement dose of 1000 pg of 
unlabelled lgG giving a curvilinear rate dissociation curve; 
the fast affinity site had 
~ffinity site had k 2 = 0.01 
k2 = 0,10 
. -1 
m1n 
. -1 
m1n , whilst the slow 
Temperature effects led to derivation of thermodynamic 
binding parameters; binding was strongly exothermic with 
marked negative enthalpy ( AH = -2.51 KCal/mole) which was 
suggestive of hydrogen bonding between lgG and its receptor. 
There was a high entropy energy change when IgG associates 
• · ( A -1 -1 to 1ts receptor LOS= +29.3 KCal. Mole .K ), typical of 
hydrophobic type of interaction. Furthermore, the stoinchio-
metric ratio of lgG to Fer 
1:1 as previously stated. 
receptor was 4:1 as opposed to 
Monovalent and divalent cations strongly modulated the 
+ 
receptor binding, (Na , 60-140 m~) caused a 
32-50%drop in binding whilst Li+ 1-4 mM gave a 50% depres-
sion in binding but no effect at therapeutic dose (Li+ < 2mM) 
Mg2 + (1-2mM) increasing binding by 8.4% and > 2m~ depressed 
binding up to 30% at 10 mM. ca2 + (2.6mM) inhibited 13% of 
binding increasing to 33% by lOmM: 2+ Mn showed a 1· .. 7% 
(iv) 
depression at 1 mM which rose to 68% at 15 mM. 
Colloidal gold adsorbed to various proteins offered a 
visualisable means of following the process of receptor bind-
ing and subsquent formation of coated vesicles which are 
responsible for transfer across the placenta. Affinity 
isolation of receptors from solubilised membrane was performed 
using protein coupled to CN Br-activated Sepharose 4B and 
enabling analysis of desorbed receptors on 80S-polyacrylamide 
gels, Molecular weights of 46,000, 48,000, 49,000 and 62,000 
for o( 1 acid glycoprotein, haptoglobin, prealbumin and o( 1 anti-
trypsin receptors were obtained respectively. IgG showed 
heterogeneity with three visible polymarphic bands with Mr 
72,000, 78,000 and 195,000. 
Radiolabelled proteins were reacted with either the 
affinity isolated receptor fractions or the unsolubilised 
purified membrane and from binding isotherms and Scatchard 
plots, binding data such as the affinity, ·receptor site 
capacity, co-operative arid homogeneous receptor effects were 
evaluated. 
StMPM 
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(v) 
SY!,ffiOLS AND ABBREVIATIONS 
= Syncytiotrophoblastic Microvillar Plasma Membrane 
= 
= 
= 
= 
= 
= 
= 
= 
Pre albumin 
0( 1 antitrypsin 
Haptoglobin 
o< 2HS-glycoprotein 
Thrombin 
o( 1Acid glycoprotein 
Fibrinogen 
Bovine Serum Albumin 
= greater than 
= less than 
= Electron Microscope 
= Molecular Weight 
= Sodium Dodecyl Sulphate - Polyacrylamide gel electro-
phoresis. 
= Microli tre 
= litre 
= Microgram 
= Gram 
= Milligram 
= Acceleration due to gravity 
= Activation Enthalpy 
= Gibb's free energy 
= Entropy 
= Gas constant = 1.987Calfmole/degree 
= Temperature 
= Degree Kelvin 
= Equilibrium association constant 
= Dissociation constant 
(vi) 
Symbols and Abbreviations Cont'd .. 
k2 = Dissociation rate constant 
kl = Association rate constant 
Ct = Uptake at time t 
So = Maternal imput in a Cis/trans exchange system 
Sol = Gold sol (or suspension of tiny gold colloid) 
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CHAPTER 1 
GENERAL REVIEW 
INTRODUCTION TO PLACENTAL MORPHOLOGY, DEVELOPMENT AND FUNCTION. 
1.1.1 Anatomical Aspects of the Placenta. 
Knowledge of function of any organ's biological system 
is incomplete without discussing morphological considerations. 
It is even more imperative, for an organ like the placenta 
with highly specialised multiple but diverse functions and 
normally requiring separate organs (Burton et al 1976) to 
try to understand the anatomical arrangements that make it 
a very unique organ in the biological heirachies. Although 
it can execute functions of an ~ndocrine nature, excretion 
of foetal waste, gaseous exchange, transfer of nutrients, 
antibody transfer and other immunological roles, including 
cellular filtration, it nevertheless remains an effective 
barrier (Steven and Samuel 1976 and 1979). The term 'barrier' 
is classically applied to the blood - brain, blood cerebral 
spinal fluid interfaces as well as the choroid plexus system 
and of course the placenta. All these interesting tissue 
functions do form anatomical as well as functional barriers 
and attention must be drawn to the fact that they are all 
embryologically ectodermal derivatives (Davson 1976). 
The placenta develops originally from a fertilised ovum, 
which after migration to the uterine wall implants, loses 
its outer layer, the zona pellucida to form a blastocyst. 
Subsquent proliferation of its outer layer forms the tropho-
blastic cell mass; this inflitrates into the endometrial 
epithelium to come into direct contact with the endometrial 
stroma. It is believed this process of implantation with 
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expression of trophoblastic cells is complete within tenth 
or eleventh day post ovulatory day (Fox 1978). 
The trophoblastic cells proliferate into two prominent 
layers, the outer forming multi nuclear layer of syncyntio-
trophoblast whilst the inner mono-nucleated cells become the 
cytotrophoblast. It is now widely believed the inner cyto-
trophoblast gives rise to the outer syncytium; initially by 
fusion of its cells, then eliminating the cell wall membranes, 
to become the syncytiotrophoblast (Richart 1961; Galton 1962). 
Often remnants of the shed cell wall membranes can be seen 
by the electron microscope (Carter 1964; Enders 1965). 
Mitotic activity is recordable only in the inner cyto-
trophoblast. The syncytium's DNA does not seem to replicate. 
Consequently, some investigators have teleoiogically, postu-
lated (Contractor et al 1977) that this allows the syncytio-
trophoblast, a layer in direct contact with maternal circula-
tion, to direct its full metabolic energy towards transfer 
processes; to and from the foetus rather than being deployed 
in cell division. 
Around the tenth to thirteenth post-ovulatory days, 
clefts appear in the trophoblastic layers and a series of 
these form intercommunicating valleys or lacunae which seem 
to incorporate maternal endometrial capillaries (Harris and 
Ramsay 1966). Some of these lacunae become confluent to 
form the crucial intervillous space. This space seems to be 
filled with maternal blood, which is important in facilitat-
ing exchange of materials between the trophoblast and maternal 
blood system. 
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1.1. 2 Primary Villi Formation 
Excrescences of the trophoblastic surface form struc-
tures which at first become the primary villi. These origi-
nally form from proliferation of cytotrophoblast which results 
in formation of central core of column of cells, called 
trabeculae, from which villi form within the first 25 days 
post ovulation (Fox 1978, Dearden et al 1983). The primary 
villi are solid, but afterwards their mesenchymal core becomes 
invaded by fibroblasts, the Hofbauer phagocytic cells (Enders 
and King 1970), as well as collagen fibres and hence become 
secondary villi. Further differentiation and acquisition 
of foetal capillaries within the villous core convert them 
into tertiary villi. This vascularisation or angiogenesis, 
it has been argued, is a_ function of the mesenchymal core 
(Dempsey 1972), although others contend the vessels are formed 
by the cytotrophoblastic cells (Hertig 1935). 
Sprouts from the well formed tertiary villus go through 
all the stages described above, become vascularised too, and 
thus produce new villi and thus proliferation of villous tree 
is achieved and consequently amplification of absorptive 
surface is attained (Ludwig 1974, Aherne and Dunhill 1966, 
Aherne 1975). Some of these sprouting villi have been observed 
to pinch off at their bases, to enter the intervillous space 
(Boyd and Hamilton 1970). Somehow as Douglas reports (Douglas 
et al 1959), these bits of villi are often found in the maternal 
circulation. Its significance is ill understood, although it has a 
possible immunosuppressive role to maternal antibody that would 
otherwise cause host versus graft rejection (Thomas et al 1959) 
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1.1.3 Anchoring villi. 
The placenta has to be firmly anchored to the maternal 
endometrium for it to perform its functions, without as it 
were "falling off". This is, at ultrastructural leve 1 
achieved by specialisation amongst some villt ,to the role 
of securing the placenta; and these are termed anchoring 
villi. They differ from other villi, in that their core is 
composed to solid trophoblast, and no mesechymal core with 
its usual compliment of blood vessels (Dearden et al 1983) 
These authors point out that these type of villi are for 
purely mechanical support and even if they got torn off due 
to certain pregnancy stresses, the fact that they are devoid 
of blood vessels, no vascular exanguination takes place 
which is otherwise potentially dangerous. 
It is also important to note that at this stage the 
distal part of the villus stem is formed by cytotrophoblast 
which is not yet invaded by the mesenchyme or blood vessels. 
These cells filling the whole villus are often referred to as 
'cytotrophoblast ce 11 columns', they do spread laterally to 
form a continuous cytotrophoblast shell, (Fox 1978) which 
splits the syncytium into two layers that lie on the foetal 
side and the other peripheral one between the shell and the 
dicidua plate. This peripheral type degenerates to be 
replaced by a layer of fibrinoid material (Nitabuch's layer), 
whilst the inner syncytium persists to become the usual limit-
ing layer or border between the trophoblast and the inter-
villous space. 
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1.2 Same Ultrastructural Microvillar Variations. 
The syncytial border referred to above is normally studded 
by microvilli formed to increase absorptive surface (Fox 1979), 
in a manner similar to the brush border of the gastrointestinal 
tract (King and Menton 1975) on the renal epithelium. However, 
there are some areas of the trophoblastic epithelium, namely 
the villus, which are devoid of microvilli (Ludwig 1974, Dearden 
et al 1983). Either these areas had them but they got denuded 
and thus lost microvilli or they never got formed at all. 
There has been considerable electron microscopic interest 
in studying microvillar variations as reported by Dempsey and 
Luse 1971, Clint et al 1979. King and Menton, 1975 saw no such 
denuded areas, lacking microvilli, whilst Clint et al 1979, 
Panigel and Anh 1964, noted such areas. It has been noted that 
the distribution of these 'smooth' areas devoid of microvilli 
is entirely random and also the change from microvilli covering 
to lack of them is gradual (Dearden et al 1983). Areas which 
invariably lack microvilli are the syncytial vascular membranes 
(Fox and Agrofojo-Blanco 1974). 
1.3.1 
Functional Anatomy of the Villi 
Vascular Syncytial Membranes. 
Some areas of the chorionic villi are extremely thin 
morphologically, lack the cytotrophoblast, no nuclei and also 
have no microvilli. Light microscopic examination of these 
areas seem to show apparent fusion of the syncytial membrane 
with the under lying endothe li urn of the foeta.l capillaries. 
Higher magnification of these areas reveal that there is 
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no true fusion but merely close apposition of the thin 
syncytial membrane and the endothelim (Strauss et al 1965, 
Fox 1979). These areas are thus called "the syncytial 
vascular membranes" (VSMs), and Fox (1979), maintains that 
this peculiar morphological thinning, connected with blood 
vessels, have a functional role namely the transfer of those 
substances where membrane thickness is an important limit-
ing factor, such as gaseous exchange; oxygen and carbon 
dioxide (Fox 1979, Baker et al 1944, Longo 1972). Transfer 
of gases or indeed simple diffusion is inversely proportional 
to the square of the distance separating two compartments, 
in this case the membrane, and so thinning of these syncytial-
vascular membranes subserves a vital role. It is postula-
ted that these areas are formed by lateral mechanical stret-
ching as proposed by Pisarki and Topilko (1966), particularly 
by distended or dilated foetal vessels (Fox 1979). They are 
also randomly distributed, often occurring along the course 
of a vessel as a dome-shaped swelling protruding into the 
intervillous space from the lateral wall of the villus (Fox 
and Agrafojo-Blanco 1974). 
These specialised areas, the vascular-syncytial membranes, 
quite apart from their gaseous transfer role, differ also 
histochemically (Burgos and Rodriguez 1966) from unthinned 
areas of the trophoblast. In first trimester placentae, 
the vascular-syncytial membranes are just discernible, however, 
as pregnancy continues, they become more prominent. This 
structural amplification correlates with functional integrity 
of the placentae and hence nutritional status of the foetus. 
This argument is ratified by finding that deficiency of 
VSMs in mature placentae is associated with foetal deprivat-
ion (Fox 1967). Fox argues that such paucity of V&Ms can 
arise from lack of differentiation of the trophoblast, 
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possibly by the stretching mechanisms to form these structures, 
which leads to poor transfer of those substances dependent 
on simple diffusional flux processes. 
Although the membrane thinness of VSMs offers an 
attractive theory in respect of enhancing transfer, Longo 
1972, seems to destroy the argument that this membrane thick-
ness,and hence resistance, is positively the limiting 
constraints in placental transfer .. From comparative studies, 
some species do not seem to exhibit VSMs, in fact some have 
thicker placental membranes, but evidently transfer seems to 
be adequate in these species. The clear resolution of why 
VSMs exist is far from complete. It is worth mentioning 
work of Ockleford et al 1981, who by immunofluorescent stain-
ing these VSM areas, for polymeric cytoskeletal protein, 
did not detect any reduction in thickness. 
1.3.2 Dynamic anatomical microvillar changes; adaptation 
to function. 
Placental villi with their microvilli impose a great 
absorptive surface for foetal-maternal exchange. There are 
constant changes in villar structure as pregnancy progresses. 
These maturation processes have been regarded as embodying 
the ageing process (Fox 1979). Probably a better way to 
8 
regard these villar changes is to depict them as maturation 
processes. Area/volume cpange increase whilst surface area 
changes from 5m2 at 28 weeks to 11m2 at term (Aherne and 
Dunhilll966). _- Thickness of villi alter from 10 pm at 
early gestation to 1.7 pm in later pregnancy (Boyd and Hamil-
ton 1967). 
Furthermore, the increasing foetal capillary diameters 
as they shift from central to eccentric position have the 
effect of creating a steep concentration gradient of any 
substance from maternal to foetal siae~. In addition the 
crowding of flow lines or cris-crossing effect has also a 
bearing on increasing maternal-foetal transfer efficiency 
within the microvilli. As the placenta matures and thus alters 
in size, the importance of close apposition of maternal and 
foetal circulations must be maintained in the end. Therefore 
it can be construed that the microvillar maturation changes 
are. adaptive features to attain the desired goal of better 
efficiency in transfer processes. Placental maturation and 
foetal growth should go hand in hand as it were. 
However, it is not uncommon to find fully grown, mature 
foetus, but with immature villi as seen in diabetes mellitus 
complicated pregnancies. Conversely, too, mature microvilli 
have been associated with immature foetus as seen in 10% of 
prematurely delivered babies (Nezelof and Roussel 1954, Becker 
1963, Fox 1969), and as much as 25% rate has been given in 
Aldjems series (1968), ~his foetal-placental asynchrony 
(Becker 1975, Fox 1978) has been observed which might there-
fore mean that there is independence between micro-
villar maturation, morphologically at least, 
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and foetal grDwth although obviously the two processes are 
strongly intertwined (Fox 1978). This imbalance preseuts even 
more difficulties in appreciating how immature villi can 
function so well in terms of transfer processes to produce a 
well 'fed' baby. This disparity or dissociation in micro-
villar morphology and function remains unresolved, A full 
term placenta is usually about 600gm and for many years 
various clinical work has associated low placental weight 
with low birth weight or even immaturity. From the above 
considerations of the growth of the placenta, its size and 
foetal maturity, it is hard to draw a hard and fast correlat-
ion between mere size and foetal outcome. 
1.3.3 'Overall Placental Microvillar Function, 
Placental microvilli, because of their large surface 
area, are fundamental to all transfer processes. These 
include absorption of carbohydrates, amino acids, lipoproteins, 
gaseous exchange, vitamins and other small molecular weight 
nutrients, electrolytes, and proteins (Longo 1972, Hill and 
Longo 1980, Hill and Young 1973). Further mention of the 
exchange of these materials and modes of transport involved 
will be made later, under specific transfer of some substances. 
Microvilli are also involved in excretion of foetal waste 
products via maternal route (Salazar. and Gonzalez-Angulo 
1967). As for macromolecules whose transfer cannot be 
effectively achieved by simple diffusion, the syncytial tro-
phoblast has surface receptors for these molecules. By micro-
pinocytosis, bits of membrane containing these substances 
and still attached to their receptors are able to pinch off 
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to form coated vesicles which then transport them across the 
membrane to foetal capillaries (Brambell 1970, Dempsey and 
Luse 1971, Fox 1978, Ockleford and Whyte 1977). Detailed 
discussion of coated vesicles and how they perform a receptor 
and then transfer role, will be given later. Foetal nutrit-
ion and development also depends on the integrity of these 
microvilli on performing their various functions, and as 
such there have been studies which have correlated abnormal 
or pathological pregnancies with microvillous immaturity, 
a generalised failure of villous maturation has also been 
associated with a relatively high incidence of foetal hypoxia 
(Becker 1975) and foetal growth retardation (Busch 1972, 1974, 
Bender et al 1976 ). One must add that these complications 
are by no means constant accompaniment of villous immaturity 
because many infants whose placental villi are immature are 
born normal both for weight and gestational period. 
The cause of this immaturity is unclear and one would 
have thought that vascular supply complications such as 
ischaemia in hypertension or preeclampsia would contribute 
to villous immaturity. This is not so because the incidence 
of villous immaturity is no higher in these conditions, and 
therefore ischaemic insults to the placenta cannot be a 
direct cause of villous immaturity. 
Nutrients themselves stimulate microvillar growth, 
for if they are restricted there is a proliferation of micro-
villi (Jones and Fox 1979) as a kind of compe11satory change. 
However mere proliferation has to be distinguished from 
accelerated villous maturation. The latter is seen in 
placentae from immature or prematurely delivered infants, 
(Becker 1975). This is not ·unexpected as asynchrony between 
foetal and villous maturity is well recognised (Becker 1963, 
1971, 1975) and therefore one finds fully mature villi from 
immature placentae and vice versa. Others like Schuhmann 
(1975) have argued that the finding of accelerated growth in 
immature placentae is more of a ~nsatory change to counter 
a deficit in villous numbers. 
1.3.4a Microvillar Circulatory Arrangement. 
For the unique uptake mechanisms of the trophoblastic 
villi, circulatory arrangements play a vital role and for 
our understanding of this and its connection to transfer 
mechanisms a brief mention of this circulatory anatomy will 
now be made. 
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Two ·umbilical arteries spiralling around a central umbtl~­
cal vein enter the chorionic membrane, and each seems to 
supply one half of the placenta. Each runs parallel to the 
chorionic plate but dividing into sub-branches, which in turn 
give off straight cotyledonary arteries which enter the 
placental substance (see Fig. 3 depicting chorionic tree and 
vessels). These vessels still follow the subdivisions of 
the chorion and finally forming capillaries to enter each 
microvillous. The capillaries intertwine and cris-cross to 
form plexuses. It is those plexuses which run over each 
other that create a unique transfer amplification arrangement. 
Longo and Power (1969) have considered a schematic 
arrangement whereby umbilical and maternal vessels of differing 
diameters are considered in close apposition so as to 
facilitate an effective arrangement, See diagram (Fig.l) 
If small compartments A and B are considered, it will be 
seen that in A, with a large blood flow, maternal and foetal 
blood will equilibrate near the initial foetal value. 
However, at B, with larger maternal vessel relative to the 
foetal one, exchange will equilibrate near the initial 
maternal value. At D~~after mixing,the blood leaving the 
placenta will have uterine vein and umbilical vein values 
which differ, even though equilibration was achieved in the 
separate A and B exchange compartments. This system is 
especially suitable for gaseous exchange and any other small 
molecular weight substances with rapid diffusional fluxes. 
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To a lesser extent, this is also true for macromolecules 
such as proteins, although existence of receptor or carriers 
on the trophoblastic membrane which separates the maternal 
and foetal circulation will obviously impose more complex 
kinetics of exchange. Consider the case of oxygen exchange 
as per arrangement in Fig.l. The mixture of maternal blood 
from compartments A and B having unequal maternal and foetal 
flow rates, results in uterine venous blood at C having a 
composition weighted heavily by unit B, namely closer to 
the inflowing maternal value as opposed to the umbilical 
vein which will be weighted heavily by unit A, The nett 
result becomes that of differing oxygen or carbon dioxide 
partial pressures in the umbilical and uterine veins, even 
though gaseous equilibration may be complete in each of the 
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placental segments A and B. Therefore if calculations are 
made, assuming that all capillaries are identical in size, 
results will not reflect the true situation imposed by 
Uterine artery Uterine vein 
Maternal side 
t 
B 
---"1 
Uni>ilical artery' Foetal side Umbilical vein 
-- ·. -
Fig. 1 
(After Hill,P.M., and I.ongo,L.D., 1980). 
the ccop1exity of foetal/maternal capillary arrangements in 
terms of the overall exchange. 
Therefore this complex geometry of vascular arrangements 
has forced several workers to drop assumptions of identical 
capillaries, and analyse the effect on transport in terms 
of different capillary orientations, countercurrent and 
cross-current patterns, multivillous and pool-type flow 
arrangements;- all which show vast differences in the 
efficiency of exchange of materials between the placenta and 
mother. This has been done by Longo (1972), Faber and Hart 
(1967), Metcalfe et al (1967). Faber has taken the issue 
even further and considered it as analogous to the theory 
of heat exchange as applied to the transfer of inert 
materials in the placenta (Faber 1969), and here quite 
complex mathematical considerations have been presented. 
1.3.4b Maternal Uterine Placental Circulation Models. 
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Ramsey and her colleagues (Ramsey 1954, 1956, 1962) 
have shown that arterial inlets from the uterine decidual 
plate sprinkle blood into the intervillous space in a funnel-
shaped stream (See Fig,2). This stream hits the microvilli 
on the opposite side, which have the effect of dispersing 
the stream sideways. This forces the blood already in the 
intervillous space out through the basal decidual venous 
outlets which drain into larger uterine veins. The arte-
rioles are coiled and spiral-shaped, which have the effect 
of modulating pressure as well as creating a jet flow effect 
(Borrel et al 1958). There has been an objection to the 
. use of the term 'jet', since cineangiography has shown 
that this term gives an undue impression of speed and 
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intermittency implied in a jet but rather, maternal blood 
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seems to enter the intervillous space gently (Ramsey 1965). 
Whatever the true situation, the spiral arteries as they 
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reach the intervillous space create a pressure difference 
relative to the more straight vessels from which they are 
continuations; the nett effect being that the full arterial 
pressure is never felt at the level of the intervillous 
space. Once in this space, there is very little resistance 
to flow which further negates the need to have any high 
pressures in the first place in order to 'push round' the 
intervillous blood back into the venous returns. Since 
flow can be achieved at such low pressures, differences in 
the intervillous space, placental flow vascular 
must be very high (Mollet al 1975). 
Ramsey's model of flow events within the intervillous 
space, leading to close apposition between chorionic villar 
circulation and that of the mother for purposes of exchange 
of materials, was found to be too simplistic. This was due 
to her system being based on random distribution of arterial 
inlets sprinkling blood into the intervillous space. Other 
models are. available, namely that of Freese ( 1966) and 
Wigglesworth (1967) and that of Gruenwald (1973). In case 
of Freese and Wigglesworth, arterial,inlets are not random 
but are centrally situated (Fig. 3), so as to inject their 
stream in villous-free space·, in otherwords villi do not 
play a part in side streaming or dispersion of the blood; 
but blood flows laterally into the interlobular spaces from 
which it is drained. Gruenwald's model (Fig.4), 
envisages the chorionic tissue with finger-like lobules 
which project into the intervillous space. Then two arte~ial 
spiral arteries are strategically placed in such a way that 
.. ' 
jet flow from one and the other forms a 'spiral' of fluid 
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flow which bathes these lohules, and finallv t~e fluid 
droooinp centrally to collecting venous returns, Whichever 
is the true circulatory description, is not yet resolved, 
Foetal vein 
Foetal artery Septum 
Septum 
\ 
Fig. 3 
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1,4 Placental mesencymal and other cytoskeletal elements. 
The chorionic mesenchyme is essentially the ground 
matrix containing connective tissue elements which offer 
support to the whole chorionic tree. These elements therefore 
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constitute the cytoskeleton of the whole placenta. These 
include fibroblasts, microtubules, microfilaments and poly-
meric cytoskeleton proteins. A review of their distribution 
has been given by Ockleford et al 1981, Dearden and Ockleford 
1983, Ockleford and Wakely 1981, but suffice to add that 
fibroblasts project out fibrous like extensions to hold 
various trophoblastic elements together, whilst microfila-
ments 8nm in diameter and made of polymeric proteins, such 
as actin, are seen immediately beneath the plasma membrane 
and arranged in an open lattice network. It is just possible 
that micropinocytosis process might involve these actin 
filaments in eliciting the pinching off of these vesicles 
which are crucial to the transfer process. The other cyto-
skeletal elements are of purely supportive natu~e and may 
not be involved in transport at all. 
1.5 Role of Trophoblastic Lysosomes. 
Lysosomes are essentially bags of hydrolytic enzymes 
and for this reason many scavenger cells such as macro-
phages deploy the lysosomal enzymes to digest foreign 
material and organisms. Tumour cells are also able to invade 
tissues and destroy connective tissue and limiting membranes, 
by the power of lysosomal enzymes. With regards to the 
placenta, lysosomes play a very important role not only in 
controlling the catabolic hydrolytic activity of the placenta, 
but it is also thought that during ontogeny and development 
of the placenta, lysosomes play a vital role in its remodel-
ling (Corash and Gross 1974). The loss of limiting membrane 
of the cytotrophoblast is thought to be due to dissolution 
of the membrane by proteolytic, hydrolytic and lipolytic 
lysosomal activity and thus cause its transformation into 
the syncytiotrophoblast (Coutractor et al 1977), The 
finding of membrane pieces in lysosomes (Rhodin and Terzakis 
1962) as well as free membrane fragments in contiguity of 
secondary lysosomes (Contractor 1977) do lend support to 
the strong part lysosomes play in membrane breakdown and 
modification too. Their most important contribution to 
foetal well being is their role with regard to transport 
and transfer of materials from mother to foetus. Take a 
case of transfer of antibodies across the placenta; once 
receptors to IgG fix this antibody, there follows pino-
cytosis and formation of coated vesicles in which the IgG 
receptor with its ligand are enclosed (Brambell 1970, 
Hemmings and Williams 1976). Fusion of these vesicles with 
prima zy lysosomes leads to secondary lysosomes and destruct-
ion of antibody. Those vesicles which escape lysosomal 
fusion are able to transmit the IgG antibody intact to the 
foetus, and it is vital for the foetus to receive this 
antibody wholesome if it is going to retain full antibody 
function (Wild 1973). 
The syncytium contains a large number of varying grades 
of multivesicular bodies. Essentially these are vescular 
bodies with lots of inclusion of small vacuoles, and hence 
their name. Those with light translucent appearance are 
designated light multi vesicular bodies ( L-MVBs) and the much 
darker ones, the dense tiDlltivesicular bodies (D-MVBs) (Martin 
and Spicer 1973). There is evidence to show that these 
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L - and D-MVBs are involved in transport (Martin and Spicer 
1973) and that proteins for transplacental transport are 
selectively transported in these bodies. Furthermore Tighe 
(1967) has made an observation that lysosomes can contain 
large granules within themselves and it is possible to trace 
transitions from these into multivesicular bodies. Thus 
lysosomes and their counterparts the MVBs are important in 
transfer process and its control. 
1.6 Placental coated vesicles and transfer. 
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The term 'coated vesicles' was first applied to organel-
les derived from internal invaginations of the plasma memb-
rane by Rosenbluth and Wissig (1963, 1964). This was because 
of the·appearance of these vesicles, having a microscopically 
dense coat on their outside which distinguished them from 
other vesicles in tissues (Pearse 1976, Cckleford 1976). 
It would appear that from evolutionary point of view, more 
advanced cell types, the eukaryotes, transfer of membrane 
from one area of a cell to another, or for packaging of pote-
ntially dan~erous enzymes, such as lysosomal enzymes, or 
secretory products of golgi apparatus, necessitated special 
organelles to do it (Navikoff and Navikoff 1977). 
From cell chemistry point of view the enclosing of 
reactants from their substrates is achieved by membrane 
transfer and thus attain cell compartmentalisation. Memb-
rane transfer is necessary in formation of lysosomes or 
presynaptic vesicles at nerve axonal junctions. In this 
way receptor.,.bound substances can cross various tissues. 
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The latter situation is particularly relevant in the placental 
transfer processes of material from mother to foetus and 
hence the importance of coated vesicles in this regard, 
(Ockleford 1976, Ockleford and Whyte 1977). 
Comparative studies have revealed the ubiquitous 
distribution of coated vesicles in various species as well 
as different tissue types within the same species or animal 
(Navorotin 1980). This underlines the fundamental importance 
of coated vesicles in the animal kingdom (Ockleford 1980, 
Navorotin 1977) and·are therefore intimately involved in 
transport mechanisms. They have two major points of origin, 
namely the plasma membrane and golgi apparatus membrane 
and once they are formed they have to be translocated in a 
process called vesicle motility, and then some which origi-
nate from plasma membrane carrying receptor bound material 
fuse with the opposite capillary membrane to release their 
contents therein. 
A detailed review of possible mechanisms of this 
peculiar translocation, or motility from the time of format-
ion is given in a book by Ockleford 1980, under the title 
of Dynamic aspects of coated vesicular function, He also dis-
cusses the problem of how two membranes fuse; that of the 
coated vesicle membrane and the target organelle to which 
it is directed. Even more interesting, in terms of cell 
economy, there seems to be membrane recycling; in otherwords, 
the vesicle membrane that fused with the target seems to 
return to the plasma membrane where it came from in the 
first place which is very intriguing although the exact 
mechanisms are still obscure. 
Take the case of the frog's neuromuscular function; 
the coated vesicles have been shown to resorb membrane from 
presynaptic membrane for re-use after the secretion of 
acetylcholine by the synaptic vesicles. Evidence of this 
has been provided by studies of Hauser and Reese (1973). 
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The case whereby the endocytosed extracellular protein needs 
to be transferred, coated vesicles seem to subserve this 
function (Roth and Porter 1964, Friend and Farquahar 1967) 
particularly when sane protection against proteolysis whilst 
in transit is a critical factor for the intact functioning 
of that protein as in the case of transplacental immunoglo-
bulin transfer (Wild 1973, Brambell 1970). 
The dense coat which gives their characteristic appear-
ance has been shown to be due to polymers of a protein called 
clathrin. Pearse (1975, 1976), coined this name after 
studying coated vesicles from pigs' brain and devising a 
procedure for isolating them, and thereby being able to study 
the coat on sodium dodecyl polyacrylamide gels for molecular 
weight characterisation of clathrin. She found that whether 
the coated vesicles were derived from pig or bullock brains,or 
adrenal medulla (a secretory tissue) (Pearse 1976), a mole-
cular weight of 180,000 daltons was consistently 
obtained. Ockleford and Whyte 1977, and Pearse 1978, have 
extended the study to placental coated vesicles in which 
again 180,000 daltons molecular weight clathrin was obtained. 
Furthermore, Ockleford and ~unn 1980, Cckleford 1976, have 
considered how clathrin molecules come to form a co·at around 
the endocytosed bilipid plasma membrane. 'Figure 5 illust-
rates briefly this sequence. Ligand binding initiates a 
sequence of conformational changes and free clathrin ends 
up in polymerisation and forms· a 'coat' around the bilipid 
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layer, internal to which is the inner glycocalyx layer. 
A fuller discussion of these changes is reviewed by 0ckleford 
and Hhnn, 1980. The final shape of these dense 
clathrin coats is not spherical but form a lattice of poly-
gens due to molecular rearrangements; in particular hexagons 
coexisting with pentagons even on the same coat. The three 
dimensional construction of these shapes by electron micro-
scopy is discussed fully by Ockleford (1976). 
Quite apart from the intri.guing molecular conformation 
of coated vesicles, their supreme role lies,for the placenta 
in selective uptake of protein (Roth and Porter 1964). IgG 
has been detected in such micropinocytic vesicles (Lin 1980). 
Also transferrin bound on its receptor has been detected 
enclosed in coated vesicles by Booth and Wilson (1981), 
These authors reported a rather surprising phenomenon, in 
that transferrin protein was apparently the only one which 
could be detected still receptor bound. Within these vesi-
cles. There seemed to be no other serum proteins detected 
in these preparations from the material included within 
these vesicles. Evidently these other proteins are trans-
ported by coated vesicles, including well documented proteins 
with specific receptors on the placental microvilli plasma 
membrane. These are IgG (McNabb et al 1976), insulin 
(Whitsett and Lessurd 1978) and transcobalmin !!-vitamin B12 
complexes (Friedman et al 1977). For other plasma proteins, 
it is not clear whether receptors do exist, and hence the 
reason for the study in this thesis to find out whether other 
plasma proteins indeed possess receptors as a prelude to 
being·endocytosed. 
2.1 The trophoblastic plasma membrane. 
In many ways, from the foregone sections, some special 
properties of the trophoblastic membrane have been touched 
upon; these include the existence of microvilli, syncytio-
vascular membranes, receptors, coated vesicles and the 
syncytium with its specialised multinuclear appearance with 
single cytoplasm due to absence of cell walls. 
Under the above heading, it is intended to discuss 
more the biochemistry of the bilipid plasma membrane,_ late-
ral movements within this layer, and more about surface 
receptors. The latter, however, may fit in better in the 
next section whereby surface receptors are better regarded 
as simply part of the generalised discussion of 'antigens 
of "!;he plasma membrane ma·trix'. 
The double phospholipid layer of plasma membrane is 
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now a well proven entity for all systems of eukaryotic cell 
systems; the phosphate terminals being the hydrophilic ends, 
whilst the rest of the long 2-carbon skeletons of lipid 
components are the hydrophilic ends, and these face inwards. 
Another identical arrangement constitutes the bilayer. 
Protein molecules are randomly dispersed within this bilipid 
matrix. They either span the whole length of the bilayer 
or stop part of the way. The whole arrangement is fluid-like 
according to Singer and Nicholson's fluid-mosaic plasma 
membrane model (Singer_and Nicholson 1972). (see diagram, 
Fig. 6). This model is now widely accepted and in fact 
explains most of our available data on membrane structure. 
For receptor-studies, the most critical molecules are 
the proteins, some constituting antigens of all kind, HLA 
system, and receptors to a host of ligands. The fact that 
this is a dynamic fluid mod~l, these protein molecules are 
Polar groups 
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constantly changing positions. Their lateral movements are 
so rapid that a single molecule can change positions 
several hundred thousands of times within say a time scale 
of 5 seconds. Furthermore, the dynamic fluidity state can 
change into a quasi-static state· ar gel as a function of 
temperature. This phase transition being dependent also on 
the type of membrane lipids. For example lipids with more 
unsaturated bonds have lower transition temperatures than 
saturated ones, longer carbon chains have higher transition 
temperatures than short ones. In addi t ion,.Cis-unsaturated 
fatty acids have lower transition temperatures than trans-
forms. These phase transition with temperature considerat-
ions are extremely critical to consider whilst studying 
antigen-receptor binding, for if the operational temperature 
is not controlled, (usually all incubations are done at 0°C, 
ie. on ice) ,one can get a phenomenon of capping. 
Rere. as soon as the ligand binds to its receptor, 
aggregation occurs of other receptors ih the vicinity or even 
the far off ones, around the site of initial binding (Pernis 
et al 1970, Pinto De Silva 1972). One therefore gets uneven 
distribution, namely capping due to shifting of receptors 
to one spot;all made possible because of the fluidity state 
within which these receptors have vast lateral movements. 
This is minimised at 4°C (Munro 1975). The phenomenon of 
capping is not a metabolic one, but purely a physical react-
ion. It can be enhanced at high temperatures or blocked 
entirely by metabolic inhibitors (Taylor et al 1971). 
Eventually the capped area is internalised and when this 
occurs, it can result in a cell or membrane surface losing 
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or being stripped of an entire antigenic determinant (Boys.e 
et al 1967). 
Many systems have been observed to behave in this manner, 
for example immunoglobulin molecules on mouse lymphocytes 
(Taylor et al 1971) and human B-lymphocytes (LooT et al 
1972), cytophilic antibody on basophils and macrophages 
(Becker et al 1973, Ferranini et al 1973). In indirect immuno-
fluorescence or peroxidase methods used to detect antigens 
on cell surfaces or in the case of my placental receptor 
study, the antigen bound to its receptor- one is using 
antibodies, directed against these antigens as divalent rea-
gents. They are capable of multiple binding and enhance 
aggregation and hence capping. Therefore in my study and in all 
operations whilst looking for receptors against plasma 
protein antigens on the placenta, were carried out on ice 
(0°C) at all times to eliminate or minimise these possibilities 
which could disrupt topographical patterns. 
There are times when the apparently undesirable capping 
phenomenon, with its disruptive effect on antigenic distri-
bution, can be put to good use. For example when one seeks 
to know whether certain surface antigens are associated or 
related in their determinants, co-aggregation or co-capping 
upon use of the same reagents provides a useful clue. This 
has been used successfully to show lack of association between 
D and K regions of H-2 antigen in mice (Neauport et al 1972), 
as well as Ig antigen receptors and HLA antigen on B-lympho-
cytes (Taylor et al 1972). 
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2.2.1 Trophoblastic Antigens. 
One of the fundamental puzzles in immunology is how 
the placental homograft survives for nine months, with 
complete avoidance of rejection by the maternal immune system 
and yet have its circulatory system in intimate contiguity 
to that of the mother (Billington 1979, Billington et al 1975). 
Medawar (1953) has suggested that the mechanism is entirely 
immunological. McComick et al, 1971 were able to demonstrate 
the presence of IgG complement and fibrinogen particularly 
on the trophoblastic basement membrane (TBM) and were also 
able to elute the TBM-IgG. These eluates have subsquently 
been shown to inhibit several blastogenic reactions by human 
lymphocytes in culture (Faulk 1972, Faulk et al 1974). 
Consequently, these and other placental antigens are 
thought to be at the very heart of inducing immunological 
tolerance. Page-Faulk et al 1975 confined their research 
to immune-proteins, fibrillar proteins and contractile proteins, 
studied by both direct and indirect immunofluorescence. 
Immune-proteins like IgG, A, M, c3 and c4 were predominantly 
localised in trophoblasts and TBM. The stroma was negative 
for these reactions but areas of fibrinoid necrosis stained 
for fibrinogen, IgG and complement. These immune-proteins 
are specifically deposited on TBM and are of maternal origin 
(Faulk et al 1974). They inhibit blastogenic reactions of 
lymphocytes in vitro (Faulk et al 1973) and are therefore 
thought to contribute to the survival of the placental homo-
graft. It is also very likely that all these proteins possess 
receptors on the trophoblast for uptake. Contractile proteins, 
actin, act·inin, and meromyosin were localised in the tropho-
blasts and fibroblasts, whilst myosin, troponin and tropo-
myosin were found in the stroma. These contractile proteins 
are, as a whole, thought to subserve locomotion, endocytosis 
and exocytosis of cellular products (Allison 1973). These 
processes cause the formation of coated vesicles which in 
turn transport proteins and other substances. Fibrillar 
proteins on the other hand, namely collagen and fibrinogen 
were mainly in the stroma and TBM. Fibrinogen was very much 
associated with IgG areas lending some support that fibrinoid 
areas represent areas of immunological activity within the 
stroma. 
In general, intervillous fibrinoid areas represent 
degenerative changes in the cytotrophoblast most evident in 
placentae from diabetes, and pre-eclamptic toxaemia (Fox, 
1968). Concurrent finding of IgG, c1q, and c3 in both the 
first trimester and full term placenta (McComick et al 1971, 
Faulk et al 1980) might indicate that immunocomplex deposi-
tive might also result in fibrinoid necrosis. On the other 
hand, the finding of fibrinoid areas is not always linked to 
IgG in every case, whereas fibrinogen/fibrin, plasminogen, 
c(2macroglobulin, and c4 are consistently identified, signi-
fying that clotting proteins play a very vital role in 
maternal/foetal relationship, Furthermore, c( 2macroglo-
bulin, a protease inhibitor might inactivate plasminogen 
and cause poor formation of plasmin, a major initiator of 
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fibrinolysis, and so result in persistence or even an increase 
in fibrin deposits. Of the clotting proteins sought for 
receptor mediated uptake, only fibrinogen and thrombin will 
be considered in this study and will be discussed later. 
This might amplify on how fibrinogen possibly reaches the 
TBM or intravillous stroma:if it had a receptor on the nlasma 
membrane. 
2.2.2 Human· placental chorionic villar matrix - solubilisat-
ion of membrane antigens. 
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The extraordinary characteristics of the syncytiotro-
phoblast which allow the placenta homograft to survive maternal 
rejection have prompted various workers to search for reasons 
as to why and how nature has achieved such an immunological 
fit. The "why" is a complicated philosophical and teleolo-
gical question but one supposes that whatever the true answer, 
it is aimed at promoting reproduction and survival of the 
animal species. As to finding an answer to "how", an attempt 
has to be made to survey the function of the antigens which 
span the trophoblastic surface, which is the nearest we can 
get in answering this question (Whyte and Loke 1970, Billingham 
1964, McComick et al 1971). 
There are a number of approaches to topographing these 
surface antigens. One is to raise heterologous antisera to 
highly purified trophoblastic membrane and then use antisera 
directed to suspected antigens, as blocking antibodies which 
then inhibits the binding of the antitrophoblastic antisera, 
when re-applied. This technique has been used extensively 
by Page-Faulk et al (1975), Whyte and Loke (1979) and mention 
of the main findings will be detailed shortly. 
The second technique is more of biochemical analysis of 
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these antigens. Here the membrane antigens are solubilised 
either in 1% Triton-X100 or sodium deoxycholate which results 
in extraction of all membrane proteins. Thereafter analysiuR 
the immunological identity of the antigens by classical 
immunoelectrophoresis, Laurel! rocket electro-immunoassay, 
or the molecular weight profile on sodium dodecyl polyacry-
lamide gels (Ogbimi et al 1979, Whyte and Loke 1979, Ohno 
et al 1980). 
To go back to the first method, it is first of all 
essential that antisera raised against the trophoblast is 
specific and limited in its activity to the surface otherwise 
antigens picked up other than on the surface would simply 
confuse the picture. It is almost unanimously agreed that 
the trophoblast is immunogenic and when injected in hetero-
logous animals, antibodies with high specificity for only the 
surface are obtained (Whyte and Loke 1979, Beer, Billingham 
and Yang 1972, Rigby and Cursen 1969). Results of Whyte and 
Loke (ibid) for example, showed that when antisera to IgG, A, 
M, E, ~ 2microglobulin, o( 2macroglobulin, and transferrin 
we preincubated with placental tissue, there was no'blocking 
of fluorescence or peroxidase reactions when trophoblastic 
antiserum was subsquently applied (direct and indirect). This 
implied that there are still other antigen components other 
than those represented by the blocking antisera to which the 
original trophoblastic antibody is directed. Others believe 
that these could be partly··.due to a multi1Jlicity. of surface 
glycoproteins which are abundant on the placental .o·lasma 
membrane (Bradbury et.al 1970). 
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It was also found that secretory products of the placenta 
such as specific pregnancy protein (SP), human chorionic 
glycoprotein (hcG), and human placental lactogen contributed 
to the antigenic pool and stained the membrane. Also mono-
specific antisera to IgG, (probably maternal), IgM., and 
albumin reacted although weakly. These staining characte-
ristics for secretory products or other antigens were 
reminiscent of similar findings envisaged using the tropho-
blastic antiserum. Conclusion from these experiments imply 
that an array of antigenic components contribute to the total 
composition of antigenic determinants to which the tropho-
blastic antiserum is directed. 
By solubilising membrane antigens, Carlson et al (1976), 
first purified trophoblastic membrane fractions using 
differential and rate-zonal ultracentrifugation and then 
proceeded to identify the various glycoproteins after solubi-
lisation in 2% (W/V) sodium dodecyl sulphate. 1% Triton-X100 
or sodium deoxycholate has also been used for the same puroose 
by other workers (Ogbimi et al 1979, Ohno et al 1980). In 
Carlson et al's series, 16 major protein bands were obtained 
with molecular weight range of 20,000 to 330,000. Out of 
these, 10 bands stained with periodic acid shift, implying 
their glycoprotein subunits. These workers oointed·out that 
SDS-PAGE bands could be aT"te-facts ·of oroteolysi:s induced during" 
membrane purification. Therefore experiments were repeated 
in presence and absence of 1111M PMSF, (Phenyl methyl 
sulfonic fluoride), a protease inhibitor. 
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No qualitative change in band numbers were observed and 
identical results were obtained in four placentae. Other 
investigators have detected up to 21 discrete bands (Ogbimi 
et al 1979). :Most of these surface proteins remain largely 
unidentified in terms of function. 
2.2.3 Specific Placental Antigens or Proteins. 
Out of the array of surface antigens only a few have 
been successfully localised in ter~s of surface distribut-
ion (Page-Faulk et al 1977, Ogbimi et al 1980). Some of 
the proteins produced by the placenta are secreted into 
the maternal circulation and are therefore detectable in 
maternal serum. They are either pregnancy specific or 
associated for a simple reason that they are not seen out-
side pregnancy and are therefore products of the placenta. 
Hans Bohn and his group at Behring Institute, Marburg, West 
Germany, have been responsible recently for over 20 soluble 
placental tissue proteins; at least 11 protein antig~ns 
have been identified by immunochemical methods (Bohn 1973, 
1974, 1975, Bohnet al 1980, 1981). The pregnancy specific 
proteins have been designated SPs and three are of parti-
cular interest, namely SP1 , SP2 and SP3 . The twenty or so 
soluble proteins are called PPs (PP1 to PP2o) (Bohn 1982). 
SP1 is of molecular weight 90,000, a f., cglobulin and is 
also called pregnancy associated plasma protein C (PAPP-C). 
SP2 is also a ;3 1 globulin of molecular weight 65,000 but 
known as sex hormone binding globulin (SHBG), whilst SP 3 
is an o( 2 globulin with molecular weight 360,000 and 
synonymously called pregnancy associated. cx 2 glycoprotein 
( o< 2 PAG) or pregnancy associated Macroglobulin (PAM). 
These SP series are pregnancy related since they are only 
found in barely detectable amounts in normal serum, but 
attain strongly elevated levels in pregnancy. 
However only SP 1 is specific for pregnancy, whilst 
SP2 and SP3 are only associated due to the fact that high 
levels can be encountered in women taking contraceptives, 
in particular SP 2 turning out to be a sex hormone binding 
globulin. Therefore SP 1 is of some clinical usefulness in 
terms of early detection of pregnancy (Grudzinskas et al 
1977), intrauterine growth retardation (Gordon et al 1977), 
a tumour marker in relation to monitoring trophoblastic 
tumour disease (Seppala et al 1978). 
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Of the PP seri·es, they are largely unknown functionally, 
and only tentative function has been recently designated 
to some of them (Bohn 1982), namely PP2 as ferritin, an 
already known protein, PP5 as an inhibitor fo trypsin and 
plasma as well as complexing with heparin and hence a 
protease inhibitor of coagulation system importance (Obiekwe 
et al 1979, Salem et al 1980), whilst PP 7 is probably a 
glutathione reductase (Marcus et al 1978). PP15 has immuno-
suppressive effects on mixed lymphocytic cultures (Bohn 
1980) as well as exhibiting immunogenicity whilst trying 
to raise antisera to it. These studies have explored its i.rnruno-
suppressive capabilities. Seppala et al 1979 have reported 
clinically that PP5 might have a very important differentia-
ting role between pregnancy and invasive trophoblastic disease. 
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Here PP 5 is barely measurable in trophoblastic tumour, 
whilst SP1 and hCG are extremely high in both pregnancy and 
trophoblastic disease. 
Mention will now be made of one promisingly important 
pregnancy related protein and that is PAPP-A (pregnancy 
associated plasma protein-A). A Miami-Florida group led 
S,P. Halbert first isolated this protein in 1972 (Gall and 
Halbert 1972) as well as t~ other related, PAPP-B, PAPP-C, 
and PAPP-D .. PAPP-B remains half-forgotten, whilst PAPP-C 
is SP1 and PAPP-D is placental lactogen. Unfortunately 
this group withdrew from persuing the clinical correlation. 
The Aberdeen group under Klapper and others (Klapper 1982, 
Ahmad, Klapper and Toop 1981, Klapper et al 1977), have 
persued this clinical relationship. 
Klapper et al (ibid) found that PAPP-A levels unlike 
SP 1 , hCG or hPL, are unrelated to placental weight and 
growth in terms of lack of characteristic increasing levels 
which taper off near term. This even led to speculation 
that PAPP-A is probably a non placental protein. PAPP-A is 
an 0( 2· macroglobulin with MW = 750,000 a~cording to the data 
by Bischof (Bischof et al 1979). A break-through came from 
the Aberdeen group who found that PAPP-A was not only 
significantly raised in preeclamptic taxaemia of pregnancy, 
but that it was even more pronounced if preeclampsia occurred 
early in pregnancy. Hence a possibility of putting PAPP-A 
to use as an early warning signal for the advent of overt 
disease. The striking similarity of PAPP-A to 0( 2 macro-
globulin, a serum protease inhibitor is more than a passing 
coincidence. They have comparable molecular weights, 
0( 2 mobility and protease inhibitory roles as PAPP-A has 
been shown to inhibit plasmin (Bischof 1979). All these 
put together lend support to PAPP-A as a possible serine 
protease inhibitor. 
2. ·3. 1 Immunoregulation of Placental/Foetal Antigens. 
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The subject of the immunologically '_previleged '· 
position of the placental homograft and the possible mediat-
ion of this by its extraordinary plasma membrane have been 
touched upon tn preceding sections. Historically this 
'previleged'' position which we know now to be due to its 
elusion of both humoral and cell mediated responses, was 
recognised by Little (Little 1924) as early as 1924. In 
modern terms this has been explained away through its 
possible lack of foetal/placental HLA, B, C, and D histo-
compatability antigens as implied in Little's quotation: 
"Under a condition in which the embryo has no definite 
physiological characteristics which are individual enough 
to be recognised as foreign by the mother"; whilst this 
statement might be true or even make sense, histocompata-
bility antigens do in fact appear during the immediate pre-
implantation cleavage of mouse embryos (Miggleton et al 
1976). 
The picture is complicated by evidence of a further 
differential expression of both the major and minor histo-
compatability antigens following post-implantation and 
embryonic development (Sellens 1977, Sellens et al 1978). 
Since these antigens are present, failure to reject them 
must be due to regulatory factors and speculation has 
ranged from hormones such as hCG, hP l·, J7TDlactin, oest ro-
gens, pregnancy associated proteins and glycoproteins 
including o( 1 fet oprotein (Gus don 1976, Murgita 1976). 
Whatever the mechanisms of these non-specific factors, 
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they must in some way affect lymphocyte, afferent and 
effector functions to stop their adverse rejection sequelae 
by the way of initiating immunosuppression (Howe 1975) as 
tested in vitro and laboratory animals (Beer 1979). The 
role of hCG in particular, is interesting. It has been 
postulated that high secretions of hCG by the trophoblast 
could affect lymphocytes functionally or hinder them steri-
cally from attacking trophoblastic antigens (Adcock et al 
1973). loke et al have found a protein of MW 49,000 and 
pi = 4.2 integrated in the isolated and purified tropho-
blastic membrane, and which showed homology with samples 
of hCG in polyacrylamide gel electrophoresis and isoelectro-
focussing. They postulated that membrane integrated hCG 
may alter protein conformation of other surface antigens 
and thus modify their immunogenicity to the mother (Loke 
et al 1970). 
The effect of PP15 and the other newly isolated preg-
nancy associated glycoproteins in immunoregulation is not 
yet thoroughly explored. 
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2.(:1.2 Specific Immun·oregulators. 
The array of various factors outlined above are non-
specific regulators in the immunological survival of the 
placenta. Whatever their role, they have in the final 
analysis to affect,influence or modify the specific effectors 
of immunological reaction namely, the lymphocytes and 
humoral antibodies of the mother. It has been postulated 
that an antibody binds on the target antigens in a non 
cytotoxic way and thus prevent the host's immunocompetent 
lymphocytes from mounting a rejection. Current view is 
not in favour of this mode of action but that free antigen 
or antigen-antibody complexes block both the target anti-
gens as well as the lymphocytic receptors and thereby prevent 
rejection (Price et al 1978). This is called immunological 
enhancement. The role of a subclass of lymphcytes, called 
the suppression T-cells, have also been found to play some 
role in modifying or inactivating primed maternal lympho-
·cytes which would otherwise attack the placental antigens 
(Billington 1979). These T-cells have been detected in 
neonatal umblical cord blood (Skowron-Cendrzak et al 1976) 
and there is mounting evidence that lymphocytes can be 
filtered from mother to the foetus by the placenta (Adinolfi 
1970' 1979). 
3.1 Foetal Chtogeny and Plasma Proteins transfer or synthesis. 
In determining as to whether the foetus, which has 
immature synthetic systems, has to import all its serum 
plasma proteins as it were from mother, one has to test for 
its protein synthetic potential at various gestations. 
This can clear some mist with regard to whether inspite 
of immaturity of systems, some of the plasma proteins are 
synthesised by foetal organs. 
Gitlin and co-workers have addressed themselves to 
the task of culturing various foetal organs to test their 
synthetic capability (Gitlin and Biasucci 1969). They 
tested for ~G, ~M, ~A immunoglobulins, c 1 esterase 
inhibitor, hemopexin, haptoglobulin, fibrinogen, plasmino-
gen, o( 1 anti trypsin, orosomucoid, ~ -lipoprotein, 
C>( 2 macroglobulin and pre- albumin. They were studied in 
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15 embryos and foetasus of 29 days to 18 weeks. In addition 
they studied york sacs of 4 selected embryos. Organs such 
as livers, spleens, thymuses were minced and incubated 
with 14c-amino acids and the incubation media were tested 
for the specific proteins by autoradiography of immuno-
electrophoresed samples. They concluded that the human 
embryos as early as 29 days synthesised c 1 esterase inhi-
bitor, transferrin, hemopexin, o(1 antitrypsin, ~-lipo­
protein, o( 2 macroglobulin and pre-albumin in culture. 
At 32 days caeruloplasmin and orosomucoid were synthesised 
but fibrinogen synthesis was not detectable before 5.5 weeks. 
~ M and ¥G were synthesised after 10.5 weeks and 12 weeks 
gestation respectively. A synthesis was not detectable 
in any of the cultures. ¥G synthesis was highest in the 
spleen for 17 to 18 week foetuses although other sites were 
noted. They then studied serum concentrations of proteins. 
tG changed from 0.52 g/1 (5,5 weeks) and 1,8 gfl (22 weeks), 
to 7 gjl (26 weeks) and 14 g/1 ( 40 weeks), 't M was hardly 
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detectable, ~A, whilst undetectable early on, but near 
or at term it was detectable. Either the foetus acquires 
the capacity to synthesise this protein or else the placenta 
becomes permeable to the protein (Stielm et al 1966). A 
few words will now be said about each of a selected list 
of plasma proteins. 
Caeruloplasmin. 
Synthesis of this protein was not evident in any other 
organ except the liver cultures and from 4.5 weeks,embryo's 
serum levels change from 4 mg/1 (6.5 weeks) to 46 mg/1 at 
27 weeks and 155 mg/~ at term. There is a sharp drop post-
natally probably due to an·oestrogen drop which normally 
stimulates the· synthesis of this protein (Gitlin and Biasucci 
1969). Transplacental transfer mechanism, if any, is unknown. 
o< 2 macroglobulin. 
This is synthesised predominantly by the foetal liver, 
although Adinolfi(1971l disputed this by suggesting that 
the apparent radiolabelling of the protein in cultures is 
simply picked up through radiolabelling of other proteins. 
However, Gitlin et al 1969 had earlier shown that radioactive 
hydrolytic peptides corresponded to those of unlabelled 
~ 2 macroglobulin. Serum levels in conceptus rises expone-
ntially from 17% of adult level (14 weeks) to 1sor of adult 
level at 30 weeks. 
Haptoglobulin. 
Serum levels are quite low,namely 1 - 2.7% of mean 
adult level for 7.5 to 41 weeks foetuses. Post-natal synthesis 
is quite rapid. Low antenatal levels are thought to be due 
to haemolysis or increased catabolism of this protein. 
Phenotypes however show a mixture of maternal and foetal 
origins (Hirschfeld and Lunell 1962). The mode of trans-
placental transfer is unknown. 
Hemopexin. 
Hepatic and lung synthesis have been observed (Gitlin 
et al 1969) and serum conceptus levels start at 10 weeks 
at 1% of adult level to 30% at term and continue to rise, 
rather than fall in the immediate post natal period. 
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Maternal levels are 1.5 times higher than non-pregnant levels. 
0(1 acid glycoprotein. 
Hepatic synthesis starts at 4.5 weeks of gestation and 
reaches 32% of adult levels at term. o( 1 acid glycoprotein 
crosses the placenta from mother to foetus by process of 
first order kinetics (Gitlin et al 1964), and so a proport-
ion of foetal concentrations is from mother. Mother's 
o( 1 acid glycoprotein is only 72% of non-pregnant levels 
and Laurell and Skanse (1963) have suggested this to be 
an oestrogen effect. Whether active receptor mediated 
transport exists is not clear. However, Johnson et al 1974 
have showed that 0( 1 acid glycoprotein in amniotic fluid 
shows phenotypes of maternal origin. 
o( 1 antitrypsin. 
The liver is the principal foetal synthetic site begin-
ning as early as 4 weeks (Gitlin et al 1969), M 6 weeks 
------------
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only 6,5% of adult level is attained, 70% of adult level 
is rapidly reached by 9.5 to 10.5 weeks and between 27 weeks 
to term levels between 110 - 175% of adult level are attained. 
Correspondingly maternal levels are around 200% of non-
pregnant levels (Gourot and Bjerre 1967). Some is probably 
transferred from mother, though the mechanism is not clear 
(Gitlin and Gitlin 1975). Nonetheless, phenotypes are not 
only ~hat of the mother,suggesting foetal synthesis (Adinolfi 
1971). However, whatever stimulates the very high maternal 
and foetal levels way above adult levels could be oestrogens 
stimulating on both maternal and foetal sides. 
Gc-globulin. 
Gc-components or glycoprotein was discovered by Hirsch-
feld in 1959 and subject to inheritoblic polymorphic 
forms synthesised primarily by the liver. Its recently 
discovered function is that of vitamin D binding and trans-
port (Review by Reinskou 1968). There is evidence of 
maternal origin in both foetal serum and amniotic fluid 
(Johnson 1974), but the transplacental modality is unknown 
and hence the interest of this protein together with several 
others in my study, as will be seen later on in examining 
receptor mediated uptake. Gc is synthesised by foetal liver 
at 4 weeks and rises to 70 mgfl at 12 weeks and to 230 mg/1 
at term (Gitlin et al 1969). Maternal level is twice this 
figure at 460 mg/1 (Toivanen et al 1969). 
Fibrinogen, 
Synthesis of this protein starts at 5,5 weeks in the 
liver. There is evidence to show that maternal transfer 
takes place although the rate of transfer is very small. 
At term foetal serum levels average 70% of adult level. 
Clotting proteins, including thrombin, plasminogen, and 
esterase inhibitors are important in placental physiology 
and it is just possible that transplacental passage of 
these proteins is carrier mediated as will be discussed 
later in this report. 
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CHAPTER 2 
MATER! ALS AND METHODS 
General Methods. 
Under this heading the following will be discussed; 
trophoblastic membrane purification, protein assay methods, 
radiolabelling techniques, filtration techniques for separat-
ion of bound from free radioactivity in radioreceptor assays. 
Other more specific methods will be mentioned in the respec-
tive chapters dealing with specific areas such as immuno-
cytological methods, namely immunofluorescence and peroxi-
• dase study, and colloidal gold labelling of various proteins 
to obtain useful electron microscopic probes for following 
protein transport across the trophoblast. Furthermore, 
methods pertinent to transfer studies such as perfusion tech-
nique will likewise be mentioned in that study. 
Purifi·cation of Trophoblastic membrane 
1. 1 Overview 
In order to examine events occurring at membrane level, 
it is imperative to study these not only under in vivo 
conditions, but more subtle mechanisms can be· unravelled 
if purified plasma membrane is obtained and then incubated 
with radiolabelled protein ligands. To isolate the tropho-
blastic membrane a number of methods have been used differ-
ing in detail but all apparently yielding reasonably purified 
syncytiotrophoblastic microvillar plasma membrane (StMPM) 
(Ogbimi et al 1979, Whyte and Loke 1970, Johnson and Brown 
1980, Carlson et al 1976). All these methods involve some 
means of grinding up cut pieces of the placenta to release 
villi and thereafter disrupt their membrane by osmotic 
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shock (Smith et al. 1974) or by mechanical homogenisation using 
various tissue grinders such as the MSE homogeniser or 
Ultra-rrurrax, or even the more gentle, Dounce glass homoge-
nisers,to mention a few that have been used. Thereafter 
pooled homogenates are sequentially filtered through either 
one coarse nylon mesh cloth and then a finer one to get rid 
of large pieces and debris. Then the uniform microvillar 
preparations are subjected to differential ultracentrifugat-
ion either with or without sucrose gradients. This differe-
ntially gets rid of nuclei, microsomes, mitochondria, cytosol, 
and other cellular material in various fractions which are 
discarded, to leave an StMPM fraction greatly enriched in 
plasma membrane. 
Some workers usually test for purity of fractions of 
interest with various enzyme markers which characterise 
various subcellular fractions; for example alkaline phospha-
tase and 5' nucleotidase are good markers of plasma membrane 
fractions (Martin and Spicer 1974). Isocitrate dehydroge-
nase is a marker of cytoplasmic membrane (Carlson et al 
1976) such as that of mitochondria, DPNH diaphorase as 
endoplasmic reticulum marker (Steck et al 1970) and aryl 
sulphatase as a lysosomal marker. Often viewing the final 
membrane by light microscopy or phase contrast gives some 
rough indication of enrichment. Better still, the electron 
microscopic visualisation offers a more refined view. 
On the initial steps, it is always wise to dissect off 
the chorionic membranes before grinding, wash the placenta 
free of blood in a suitable buffer, and very often add 
EDTA and a protease inhibitor such as phenyl 
sulphoric fluoride to stop proteolysis. All operations 
should be carried out on ice or at 4°C and avoid any pro-
longed manipulations at room temperature. 
Ogbimi et al (1979), have combined the cold saline 
extraction of microvillar membrane method of Smith et al 
(1974) which they slightly modified and then further puri-
fied these St~ by phase centrifugation method of Hourani 
et al (1973). Electron microscopic visualisation showed 
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by and large the preparations had membrane with plenty of 
microvilli projections. They also noticed some limited 
contamination by mitochondria and occasionally lysosomal 
structures. Hydroxyproline assays revealed no significant 
content of this enzyme and hence freedom of the membrane 
pellet from collagen contamination. These workers have also 
noted a marked absence of f!, 2 microglobulin from solubili-
zed fractions in contrast to other cellular membranes and 
hence suggested that absence of fo 2 microglobulin in St"MPM 
could be a further marker of lack of contamination by other 
membranes. Furthermore they reacted lectins with the 
soluble fraction and found strong and the only reactivity 
to wheat germ agglutinin. They noted a high carbohydrate 
content (240 pg/mg total protein). They also suggested 
that immobilised supports containing this lectin, wheat 
germ agglutinin, can be a powerful adjunct in further memb-
rane purification to already existing methods. 
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1.2 Purification Procedure Adopted in this Study. 
Smith's original method (Smith et al 1974) to which other 
workers have subsquently added modifications is essentially 
based on his observation that when microvilli are exposed 
to cold 0.9% saline they pinch off and can be collected and 
then membrane is purified thereafter. This method has the 
advantage of minimising contamination from other types of 
intracellular membranes inherent in the use of more disrup-
tive homogenisation methods which use various blenders and 
tissue of grinders. Smith's method nonetheless requires 
cutting up the placenta into tiny pieces or the whole tissue 
is minced to start with and before the start of saline extra-
ction which inevitably still leads to the same problem of 
contamination. 
Booth et al 1980, have recently devised and published 
a purification method based on that of Smith but with 
improvements and modifications. Here the non-microvillar 
plasma membrane if present, is preferentially aggregated 
b M 2+ . Y g J.ons. They have tested its yield, in terms of 
specific activities, enzyme markers, electron microspically 
and f.l 2microglobulin content. Marked enrichment with 
membrane was achieved as exemplified by the ratio of final 
fraction to starting homogenate of 24:1 for alkaline phos-
phatase and 23.8:1 for 5' nucleotidase, both plasma membrane 
markers. For similar fractions, enrichment ratios were 
not significant for succinate dehydrogenase and NADPH-cyto-
chrome C reductase which were not detected at all in the final 
fraction, whilst in a step before the application of Mg2+ ions, there 
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were enrichments of 0. 51 and L 1 fold respectively. This 
Mg2+ confirmed the efficacy of in eliminating mitochondrial 
contaminants in the final membrane pellet. Booth et al's 
purification procedure was so detailed ~nd seemed to be well 
vindicated. Consequently I have adopted their protocal 
step by step in preparation of StMPM and subsquently using 
these preparations for all radioreceptor assays as well as 
immunocytochemical methods in my attempts to study placental 
receptors to some plasma proteins of interest. 
1.3 Placenta and Processing Procedure. 
These were obtained from the Department of Obstetrics 
and Gynaecology labour ward at the Leicester Royal Infirmary. 
Placentae were from either elective caesarean or full term 
spontaneous deliveries. All placentae were given a quick 
wash with cold phosphate buffered saline pH 7.4 and trans-
ported to the laboratory on ice. Chorionic membranes were 
dissected off and blood vessels on the foetal surface were 
scraped off and then the whole placenta was cut into 15-20g 
pieces. These were minced using an MSE homog~1iser (MSE 
Scientific Instruments, Crawley, West Sussex, England), with 
100 ml glass container fitted into a Bakelite container. 
40 mls of 0.15M NaCl were added to each 15-20g placental 
pieces and the MSE homogeniser was worked in 4-5, 3 minute 
bursts at half-maximal speed until the whole placenta was 
homogenised. 
600 - 1000 ml of pooled homogenate was filtered through 
a fine mesh nylon gause to remove large particles. All 
solutions and buffers contained 2mM phenyl methyl sulphonic 
fluoride to inhibit proteolysis. The filtered homogenate 
was taken through all stages as outlined in the f·ollowing 
flow-chart. (See Fig. 7 ) . 
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The OTD-65 r-~frigerated ultracentrifuge (DuPont Instru-
ments) set at 4°C and using a T.865 constant angle rotor was 
used for the 90,000g spin for 30 minutes to the final 15,000g 
spin for 30 minutes. :Fbr the initial spins at 800g for 10 
minutes and lO,OOOg for 10 minutes, the Sorvall R C-5B (DuPont 
Instruments) ultracentrifuge was used with a GSA rotor which 
could spin large volumes of say 250 ml per polycarbonate 
container (six in all on the GSA rotor) once again set at 4°C. 
The final pellet was then suspended in 50mM Tris-HCl pH 
7. 4 buffer to give 5 mg of protein per ml or ·at other times 
3 - 4 mls of buffer were added to the final pellet and vorte-
xed then stored at -20°C till required. Fxesh unfixed fract-
ions P3 , P·4 and P5 (see line diagrams in Fig. 7) were 
examined by light microscopy and also using phase contrast· 
Normarski optics (Allen, David and Normarski 1969) fitted to 
a universal microscope (Carl-Zeiss). Eigure 8 shows 
fractions P 3 , P 4 and P5 , whilst figure 9 shows the Normar-
ski contrast optics for viewing the same P 3 , P 4 and P 5 fract-
ions. In these fresh unfixed preparations the change from 
heterogenous to homogeneous appearance as one examines fract-
ions P3 to P5 , particularly with Normarski enhancement signi-
fies a good final yield of plasma membrane enriched fractions 
(microvillar membranes seen as short uniform dark projections 
throughout the field). 
4°c Centrifuge x 800g 10 min. 
PELLEl' SUPERNATANr 
4°C Centrifuge 10,000g 10 min. 
SUPERNATANr 
4°C Centrifuge 90,000g 30 min. 
SUPERNATANr 
( discard ) 
PELI.El' [§] 
• 
suspended in 50 ml of 10mM-mannitol, 2mM 
TRIS-HCl pH 7. 1 with aid of loose fi tt in~ 
D::>unce hO!Jl)geniser to give fraction (P3). 
e Solid ll.gCl26H2o added to 10rrM concentration 
stirred occassionally for 10 minutes on ice. 
4° Centrifuge 2200g 12 min. 
PELI.El' ~ SUPERNATANr 
4°C Centrifuge 15000g 
FINAL PELLET jP5 j 
Fig. 7 
30 min. 
SUPERNATANr 
(discard) 
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Fig. 8 
This shows Fractions P 3 , P4 and P5 ; sequential purificat-
ion of placental trophoblastic membrane as per purification 
schedule in Fig. 7. At the indicated stages unfixed portions 
w~·re examined on a slide with a Carl-Zeiss microscope. 
shows dilute heterogenous preparation, which transforms into 
a more concentrated but homogenous pieces of membrane showing 
as dark spots throughout the field. ( Magnification .x 110 ) 
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Fig. 8 
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Fig. 9 
As in Fig. 8, the same P 3 , P4 , and P 5 membrane purificat-
ion stages are shown again in an unfixed state using Normarski 
interference contrast microscopy fitted to a photomicroscope 
(Carl-Zeiss). 
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Electron microscopy of each fixed piece of P3 , p4 and 
the final pellet are shown in Figures lOa to lOc. P 's 
--3 ' 
the 90,000g pellets and prior to M 2+ g addition are shown in 
Figure lOa. This figure shows bits of microvilli which 
appear as rod-like, rounded and sometimes dumb-belled struc-
tures depending on the plane of view. However, there is 
also marked contamination of other vesicular and much bigger 
membrane structures are seen in the central fields of view 
in each of these photographs. P5 •s the final pellets are 
shown in Figure lOc. In this figure the surface of StMPM 
is seen with microvilli and plenty of micropinocytic vesicles 
in the syncytium and a foetal blood vessel with a red blood 
cell, whilst Figure lOb shows again the surface of StMPM 
with microvilli. 
The protein content of StMPM pellet in order to standar-
dise amounts pipetted in radioreceptor assay incubations, 
were determined by the modified micro Lowry and Bio-Rad protein 
assay methods. 
Protein Assay Methods. 
2.1 Micro-Lowry technique. 
The Lowry protein assay method (Lowry et al 1951) in 
principle involves the use of folin-ciocatteu's reagent 
(phosphomolybdic tungstic acid), with the phenolic tyrosine 
residues in a protein to give a blue colour. Micromodifica-
tions have been made to assay proteins at microgram level. 
( Protein ) 
Tyrosine 
+ Phosphomolybdi~ Blue 
tungstic acid ---)ojo colour 
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Figs. 1 0 ( a) , ( b ) and ( c ) . 
Transmission electron micrographs of membrane purificat-
ion stages P3 , P4 , and P 5 . Fig. lO(a) shows impure membrane 
pieces with rod-like microvilli, and at times circular depend-
ing on the plane of sectioning. Fig. lO(b) shows the limiting 
membrane surface with finger-like microvilli projections 
extending out into the maternal intervillous space from where 
nutrients are absorbed. 
Fig. lO(c) again shows microvilli on the syncytiotropho-
blast in the bottom half of the photograph. A multiplicity 
of rounded vesicles are seen scattered through the syncytium. 
In the top half is a semi-lunar·wall of a foetal vessel with 
a dense body in the centre (Red blood cell). This arrange-
ment, the contiguity of a blood vessel to the absorptive micro-
villi ensures rapid transfer of nutrients and proteins to the 
foetus. 
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Fi~.lO(a) 
Fi£.10(b) 
Fig.10(c) 
This method is not sensitive in presence of other phenol 
containing compounds. As regards assaying membrane protein, 
modifications have to be made. 
Soluble membrane protein is extracted by reacting the 
StMPM with 1M NaOH at 37°C for 2 hours, constantly stirring 
the incubation mixture every 15 minutes. Some proteins are 
then solubilised,others are not, and one has got to make a 
reasonable assumption that more membrane protein is substa-
ntially extracted. In the Micro-Lowry technique optimal pH 
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is necessary for the Folin-ciocalteu's reaction. 1M NaOH 
hydroxide in solubilised membrane protein mixture would greatly 
alter the sensitivity of the assay and so neutralisation of 
NaOH with 3M HCl is carried out. The following protocol was 
followed: 
MODIFIED LOWRY PRai'EIN ESTIMATION ADAPTED FOR DETERMINATION 
OF MEMBRANE PROTEINS IN 1M NaOH. 
Because the various colour development steps are sensitive 
to pH changes the presence of 1M NaOH in the sample shifts 
the reaction pH away from its optimum. By nertralising the 
excess alkali with acid, the buffers in the reagents> can 
control the pH balance effectively. 
STOCK SOLUTIONS 
a. 1M NaOH 
b. 3M HCl 
c, Sodium Carbonate 
d. Copper Sulphate 
40g/l 
Concentrated HCl is 11M, so 3. 6 m1 
Cone. HCl is made up to llm!with water. 
2g anhydrous N~COJ per 100 m1 water. 
1g euso4 .5~0 per 100 m1 water, 
sro::x soumCNS Cont'd 
e. Soditm1 Tartrate 
f. Bovine SertmJ Albumin 
2g (OI(ai).OXNa)2. ~0 per 
100 ml water. 
4.58 ~ BSA/ml dissolved in 1M 
NaOI (Store at -20°C) 
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N.B. Takes about 1 hour to dissolve 
at roan temperature. 
g. Folin Ciocalteu's Reagent 
REAGENTS. 
Folin A 
Folin B 
MErnrn. 
Add 1 ml of d) and 1 ml of e) to 
100 ml of c) (need 25 ml for 10 
assays). Mix and prepare daily. 
Dilute 1:1 with water (need 2.5 ml 
for 10 assays). 
1. Place a piece of liEIIi:>rane pellet in 1ml 1M NaOI in a sealed tube 
and incubate at 37°C for 2 hours, whirlimixing every 
10-15 minutes. 
2. Add 0.145ml 3M HCl and mix. 
3. Take 2 x 0.5ml aliquots into 9ml plastic tubes. 
4. Add 2.5ml Folin A to each tube and leave at room tempera-
ture for 20 minutes. 
5. Add 0. 25ml Folin B and :M1X IMMEDIATELY after each tube. 
(Seconds delay diminishes colour reaction). 
6. Leave at room temperature for 45 minutes and read absor-
bance at 750nm against a distilled water blank. 
STANDARDS 
Take 0 - 50 Fl (in 10 pl aliquots) of BSA Stock Solution 
and make up to lml with 1M NaOH. 
Then proceed as from Stage 2 above. 
The resultant amounts of standard protein in the 0.5ml will 
then range between 0 and 100 ug BSA. 
Draw a standard curve (a straight line going through the 
origin) as shown in the graph. From the gradient one can 
calculate ·from y = a + bx, the amount of protein per ul of 
membrane: 
pg PROTEIN PER )11 OF MEMBRANE c X 2.29 = 
GRADIENT 
where c = corrected absorbance ( observed - blank) 
blank = 0Fl BSA in standards 
2.29 = 0.5ml sample from 1.145ml total. 
2.2 Bio-Rad protein assay procedure. 
The Bio-Rad protein assay is a dye binding assay based 
on the differential colour change to various concentrations 
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of protein. Here the principle is based on the observation 
that absorbance for an acidic solution of Coomassie blue G-250 
shifts from 465 nm to 595 n~ when binding to protein occurs 
(Bradford 1976). It is found that the extinction coeffi-
cient· of dye-albumin complex was constant over a 10-fold 
concentration range and thus Beer's Law was obeyed. The 
beauty of this Bio-Rad method is in that essentially one 
reagent is required and five minutes to perform as compared 
tothree or more reagents and almost 1 hour in the micro-
Lowry method and yet the sensitivity is comperable at lug 
protein. Furthermore, chemical interference is very slight 
compared to the Lowry method where big effects are noted. 
Standard Assay Procedure 
Range_20- 140 pg protein. 
Prepare several dilutions of protein standard supplied in 
the kit such that a range of 0.2 - 1.4 mg/ml is covered 
and then; 
1. Place 0.1 ml of standards and appropriately diluted 
samples in clean dry test tubes. Place 0.1 ml sample 
buffer (supplied) in blank test tube. 
2. Add 5.0 ml of diluted dye reagent (1:4 ratio of dye 
to deionised water). 
3. Vortex or mix several times. 
4. After 5 minutes to 1 hour measure OD595 versus 
reagent blank. 
5. Plot on595 versus concentration of standards - read 
unknowns therefrom. 
Both the standard curves for the Lowry micro method and the 
Bio-Rad assays with respect to assaying membrane protein 
are shown in Figures 11 and 12 respectively. 
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Example Comparison of two methods in accurately estimating 
membrane protein concentration. 
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Fig. 11; A typical standard curve using ~odifiect micro-Lowry 
protein assay capable of ll'easuring 0-110 ,Pg of protein. 
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Fig. 12; A typical standard curve for assaying membrane protein 
using a Bio-Rad rricro-assay. This is based on maxi-
mum absorption at 595 nm when an acid extract of 
Coomasie-Blue G250 dye combines \Vi th protein. Sensi-
tivity is comparable to micro-Lowry. 
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Micro Lowry method 
5ul of StMP~ extracted solution 
Mean absorbance at 750nm duplicated = 0.447 
Gradient of standard curve = 0.50 X 10-2 
(ug) Membrane .protein in 5ul StMPM = 0.447 
10-2 
X 2.29 
0.50 X 
= 202. 06)lg 
whence 
1ul = 40.40pg 
Bio-Rad method 
Same membrane used and; 
Mean absorbance at 595run of duplicates = 0.978 
Corresponding to (0.1 ml sample) = 169.5pg 
The reaction volume was made up of (0.5ml of 1M NaOH + 
73pl 3M HCl + 25~1 StMPM), 
giving a total volume = 598pl giving 
Protein dilution of 25/598 
Thus 100pl of 25/598 dilution of StMPM = 169.5pg 
Therefore 100pl of undiluted StMPM = 598 
-- X 169. 5pg 
25 
or 4054. 44pg 
and so lpl of StMPM = 40. 54pg 
Therefore both methods reliably gave identical results, the 
Bio-Rad being a much simpler one to use. Furthermore the 
' 
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Bio-Rad procedure could be adjusted to span a range of 
1 - 20 pg/ml, by not diluting the dye concentrate supplied 
(0.2 ml of it used) and adding 0.8 ml of standards or samples 
in Step 1, instead of 0.1 ml. The rest of the procedure is 
unaltered, this allowed assay of chromatography elution 
fractions of tritium labelled proteins to be measured where 
possible, namely where one used lmg or more of protein to 
the labelling procedure otherwise other methods were used 
to calculate protein incorporation and from amounts used, 
the specific activities could be calculated. 
Radiolabelling procedure for producing various tritiated 
protein ligand derivatives. 
3.1 Preparation of reagents. 
a) 0.1M Borate buffer was made as follows: 
Boric acid 6.18gm 
Sodium tetraborate 9.5gm 
Sodium 'chloride 4. 38gm 
make up to 1000 mls with distilled water 
and adjust pH to 8.5 with HCl. 
b) Protein sample 
1mg of each protein was weighed out and added to 
20 pl of 0.1M borate buffer pH 8.5 in a plastic 
vial previously coated with gelatin (see prepaPation 
of column buffer). 
c) Glycine stop solution. 
0.2M glycine was made up in 0.1M borate buffer 
pH 8.5 (0.15g of glycine per 10 ml of borate buffer). 
3.2 Preparation of column for separation of labelled and 
unlabelled IgG-H 3 
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a) Pump speed and delay; using an LKB 2120 vario perpex II 
pump the optimum speed was found to be 1.4. This did 
not compact the column or force air bubbles through it. 
An air bubble was used to measure the delay between 
the UV monitor and the fraction collector. Therefore 
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the number of drops counted between recorder deflection, 
when the bubble passes the UV monitor and reaching 
the dropper is the delay which was 40 drops. Therefore 
fraction collector was set at 20 drops and delay at 
20 drops. 
b) Column buffer 
Phosphate buffer was made up as follows: 
(i) Stock Solution A 
0.2M sodium dihydrogen orthophosphate. 
(ii) Stock Solution B 
0.2M Disodium hydrogen orthophosphate 
anhydrous (MW = 141.96). Hydrous form (MW 177.99). 
Column buffer was therefore made from 20 ml of solution.A 
added to 80 mls of solution B adjusted pH= 7.5, and this 
gave a 0.05M phosphate buffer, pH 7.5. To 50 mls of this 
0.125g of Gelatin was added. The latter was to minimise 
non-specific protein adsorption of the sample containing 
tritiated protein to the column. 
3.3 Preparation of column LKB-K9 column 
1gm of Sephadex G-50 fine was added to 
20 mls of 0.05M phosphate buffer pH 7.5, with 0.25% gelatin, 
and allowed to swell overnight at room temperature. The 
gel was poured on to the K9 column and allowed to settle. 
3.4 Radiolabelling procedure 
250 pl of N-Succinimidyl (2,3 - H3 ) propionate (NSP) 
(Radiochemical Centre Amersham Product, Code TRK 556) were 
added to a conical glass test tube. A jet of N2 blowing 
gently through a fine glass pipette (Bilbao pipettes) was 
used to dry off the toluene solvent. The glass test tube 
had already been placed on ice (0°C) and then various 
amounts of protein (see table for exact amounts as per the 
desired NSPfprotein ratiQ ) previously dissolved in 20 pl 
of borate buffer pH 8.5, were reacted with dry NSP for 15 
minutes. The reaction was stopped by addition of 500 pl 
of 0.2M glycine. Figure 13 shows the essentials of the 
protein labelling reaction. 
Separation of labelled protein. 
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The radioactive protein sample was applied to the Sepha-
dex G-50 column and run through at 1.9 ml fraction (20 drops 
per tube). Absorbance was monitored at 280 nm for column 
elution fractions. If they did not register any appreciable 
deflection, .tt was sufficient to monitor the radioactivity 
alone. Fractions were counted by aliquoting 20 pl of each 
tube in 5 ml Fisofluor I (Fisons, Loughborough, Leicestershire), 
and then counting in a Tricarb liquid scintillation spectro-
meter. 
Control. 
Each cold (non.:.labelled protein) at the same concentrat-
ion as the labelled one was added to the 0.05M phosphate 
buffer pH 7.5 and then run through the column monitoring 
* 
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the elution fractions as before. This confi:nred where the 
protein peaks were located in CCfl'!larisori to the protein an!i g-lycine 
peaks when labelled proteins were separated. I I This cold 
control also helped in setting the amplitude of the deflect-
ion expected from a 1mg protein on to the chart recorder. 
Settings on l.KB 2120 fraction collector were as follows: 
Absorbance Range 0.1 
Chart speed 0.1mm/sec 
Log scale 100mV 
Linear scale 50 !!IV 
Flow rate 20 drops/tube 
Table 2 gives NSP/protein ratio and amount utilised 
in 20 pl of borate buffer for reacting with 250 pl NSP. 
Incorporation of the radioactivity into the protein peak 
7~ 
as well as specific activities are also indicated. All 
calculations are based on 250 pl NSP namely 5·.-812 x 10-6mMoles 
and supplied as lmg/ml with specific activity of 43Ci/mmole 
The appropriate ratios are worked out by taking into account 
the molecular weight of each protein. 
· 3.5 Logistics of delivering microgram amounts for reacting 
with NSP. 
Where low NSP/protein ratios are required, this means 
more protein is delivered and in some cases, say 1:1 ratio 
NSP/IgG, 1mg of IgG·was easily dissolved in 20 pl buffer. 
However, as shown in Table 2 where lower microgram amounts 
required to give 3:1 NSP/protein ratios there was a problem 
Protein (NSPfProtein) 1mg of protein 20ul aliquot 
ratio dissolved in; of buffer 
( )ll ) delivers 
of buf-fer ( pg ) 
lgG 1:1 20 1000 
Transferrin 3:1 114 174.3 
PreAlbumin 3:1 187 106.5 
Gc-Glycoprotein 3:1 127 156.9 
Haptoglobin 3:1 104 193.0 
o< 1 1161d· ~glycoprotein · 3:1 240 85.2 
Fibrinogen 3:1 35 571.4 
0( 1Antitrypsin 3:1 191 104.0 
Throoi:>in 2:1 186 107.5 
0( :f!S-Glycoprotein 3:1 210 94.9 
Table 1 
During radio-labelling procedure, the Table shows the 
best way of delivering microgram amounts initially weighed 
out as lmgjappropriate volume of buffer and then 20 ul were 
added to the NSP-H 3 , to give the indicated labelling ratios. 
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of weighing these small amounts. A quicker way was to weigh 
out ling for all proteins and then dissolve this in a calculated buffer 
volU!JJ3s such that when 20 ).1]. of this solution is pipetted the desired 
amounts of protein to give appropriate NSP/protein ratics are delivered 
as per table L 
3. 6 Determination of Specific Activities. 
a) Column method 
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Fran the elution profile of each protein the incorporation of the 
tritium label was calculated fran the counts associated with the protein 
peak relative to the total counts, that is the protein and glycine 
peaks added together. Percentage of incorporation was then calculated 
as per table 2 . 
A worked example of incorporation of tritium into IgG will be consi-
dered here. 
From elution profile on Sephadex <r-50, · 
Fraction CPM (radioactive counts) 
1 24.0 
2 24.3 
3 24,5 
4 22.0 
5 36174.3 
6 500266,8 
Protein peak = 995;!12 cpm 7 228779.0 
8 88023,0 
9 41973.8 
10 45634,3 
11 512282,3 
12 882009.5 
13 509899.6 
14 87932.8 Glycine peak = 2 '076 ,360 cpm 
15 16626.5 
16 7120,0 
17 4615,8 
18 3847.8 
19 2971.8 Total = 3,071,672 cpm 
20 3420 0 
Based on 20 pl aliquots of eluted fractions, 
Protein yield 
1 vial of NSP 
But 1 Ci 
=(995312/3071672) X 100 
= 32.4% 
= 1 mCifml as supplied 
= 3.7 x 1010 dps 
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1 mCi 
= (3.7 x 1010 ) 60 dpm (At 100% efficiency) 
= 10-3 (3.7 x 1010 ) 60 dpm 
And 250 ul NSP = l mCi = 0.25 mCi 
3 10 therefore this is equal to 0,25 x 10- (3,7 x 10 ) dpm 
= 55.5 x 10 7 dpm 
Assuming no significant loss, 1mg of IgG that was reacted, 
will represent approximately 1mg in the fractionated protein 
peak. 
If only 32,4% of the total counts are incorporated 
according to the yield then the counts in protein peak 
= 0.324 X 55,5 X 107 dpm 
therefore 1000 pg 
1pg 
= 179820000 dpm 
= 179,820 dpm 
b) 10% TCA (Trichloroacetic acid) precipitation method. 
The reaction mixture in all instances consisted of 
500 pl of 0.2M glycine and 20 pl of protein in buffer 
(total 520 pl) and prior to application of this mixture 
to the column specific activity was assessed using 10% TCA 
precipitation as shown in Fig. 14. 
520 ul (original mixture) 
5 pl mixture 
+ j 
200 pl 0.2M Phosphate 
buffer pH 7.5 
Take 20 pl of this 
+ 10 ml Fusiflour 
scintillant 
TOTAL COUNTS 
5 pl mixture 
+ 
50 pl 1% BSA in Phosphate 
buffered saline pH 7.4 
Add 1 ml 10% TCA 
Centrifuge 
discard 
supernatant 
Pellet + 100 pl 0.2M NaoH 
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Take 20 pl + 10 ml scintillant 
Specific counts 
TOTAL COUNTS 
= % Yield 
'----~ 
-~ 
COUNT 
(Specific Counts) 
calculated 
Fig. 14 - shows a 10% Trichloracetic acid precipitation method for 
working out specific activities of radio-labelled proteins. 
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Protein NSP /Protein Protein in Incorporated Specific 
ratio 20ul buffer percentage activity jug 
( }lg ) of radio- protein 
activity in (cpm/ug) 
protein peak 
1 IgG 1:1 1000 32.4 179,820 
2 Transferrin 3:1 174,4 69.8 81,847 
3 Pre Albumin 3:1. 106.5 42.0 432,393 
4 Gc-G1ycoprotein 3:1 156.9 30.4 387,872 
5 o<1Acid glycoprotein 3:1 85.2 30.6 583,103 
6 Haptoglobin 3:1 193.0 59,8 336,836 
7 Fibrinogen 3:1 581.2 14.5 10,718 
8 o( 1 Antitrypsin 3:1 104,6 .. 72.9 121,370 
9 Thraii:Jin 2:1 107.5 10.0 186,986 
10 o(zHS-Glycoprotein 3:1 94.9 19.7 49,943 
Table 2 - shows the labelling ratios, when the indicated micrograms of protein· 
were added to 250 )ll NSP-H3 (0.25 mCi NSP equal to 5.812 x 10-6 nrnole 
for a 43 Ci/mrnole batch or 4.23 x 10-6 mmole for a 59 Ci/mmole 
batch), to give the displayed percentage radioactivity incorporated 
and specific activities. 
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3. 7 Assessment of counting efficiency· of Tricarb scinti"llation 
spectrometer. 
Take 1 pl of supplied NSP at 1 mCi/ml 
i.e 1/1000 mCi taken 
= 1/1000 X 10-3 (3.7 X 1010 ) 60 dpm 
Theoretical activity is 10°6 (3.7 x 1010 ) 60 dpm 
= 222 x 104 dpm 
If 10 pl is added to 10 ml scintillant and counted as ( x )dpm. 
Efficiency = ( x/225 x 10 4 ) 100% 
Worked example 
NSP was supplied as 1 mCi/ml and from which 
1 pl = 10-3 mCi 
= 10-3 x 10._3x 60 (3.7 x 1010 ) dpm 
(since 1 Ci = 3.7 x 1010x 60 dpm) 
1 pl of same NSP was diluted 1/80 and 
20 pl of this when counted on the Tricarb spectrometer 
gave = 165164 dpm 
Hence the total 80 pl contained (80 x 165164) dpm 
20 
But this is equal to the original 1 pl before it was 
diluted 1/80. 
Therefore 1pl _ ·so. 165164 = 660658 dpm 
20 
Efficiency of scintillation 
spectrometer. 
= counts registered fran 1ul 
calculated theoretical counts 
= 660658 
222 X 10 4 
= 30% 
3.8 Filtration Techniques 
All experiments involving labelled proteins and 
incubated with purified trophoblastic membrane, necesi-
tated separation of bound from free radio.activity in 
order to assess the degree of label binding. There was 
a need to have a .. rapid, reliable and easy method to use. 
To this end, two methods were used, namely the Amicon 
Millipore filtration system and another one constructed 
by the author from improvised old bits of Technicon Auto-
Analizer A1 or A11 . These included the flow pump linked by 
tubings to a system of three piece funnels that had been 
bought from Whatman (Maidenhead, Surrey, U.K). This 
latter method will be described first mainly because it 
was constructed at very little cost compared to a £400 
Amicon Millipore system, 
a) Improvised filtration technique, 
There are three major components of this system; the 
flow pump linked to a system of pump tubings which in 
turn were connected to reservoir attached to 3 piece 
funnels through which samples were introduced, 
Figure 15 illustrates all the main parts diagramatically, 
Also the photograph in Fig, 16 shows the whole assembly 
capable of taking 12 filtration funnels with a filtration 
time of 5 minutes for all. 
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Fig. 15 
This shows some components of the improvised filtration 
system. It consists of a three-piece funnel (Whatman Produ-
cts, Maidenhead, Surrey), connected to a 15ml reservoir, in 
turn connected by tubings to a Technicon A1 peristaltic pump, 
normally used for the Technicon A1 AutoAnalyzer (Technicon 
Instruments, Basingstoke, Hants). Up to 12 funnels could be 
connected to the pump as shown in Fig. 16. 
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./Funnel 
Acrylic plate 
15ml plastic 
reservoir 
e.c hi nc on A I 
Technicon Peristaltic ----If-------, 
pump 
Fig. 15 
Tubings 
Fig. 16 
A photograph of the filtration system described in 
Fig.15 is shown; consisting of filtration funnels and tubin~s 
connecting to the Technicon A1 peristaltic pump. The oumo's 
transformer on extreme ri~ht is shown too . 
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The following is.a description of some of the components, 
3 Piece-funnel 
These were twelve in all to increase the number of 
filtrations that can be done simultaneously. The funnels 
were purchased from Whatman Ltd., Maidenhead, Surrey, and 
consisted of a 15ml funnel, a central acrylic perforated 
plate on which Whatman Glass fibre discs GF/C (Pore 4mm 
diameter.l.2 pM) filters were mounted, and the bottom 
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receptacle attached to 
in Fig 16). 
15ml reservoirs (see photograph 
Tubings 
These were pump tubes (white/purple and of 4mm in 
diameter for 3 ml/min flow rates and supplied by Technicon 
Co. for the Technicon AutoAnalyzer A1 or A11 machines., 
(Technicon Co. Ltd., Basingstoke, Rants). There were 12 
tubings in all and securely pressed under the chain driven 
rollers of the pump. 
This was taken from a dismantled oldAutoAnalyzer A1 
and could pump through of tubings used at a rate of 3mls/ 
minute. It must be emphasised that due to the way the 
tubings were attached to the reservoirs and then left 
open ended at the other end, only air was pumped and the 
fluid flow. was restricted between the funnel and the 
collecting reservoirs. The system ran satisfactorily. 
b) The Amicon Millipore Filtration System 
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Fig . 17 shows an Amicon filtration chamber (Amicon 
CorPoration) which takes a maximum of 12 glass-fibre filter 
discs (Whatman). This unit is connected to a vacuum generated 
by a pump on the right. The vacuum pressure should not exceed 
15 Ib/in2 . The whole system costs about £400 in comParison 
to a cheap version that was constructed from various bits of 
old Technicon machinery shown in Fig.16 . 
In both systems filtration was rapid (12 filters every 
3 minutes) when either a 1.2 urn GF/C or 0.7 urn GF/ F Whatman 
glass-fibre disc was used. 
this system which takes 12 GF/C filters. These were pre-
soaked in 50 mM Tris HCl buffer pH 7,4 containing 5% 
BSA and then placed in appropriate groves designed to 
take these discs. The top cover was secured in position 
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by a screwable top and then contents of reaction mixture 
are directly poured on to the wells containing the GF/C 
filters and suction. created by vacuum pump assists filtra-
tion. Only 2 minutes is need for 12 filters. 
Discussfon. 
In either case the filtration is rapid between 2 to 5 
minutes depending on which system is used. This is cont-
rasted to about 20 minutes if the reaction mixture was 
left to filter through by the weight of the fluid column, 
usually 15 mls. Filters were then dipped into 5 or 10ml 
of Fisoflour I scintillant and counted. Some manufactu-
rers recommend the following; 
• 
presoaking of filters in buffer containing 5 - 10% 
Bovine serum albumin. 
e Dry filters after filtration to minimise quenching of 
scintillant. 
• Choice of scintillant, that can usually dissolve the 
filter completely for effective release of bound ligand. 
Whilst presoaking with 5-10% BSA helped to minimise 
non-specific binding the drying of filters was not found 
to be a critical factor, Very close counts were obtained 
with and without drying (usually at 100°C for 10 minutes) 
and therefore all the subsequent experiments drying was not 
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necessary and filters were dipped straight into the 
scintillant immediately after ·filtration. Duplicates were 
always done. 
CHAPTER 3 
IMMUNOCYTOCHEMICAL METHODS - THE USE OF IMMUNOFWORESCENCE 
AND PEROXIDASE PROBES IN STUDYING THE TOPOGRAPHY OF PLACE-
NTAL MEMBRANE RECEPTORS. 
Introduction 
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Immunocytochemistry provides a rapid, usually very repro-
ducible results particularly in localising antigens of 
cytosolic or membrane origin. To this end, various 
workers have employed immunofluorescent techniques to the 
study of the placenta for both the peri-implantation (Johnson 
1975) and post-implantation antigens (Page-Faulk et al 1975). 
Other workers have been interested in delineating cytoskeletal 
elements which provide the backbone support for the placenta 
and have also used fluorescence to localise polymeric mole-
cules such as tubulin (Ockleford and Wakely 1981), desmin, 
actin and polymeric proteins (Ockleford et al 1981). 
Youtananukorn (Youtananukorn et al 1972) reported on 
cell mediated immunity to placental antigens by maternal 
lymphocytes. However, these antigens were not identified, 
Faulk et al (1975) in the search for these antigens on post 
implantation placenta were able to show that immunoproteins, 
fibrillar proteins, and contractile proteins were very 
important antigens. Antibodies directed to such antigens 
were found to have concormitant blocking effects to cell 
mediated lymphocytic reactions, which points _ to the 
immunologically protective role of these surface antigens. 
To study the distribution of these antigens, 
these workers used both direct and the two stage indirect 
immunofluorescent assays. They raised they own antisera 
to isolated immunoproteins (lgG, A, M), complement (C3 , 
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c4 ), fibrillar proteins (collagen), contractile elements 
(actin;tropomyosin) and conjugated it with fluorescein 
isothiocyanate (FITC) by dialysis technique of Clark and 
Shepard (1963). Unreacted FITC being removed on Sephadex 
G25 column. Conjugates were then carried through staining 
reactions and specificity checks as described by Faulk and 
Hijmans ·( 1972). Any antigen of interest can thus be 
studied in a manner analogous to the above study of Page-
Faulk and others using placental tissue prepared by snap-
freezing for cryostat sections or treatment with 3% Forma-
lin in phosphate buffered saline, and then sectioning. 
For direct fluorescence FITC-labelled first antibody 
(usually Rabbit anti-human) can be applied.Where amplifi-
cation or higher sensitivity is required the FITC label is 
attached to the second antibody layer (usually goat or 
swine anti-rabbit serum). For even higher sensitivity a 
third layer the peroxidase-anti peroxidase conjugated 
attached to the second antibody, can be utilised in the 
immunoperoxidase assay. 
Instead of block cut sections, isolated purified 
placental microvillar membranes (StMPM) can be used to 
study membrane topography. In the present study StMPM was 
used with respect to delineating surface receptors to the 
~roteins mentioned below. 
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Materials and Methods 
Proteins Studied; 
These included IgG, transferrin, haptoglobin, 0( 1 acid 
glycoprotein, o( 1 anti trypsin, fibrinogen, o( 2HS-glyco-
protein, · Gc-glycoprotein , and preAlbumin. 
Placental Membrane (StMPM), was prepared as per method of 
Booth et al (1981), as outliend in the protocol on page 52 
Fig. 7. Membrane protein was adjusted to 40 ug/ml using 
a modified Lowry protein assay discussed 6n page 60. 
Antisera 
Antisera (rabbit anti-human) to IgG, transferrin, 
haptoglobin, o( 1antitrypsin, 0(1acid glycoprotein, fibri-
nogen, were purchased from Dakopatts (Mercia Brocades, Wey-
bridge, Surrey). Antiserum to Gc-glycoprotein and ~ 2HS­
glycoprotein were purchased from Behring Institute (Hoechst 
Ltd, Hounslow, Middlesex, U.K). FITC or peroxidase labe-
lled antisera (Goat or Swine anti rabbit) were purchased 
from Miles (Miles research laboratories, Slough, Middlesex, 
U.K.) 
Highly purified plasma proteins were purchased 
from Behring Research Institute (Marburg West Germany). 
My thanks to Dr. Wolfgang Becker, Head of Research Division, 
Behring Institute for assisting me in obtaining these 
proteins and for the one extra pack of Prealbumin and Gc-
globulin which were actually donated. IgG and ~ 1 acid 
glycoprotein were purchased from Miles (Miles research 
90 
laboratories, Slough, Middlesex). 
Assay Protocol. 
a) Immunofluorescence 
(i) Tests 
Each protein was dissolved in phosphate buffered saline 
(PBS) at 1 mgjml concentration. 300 ~1 of each protein 
solution were added to 300 pl of membrane solution at 
40 mgjml of Protein content in 1cm x 7. 5cm plastic tubes 
(Starstedt Ltd, Beaumont Leys, Leicester). 
(ii) Membrane Control 
300 pl of membrane alone were added to the tube and 
this membrane was never incubated with any protein ligand. 
Both test and membrane control, were left at room 
temperature for 1 hour constantly mixed by the roller and 
rocking actions of a mixer, then mixing and incubations 
were continued overnight at 4°C. The next morning both 
test and control were centrifuged with;washing three times 
with cold PBS. Membranes were re-suspended :in the original 
volume, i.e. 600 ?1 (test) and 300 pl (for control), then 
all subsquent operations were done on ice at 0°C. 
The following schedules A and B were followed for both 
membrane previously incubated with ligand, and membrane 
alone. 
Schedule A - Manbrane incubated with ligand, processed through steps 1 - 7 
as follows; 
Step 1 
Step 2 
test (2) 
200 ,ul 200 }ll 
~--) 
To each tube 
100ul of rabbit antiserum 
at 1/50 dilution (1/100 for 
IgG and Transferrin) were added, 
1 
Step 3 lEAVE CN ICE FOR 1 HOOR 
1 
Wash and centrifuge x 3 
1 
Step 4 Add 50 ).11 of 1/20 
FITC Goat-anti-rabbit 
serum - LEAVE for 30 minutes 
1 
TEST 
CXNI'ROL 
200 Jll 
Add 50 ul of 
1/20 FITC goat 
anti rabbit serum 
go to Step 5 
91 
Step 5 Wash and centrifuge x 2 wash and centrifuge x 2 
Step 6 
Step 7 
1 ( I 
Add 1 ml of 1% BSA with 0.1% Azide in PBS 
Wash and centrifuge x 1 
-l-
Add a drop of foetal calf serum via a pasteur pipette,· gently mix 
and then a droplet is mounted on slides for fluorescence micro-
scopy. 
, 
Schedule B - Membrane alone (Membrane without ligand, ie. 
Step 1 
Step 2 
Step 3 
Control). 
CXNI'ROL I 
\ 
150 pl aliquot 
l 
Add 100 J.Il of 1/50 
~bit antiserum 
(any of the rabbit anti-
serum will do) 
l 
Leave for 1 hour 
t . 
Proceed as in step 4 to 
the end as in Schedule A. 
CXNI'ROL II 
I 
150 )ll aliquot 
\ 
Add 100 )ll of 1/20 
FITC goat anti-
rabbit 
go to step 5 and to 
the end as in Schedule A. 
These procedures completed the fluorescence experiments. 
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To summarise, the tests and test control were done with membrane 
pre-incubated with ligand. The test control helped to exclude 
non-specific reaction by FITC goat anti-rabbit serum since 
in this system everything was present except rabbit antiserum. 
The latter two controls (I and II) obtained when the ligand was 
excluded from the membrane also helped to exclude non-specific 
binding to the membrane due to both the rabbit and goat 
FITC anti-rabbit serum. 
(b) Immunoperoxidase Method 
Here all steps were identical as in A and B schedules 
except in the following respects; 
(1) After an overnight mixing at 4°C, and before step I 
was embarked upon, endogenous peroxidase was first 
blocked by reacting membranes with 3% H2o2 in methanol 
at room temperature for 30 minutes. Then proceeding 
with steps 1 to end in both A and B schedules. 
(2) Rabbit anti human sera were used in 1:2.5 dilutions; 
whilst peroxidase-labelled goat-anti rabbit sera were 
used in 1/5 dilutions, this was applicable whenever 
these had to be applied in A and B schedules. 
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( 3) Step 6 was not necessary. Although three instead of two 
washings were done at step 5. Also step 7 was not 
needed. 
(4) So from step 5 - Membranes were mounted on glass slides 
and left to dry and then slides were fixed in methanol 
for 10 minutes. 
(5) The peroxidase reaction was developed by dipping slides 
into 3-3'-diaminobenzidine tetra hydrochloride (BDH Poole 
Dorset) at 0.2g in 300'ml in PBS that had been pre-filtered. 
(6) Dehydration via graded alcohols was done (xylols) and 
then slides were ready for microscopy .. 
RESULTS 
Immunofluorescence. 
Figures 18a to 18k,illustrate various positive fluore-
scence for. different protein ligands. Controls are also 
shown in Figs.19(a),(b) and (c) are representative of nega-
tive controls, as described in the text and against the 
photographs. Generally all proteins studied gave positive 
reactions and prior aggregation of ligand (as was found 
necessary for peroxidase reaction, see below) was not 
necessary. This implied that fluorescence might be a more 
sensitive method when compared to the peroxidase method 
which depends on enzymatically catalysed reaction and this 
assay might thus have less sensitivity or resolution. 
Table 3 shows more detailed' fluorescence distribut-
ion around the purified microvillar placental membranes. 
For the sake of comparisons, some IgG was aggregated (see 
Fig. 18c ), in order to see if there were any substantial 
differences with the non-aggregated IgG, and not because 
increased sensitivity was being sought, 
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Table 4, describing microscopical fluorescence appear-
ances of placental membranes incubated with protein ligands 
in terms of impression of degree of positivity is also given. 
1 
2 
3 
4 
Protein 
IgG 
IgG 
(Aggregated) 
Fibrinogen 
o( 1 antitrypsin 
Description of fluorescence topography 
Heavy but diffuse distribution. Stippled and 
coarsely granular, 
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Srure as in No. 1 
Moderate density but coarsely granular, 
Diffuse and heavy distribution, stippled, linear 
in parts. 
5 0( 1acid glycoprotein Granular and stippled distribution, Sane areas 
6 t>( :fiB-Glycoprotein 
7 Transferrin 
8 Haptoglobin 
9 Gc-glycoprotein 
0 PreAlbumin 
Table 3 
free, 
Moderate density, coarse granules and patcby head 
' 
on view showed trabeculated appearance, 
Marked density, patcby with blobs of fluorescence 
in places. 
Areas of linearity, interspersed with granular 
distribution. 
Granular fluorescence, 
Very sparse distribution; mildly granular, 
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Figs·. 18 (a), (b), and (c). 
(a) and (b) - Fluorescence positive trophoblastic membrane 
for monomeric IgG. Here marked positivity 
is shown for every available membrane in the 
field. The distribution is granular and 
coarse giving a stippled appearance. 
(c) - Aggregated IgG shows more or less the same 
appearance as in (a) and (b), except that 
the granular stippling is even more marked. 
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:FJ.g-.18(a) 
Fig.l8(b) 
Fig.lR(c) 
98 
Fig, 18(d) Haptoglobin 
Fig. 18(e) - ~ 2HS-Glycoprotein 
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Fig. 18( f)_ Gc-glycoprotei n 
Fig. 18(g) - o( 1 Antitrypsin 
100 
Fig~ 18(h) - D( 1Acid glycoprotein 
l!ig. 18(i) Fibrinogen 
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Fig. 18(j) Transferrin 
Fig. 18(k) Pre albumin 
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Fig. 19( a) - Test control 
200 pl membrane + 50 ~l 1/20 FITC goat anti rabbit. 
+ 
ligand 
Fig. 19(b) - Membrane control I 
150 ~l membrane without ligand + 100 pl of 1/20 rabbit anti 
human serum + 50 ul of 1/20 FITC goat anti rabbit. 
Fig. 19(c) - Membrane control II 
150 pl membrane without protein ligand + 100 pl of 1/20 
FITC goat anti rabbit serum. 
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Fig.19(b) 
Fig.l9(c) 
Immunoperoxidase Experiments 
RESULTS were all negative except for Gc-glycoprotein, when 
rabbit and peroxidase antisera were each done at 1/20 and 
then at 1/2.5 and 1/5 dilutions respectively, The latter 
dilutions for both sets of antisera were considered very 
concentrated and should have been quite adequate to give 
positive results and were near to utilising neat antisera, 
It was rather puzzling at first why fluorescence gave 
adequately positive results but not the peroxidase. It was 
then put down to a matter of sensitivity between the two 
assays. Prior aggregation of ligand was considered and 
this should step up sensitivity considerably. Therefore 
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each 1 mgfml of protein was treated to 60°C in a water bath 
for 1 hour, prior to incubating with placental membranes. 
When this was done and repeating the assay through A and B 
schedules, good, POSITIVE peroxidase reactions were obtained, 
The importance of ligand aggregation and receptor binding 
was thus considered a very important factor and it presu-
mably increased sensitivity through the numbers of available 
binding sites. 
Figures 20a to 20g illustrate various peroxidase 
positive results for different protein ligands. All CONTROLS 
were negative as exemplified in Fig,21, Table 4. summarises 
results of these two techniques. 
Summary 
Considering that controls were all strongly negative, 
Immunofluorescence 
-
Ligand 1st antibody 2nd antibody 
Protein pretreat- (Rabbit anti- ( FITC labe Bed 
rrent human) Goat anti -
rabbit) 
1 IgG NIL 1/100 1f'?XJ 
IgG aggregated 1/100 1/50 
2 Tf NIL 1/100 1/20 
3 Hp NIL 1/50 1/20 
4 Fib NIL 1/50 1/20 
5 Gc NIL 1/50 1/20 
6 o( 1AG NIL 1/50 1/20 
7 0( 1AT NIL l/50 1/20 
8 o(.jfS NIL 1/50 1/20 
9 Pre Alb NIL 1/50 1/20 
Table 4 
Result 
+ + + 
+ + + 
+ + 
+ 
+ 
+ 
+ 
+ + 
+ 
+ 
Irmrunoperoxidase 
Ligand 1st antibody 2nd antibody 
pretreat- (Rabbit anti- Peroxidase 
rrent human) labelled 
.Goat anti rabbit 
aggrega- 1/2.5 1/5 
ted 
aggrega- 1/2.5 1/5 
ted 
aggrega- 1/2.5 1/5 
ted 
aggrega- 1/2.5 1/5 
ted 
aggrega- 1/2.5 1/5 
ted 
aggrega- 1/2.5 1/5 
ted 
aggrega.:.- 1/2.5 1/5 
ted. 
aggrega- 1/2.5 1/5 
ted, 
aggrega- 1/2.5 1/5 
ted. 
Vey: +++ Harked reaction 
++ ''o<:lerate reaction 
+ Reasonable reaction 
- No rear.1: inn 
Result 
+ + + 
+ + 
+ + + 
+ 
+ 
+ + + 
+ + + 
t.+ + 
-
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this im·plied that non-specific binding due to rabbit anti-
body, or labelled goat antiserum were excluded. Further-
more, when preincubation of proteins with membrane was 
omitted, subsequent treatment of membranes with both rabbit 
and labelled goat antisera still gave negative results; 
implying the significance of protein binding to the membranes 
in the first instance. Therefore structures which are 
responsible for the initial protein binding are most likely 
to be the respective specific receptors on the surface of 
placental membranes. 
Results of this study have shown positive fluorescence 
in all instances, but with varying degrees of intensity and 
density. Appearances of granular, strippled or at times 
coarse areas was also observed. Peroxidase reaction was 
less sensitive in that initially at several lower antisera 
dilutions, no positive results were seen, However, after 
prior ligand aggregation, good positive reactions were 
then observed. 
Specificity of receptors is the other important check 
to do and this involves competetive incubation of ligand 
with excess 'cold' protein, The word 'cold' is likened in 
this context to competition between radio-labelled and 
unlabelled proteins for the same antibody binding sites in 
radioimmunoassays. This can be done by incubating the first 
antibody with excess protein prior to applying it to membranes 
originally incubated with the same ligand. This was done 
and negative results were obtained, 
Other circumstantial evidence for receptor to these 
proteins will be obtained in the experiments using the 
isolated in-vitro placental perfusion system for dynamic 
uptake of these same proteins. 
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POSITIVE IillOJNOPEROXIDASE REACTIONS FOR SPECIFIC PROTEIN BINDING 
TO PLACENTAL MEMBRANES. 
Fig . 20(a) 1 Transferrin 
Fig. 20(a) 2 Transferrin; same as in (a)1 showing 
larger pieces of membrane with oositive reaction. 
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Fig. 20(b) Fibrinogen 
• 
-
Fig. 20{ c) - 0( 1 Acid glycoprotein 
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Fig. 20(d) Gc-glycoProtein 
• 
Fig, 20( e) - o< 1 Anti trypsin 
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Fig. 20( f) Haptoglobin 
I 
• 
Fig . 20'{ g) - o( 2HS-glycoprotein 
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Fig. 21 
All the three controls as described below gave negative 
immunoperoxidase reaction similar to that shown in the above 
photograph. These controls were: 
• 
• 
• 
Membrane alone (no ligand) + Rabbit anti human serum 
(1/2.5) +peroxidase labelled goat anti rabbit (1/5). 
Membrane + ligand as protein + peroxidase labelled goat 
anti rabbit (1/5). 
Membrane alone (no ligand) + neroxidase labelled goat anti 
rabbit (1/5). 
113 
CHAPTER 4 
SELECTIVE ANTIBODY TRANSFER MECHANISM; THE STUDY OF PLACENTAL 
I gG ( Fc·J ) RECEPTOR. 
Aims of the Study. 
Of the placental receptors the IgG one is the most widely 
studied although its structure and some physicochemical chara-
cteristics are not clearly known. In this regard, the study 
of its characteristics have produced conflicting results due 
to different techniques used for binding studies, for example, 
fluorescein-conjugated IgG or adsorption of erythrocytes sensi-
tised with IgG (Johnson et al 1976, Matre and Johnson 1977) or 
direct binding of i 125-IgG (McNabb et al 1976, Balfour Jones 
1978), cryostat sections of placenta (Matre et al 1975) and 
isolated membranes (Johnson and Brown 1981). 
Therefore different binding affinity constants and 
binding sites have been obtained (McNabb et al 1976) with 
6 -1 12 (Ka = 4 x 10 M and 2 x 10 sites/mg membrane protein), 
(Johnson et al 1981), (Ka = 4 x 10 7M- 1 and 1.5 x 1014 sitesfmg 
membrane protein). Others have demonstrated biphasic nature 
of binding sites from Scatchard plots (Rees and Wallace 
1979) with high and low affinity states. The latter authors 
proposed heterogeneity of sites but most subsquent data by 
others could not substantiate this heterogeneity. Most have 
demonstrated a homogenous nature of Fe~ -receptor sites. 
There have also been controversy with regard to the effect 
of temperature on Fe lr -binding. Others argue (Balfour and 
Jones 1978) that there is no binding of pH 8.5, whereas 
Niezgodka et al (1981) showed binding even at pH 9.0. 
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It was therefore decided that IgG (Fe~ ) receptor be 
re-studied with particular reference to: 
1) Association and dissociation kinetics to re-assess the 
affinity constants. 
2) Check as to whether there is heterogeneity of binding 
sites. 
3) To test the stoinchiaretry of binding which has been 
thought to be a 1:1 binding for a hypothetical receptor 
of molecular weight 60,000 (Johnson and Brown 1981), 
although no specific experiments are mentioned to verify 
this binding ratio. 
4) The effects of temperature were re-studied for a number 
of reasons. Rees and Wallace (1979) and Niezgodka et al 
1981, .have claimed preferential binding at 4°C rather 
than 37°C. The reasons for this, if any, have never 
been sought particularly in terms of whether lower tempe-
rature alters the total number of binding sites or 
affects the affinity constant. The study was therefore 
made with a different choice of temperatures namely 45°C, 
0 0 20 C, and 0 C. These same temperatures were used to 
look at the thermodynamics of binding for Fey receptor 
in terms of energy changes, such as activation ethalpy !l.nd 
entropy changes over this temperature range which gives 
some clues as to the nature of binding. 
5) The effect of monovalent and rliv,.lent cations in modulat-
ion of IgG-Fc~ receptor interaction, were studied with 
possible view that in vivo ionic changes can regulate 
l~G uptake. The role of cations in modulation of Fe~ 
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receptor has hardly been studied, just as the thermodynamics 
of binding in terms mentioned above has not been looked into 
previously. 
Introduction 
4.1 Development of Foetal Immune System 
The foetus survives in its maternal host through an 
obviously complex immune adaptation in which there is suppres-
sion of maternal rejection, as well as prevention of its 
immunologically competent cells from damaging itself (self 
preservation). Furthermore the maternal tissues in contact 
with foetus, do not normally spark off severe foetal immune 
reactions capable of damaging maternal tissues. These three 
elements of maternal/foetal immunobiology are ill-understood 
but must be due to a multitude of fine immune regulators. 
Moriya et al (1979) and Oldstone et al (1977) have demo-
nstrated relatively high suppressor T-cells activity in cord 
blood and suggested that these function by suppressing 
maternal rejection. Siegel and Gleicher (1981) believe that 
these suppressor T-cells operate simultaneously in all the 
three tolerance areas mentioned above. The suppressor cells 
in eliminating or diminishing activity of immune competent 
cells must strike a balance between total suppression and 
thus cause undesirable antigens such as bacteria, to thrive 
and infect the foetus, and retaining some capability to 
recognise and deal with some otherwise dangerous antigens. 
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A review of the development of cellular immunity from 
stem cells in haemopoetic centres, through several other 
sites, to localising in lymphoreticular system, is given by 
Siegel et al (1981). On the other hand, the development 
of humoral immunity in relationship to ontogeny is much 
slower. The undifferentiated B cells migrate from their 
haematopoetic centres to the human foetal gastrointestinal 
tract equivalent of the bursa of Fabricius. There they 
mature, tempered by antigenic exposure or modulation, and 
finally form into antibody producing cells. 
These B-lymphocytes express Ig-receptors as early as 
9 - 10 weeks of gestation and at 14! weeks (Siegel et al 
1981), the proportion of Ig-bearing B-lymphocytes reaches 
an adult level. First, lgM then IgG, lgA, and lgD receptor 
bearing lymphocytes, in that order appear. 
4,2 Antibody Synthesis. 
Despite reaching adult levels for Ig-receptor bearing 
lymphocytes as mentioned above, their actual synthetic 
and production activity of antibodies remains very low 
(Bridges et al 1959). Most of foetal antibody activity is 
thus due to placental transfer, particularly of IgG, In 
agammaglobulinaemic mothers lgG is almost completely absent 
from their newborns (Zak and Good 1959), signifying the 
maternal origins of IgG (Gitlin and Biasucci-1969). 
Nevertheless some foetal IgG synthesis still takes 
place as evident from studying Gm markers (Martensson et al 
1964). Gitlin and Biasucci (1969), have observed, for 
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example, that foetal synthesis of IgG starts at around 
10 - 12 weeks gestation, whilst IgM was shown at 10! weeks, 
and IgA at 30 weeks gestation (Miller 1978). These experi-
ments employed labelled aminoacids and detection of radio-
label incorporation into each immunoglobulin. IgD and 
IgE are almost at the limit of detection in terms of whether 
they are synthesised by the foetus. 
Cord blood has been frequently utilised as indicative 
of foetal immunoglobulins status, It must be pointed out 
that whilst IgM and IgG increase with gestational age, IgA 
(and its subclasses IgA1 and IgA2 ), and IgD are not affe-
cted by gestational age, (Cederqvist et al 1978). 
Furthermore, IgM and IgG are higher in foetuses weigh-
ing 2000 grn or more while IgA (IgA1 and IgA2 ) are hardly 
influenced by birth weight. Interpreting cord Ig levels 
is thus dependent on knowing the additional information, 
For example, an IgM level of 10mg/100ml is significantly 
elevated at 35 weeks gestation or :if. birth weight is 
less than 2000gm. The same value, however, is normal in a 
foetus of more advanced gestation and/or weighing more than 
2000grn, Intrauterine infection is accompanied by raised 
IgG or IgA classes, say in congenital toxoplasmosis (Cede-
rqvist et al 1977), 
4.3.1 Brambell's_hypothesis for maternal/foetal antibody 
transfer. 
The year 1966 becrure a turning point in our knowledge 
of maternal transmission of antibodies to the foetus,. 
Brambe11 (1966), first focussed attention to prenatal 
antibody transfer through foetal membranes, such as the 
york sac for rabbits and rats. In animals such as cows 
and pigs, antibody transport via placentae does not occur; 
their young get antibodies via absorption from colostrum. 
In humans, because the haemochorial type of placentae 
exists, that is to say, a very thin type of placenta, 
antibody transport to the foetus readily takes place. 
4.3.2 Selectivity of the Placenta in Antibody Transport. 
In prenatal transport of immunoglobulins across 
the rabbit york sac endoderm as well as the postnatal 
118 
transport across the gut enterocytes of rats and mice, 
selective events govern antibody uptake rather than mole-
cular weight characteristics. Selection is in terms of 
antibody class, structure , and species. for example, only 
IgG is selectively transported whilst IgM, IgA, lgD and 
lgE are not; a fact attributable to lack of appropriate 
receptors (Wild 1975). Only IgG possessed receptors, as 
proposed by Brambell and their binding of lgG was a pre-
lude to its transport (Brambell 1966, and 1970). 
Even amongst IgG, its subclasses are differentially sele-
cted for binding and uptake due to minor stereospecificities; 
IgG3 more than lgG2 or IgG1 . Molecular mass is of no 
importance with respect to uptake since lgA and IgG are 
virtually of similar mass but lgA is not taken, Also 
insulin with a very small mass has vast avidity for memb-
rane binding. 
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4,3,3. Coated Vesicles and Antibody Transfer and Protection. 
Already mention of these specialised organelles 
has been made in the review chapter (page 21), Brambell 
(1966. • 1970), suggested the existence of IgG (Fe) receptor 
on the limiting membrane of endocytic vesicles for both 
york sac and placenta. Such receptors would thus provide 
selective protection against proteolysis during transport 
within endocytic vesicles in which non-selectively endo-
cytosed proteins fused with lysosomes and then get degraded 
(in phagolysosomes). 
Brambell's ideas were almost right though were lacking 
in meaningful detail. Wild (1979, 1975) 'paraphrased' 
in the scientific sense, Brambell's ideas. He postulated 
a different role for Fc-receptors, suggesting that they 
become associated with coated vesicles which form from the 
membrane surface and so serve to segregate the IgG selec-
ted for transport from immunoglobulins and other proteins 
destined for proteolytic phagolysosomes. Selection there-
fore would be a surface event and independent of proteolysis 
since the coated vesicles would not fuse with lysosomes in 
the first instance. Ultrastructural studies have lent 
support to Wild's ideas, as coated vesicles with IgG (rabbit 
and human but not bovine) have been traced from formation 
stage to transport across tissues and exocytosing their 
contents at the endothelial surface of foetal vessels, 
(Moxon et al 1976). 
Materials and Methods 
Establishing theoretical methods of receptor - ligand 
interaction. 
Some background theoretical aspects are mandatory 
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for discussion if the basis of methodology and calculations 
that are used in this section are to be appreciated. These 
methods will include a brief mention of 
a) Receptor-ligand interaction and use of certain equations 
for subsequent assessment of association and dissociation 
binding kinetics. 
b) The basis of log-dose response curve· and its application 
to the study of lgG-Fcr receptor binding; with this 
goes mention of the theory of inverse Scatchard plots. 
c) The Vant-Hoff equation and its respective plot was used 
to derive the activation ethalpy and enthropy as energies 
of Fey -receptor binding to its IgG ligand, 
These theoretical aspects will be mentioned as and when 
appropriate sections are being dealt with. 
A) Ligand/Receptor theory 
R + X· 
where R = Receptor 
X = Ligand 
RX = Receptor ligand complex 
D = Dissociation. product of complex 
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k1 , k2 , are forward and backward reaction constants, 
k 3 = dissociation constant of complex. 
therefore [ R] [x] 
[ RX] 
= = Ko 
if Rr = Total receptor concentration 
then Rr = R + RX 
Equilibrium 
Dissociation 
Constant 
,,(1) 
Rr RX = R . . . . . . . . . . . . . . . • . . . • . • . . . . . . ... ' .. ( 2 ) 
substitute (2) in (1) 
we have RX) (x] [ Rr 
= Ko • . . . . . . . ...•..........•. ( 3 ) 
Rearranging; 
RX X 
= .••.......•...........•..... ( 4 ) 
Rr Ko + X 
whence RX / Rr · represents fractional binding of 
receptor or receptor occupancy. There is substantial 
evidence to prove that post-receptor membrane effects, 
in the internal milieu of a cell, depends on the degree 
of receptor. occupancy, namely the fractional binding. 
From enzyme-substrate kinetics, we have the well known 
Michaelis-Menten relationship; 
v = s 
. . . . . . . . . . . . . . . . . ·. . . . . . . ........... ( 5 ) 
VMAX K + S 
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where V, is velocity of reaction, VMAX is the maximum 
velocity and $, is substrate concentration whilst K is 
the equilibration constant, Equation (4) and (5) have 
marked similarities, and so for receptor/ligand interaction, 
Michaelis Menten type of kinetics do apply and consequently 
the Lineweaver-Burk double receprocal plot,from this 
equation,is an extremely useful tool in deriving receptor 
kinetic data, 
Thus from (4) 
if 
and 
then 
RX 
RT 
1 
B 
= B (observed binding) 
= BMAX (maximum binding) 
= Ko 
BMAX 
1 + 1 
X BMAX 
• . . • • . . . • . . • . . . ( 6) 
This is a very useful plot and Ko. the dissociation constant 
can be derived from the gradient of the linear graph. Equations 
similar in form to this double reciprocal plot, but derived 
rather differently, will be discussed later in the section 
on placental perfusion, where foetal uptake of protein, gave 
characteristic rectangular hyperbolas of Michaelis-Menten 
kinetics although some minor modifications were made to 
the exact form of the equation. ( see page 201 ) . 
B) Log-dose Response Curves (LDR) 
Figs.22 and 23 illustrate a very useful tool in studying 
receptor binding from various points of view and so binding 
can be monitored in terms of LDR curves (Avram Goldstein 
et al , Principles of Drug Action; The Basis of Pharmacology, 
John Wiley & Sons, 1974, pp, 89-127), The LDR curve was 
used to calculate also the stoinchiaretry of Fe r binding 
as will be mentioned below. In most cases in this study, 
with the exception on data for ·stoinchj;anetric assay, the 
hori~ontal axis (log dose) was modified in that instead 
of the dose representing increasing ligand concentration, 
and for the sake of economising on valuable radiolabel, 
the membrane (which is easy to prepare) concentration was 
_varied whilst the amount of label was fixed. This was 
a kind of immunoradiometric assay, From such curves, 
inverse Scatchard plots were the only way of deriving 
binding parameters such as affinity and maximum binding 
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sites as will be shortly shown. First of all the stoinchi-
ometry of binding, 
1ooz 
Binding 
A 
-1 
-Ka 
o~~----~----~ Log dose 
Fig, 22 
Response 
M 
a c 
Fig. 2t3. 
Log (dose) 
Log.dose Response Curves (LDR) 
a = normal LDR 
b = shift to right due to competitive inhibitor 
c = even greater shift due to still high competitive 
M = maximum receptor binding 
d = same as (a) 
e = non-competitive inhibitor 
f = higher dose of non-competitive inhibitor 
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dose 
M2 ,M3 = impaired maximum binding due to non competitive inter-
ference. 
Derivation of the stonchiometry of binding from Log-
Dose Response curves 
From equation ( 4) on page 121 
Let f RX X = B 
BMAX 
= = .· ....... (7) 
Rr Kn + X 
rearranging; 
X = KD c -::F F) •••••••.••.•••.•. (8) 
But Rr = X + RX 
······················· 
Total= Free·+ Bound 
ligand 
Rr - RX = X 
Under conditions of excess free ligand. 
Rr ~X 
(9) 
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Since the amount bound, RX, becomes negligible in relation 
to high free ligand. 
Therefore combining (8) and (9), 
Kn ( F ) 
1 - F 
(ie, Total ligand mostly existing as free) 
df d [nl\o(· F ) · = d1n x 
1 - F f[ 1- f] 
= 2. 303 F ( 1 - F ) and so d F 
d log X 
I I I I I I I I (10) 
df/d log X = GRADIENT of LDR curve 
at f = 5o%(Point A in Fig. 22} we have 
df/d log X = 2.303 X 0.5 X 0.5 
= 0.576 
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Therefore for a 1:1 ligand/receptor interaction the gradient 
at 50% of total binding must be 0.576 
Thus at 50% binding 
for (1:1 binding) X+ R ~XR (df 
d1og X 
= Q.576) 
for (1:2 binding) X+ 2R~XR2 (.9.!....__ = 0.288) 
dlog X 
for (2:1 binding) 2X + R~X2R (.9.!....__ 
dlog X 
= 1. 15) 
and so multiples of 0.576, gave the appropriate binding ratio. 
In the experiment that follows, attempts to assess the Fer-
lgG, interaction in terms of stonchiometric binding~ere 
.:made. 
D) (a) Data on st-oincb.iometryof IgG-Fcy interaction. 
A reaction volume of 0.5 ml per tube consisted of 
350 pl of 50 mM Tris HCl pH 7.4, 100 pl of 5% Bovine serum 
albumin, 660 pg of membrane protein, and varying amounts of 
After incubation at 37°C and gentle vortexing every 
15 minutes, aliquots of 50 pl from the reaction mixture were 
rapidly filtered through GF/F (Whatman) fibre glass filter 
discs in a 3-piece funnel and under negative pressure 
"' 
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Fig. 24 - shows a log dose response curve for labelled IgG-H3 
binding on placental membranes. The horizontal arrow (~) gives 
the 50% binding; the point where the gradient df/d log x, 
(equal to 2.40) was taken. This gave a 4:1 stoinchiometric. 
binding ratio for IgG/receptor interaction as described in the 
text. The vertical arrow ( ,J, ) gave the corresponding affinity 
7 -1 
constant of Ka = 2 x 10 M far IgG. · 
provided by the improvised filtration technique (see pp.82) 
and Fig. 16 ) . 
Duplicate assays were performed. Bound counts were 
expressed as percentage of maximum specific binding and 
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then plotted against ligand concentration as shown in Fig.24. 
At 50% binding (Fig. 24) 
df 
= 
72.5% 
d log X log 5.0 - log 2.5 
Since 1:1 binding gradient is 0.576 
A gradient of 2.40, gives 
2.40/0.576 4.1:1 
= 2.40 
Thus from these experiments it would appear that 4 IgG 
molecules to 1 of receptor, interact and not 1:1 as pre-
viously assumed (Johnson and Brown 1981) and without 
concrete data to prove it. 
Thus from the point of view of cell economy a 4:1 as opposed 
to 1:1, IgG-Fc )' binding would make subsquent uptake a 
relatively efficient system in animal systems inspite· 
of available data to suggest that only 12% of injected 
labelled IgG is subsquently transferred to the foetal circu-
lation (Wild 1973). 
Comment on LDR-curve for stoinchianetric determination; the 
horizontal axis in Fig. 24 shows IgG-H3 concentration 
expressed in pg/0.5ml. It does not really matter whether 
these were expressed in pg/1 or molar concentrations. When 
the change in log X is considered, ie. log x2 - log x1 
= log x2 
x1 
, and so it is the log of the respective 
ratio that counts which then is independent of units 
concentration for X. 
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D) (b) Affinity equilibrium constant from the same LOR-curve. 
Furthermore, from Fig. 24 and at 50% binding an arrow 
points to a value on the X-axis from which an approximate 
equilibrium constant can be derived for the Fe 't -IgG reaction. 
eg. 1 
Ka 
= 3,6 pg/0.5ml Reaction volume 
= 7. 2 pg/ml 
= 7,2 X 10-6 X 103 gjl 
If MW IgG = 150000 daltons 
then 1 
Ka 
Ka 
= 7.2 x 10-3 /150000 moles/litre 
= 
This value compares well with published affinities ranging 
6 8 -1 from 4 x 10 - 5 x 10M (Johnson and Brown 1981). This 
is a further check against the validity of the gradient 
derived at 50% binding and subsquently used for .stoinchio-
metric determination. If the gradient point was erroneous, 
its corresponding point on the X-axis, for affinity 
constant calculation would also be wrong. However, as the 
X-axis value reasonably predicted the affinity constant, 
it must be assumed that the gradient was also meaningful. 
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Transformation of LDR-curves into Inverse Scatchard plots 
for assessment of Fe 'II -binding parameters. 
-The ordinary Scatchard linear plot (Scatchard 1949) 
has the form of; 
vl = AB v/ (1- v),K-1 
where b = Bound ligand concentration for both labelled and 
unlabelled; and L = Total ligand concentration, then y = 
b/L, Ab =Total antibody or receptor binding sites, and K, 
the equilibrium constant. The axes yL and yj(l-y) are 
linear. 
This is a disguised quadratic equation in y, with two roots 
y 1 = b/L, y 2 = Ab/b. The second root is particularly 
suitable for data from immunoradiometric assays where the 
antibody or receptor (Ab) is labelled (Addison 19.74). 
The inverse version of the Scatchard plot 'is obtained thus, 
by setting w = 1 - y 
wl = 
with ordinate w/ (1 - w) and abscissa wL, the plot is linear 
-1 -1 
with slope of Ab and intercept ( - K ) on the wL axis, 
There are still two roots in w, since the equation is 
quadratic still, w1 = L b/L and w2 = (b - Ab)/b, w2 is 
a better suited root in immunoradiometric assays and for 
that matter LDR-curves. 
Therefore the abscissa is left at Lw2 whilst ordinate is 
usefully transformed from w/(1 - w) by putting 1 + w/(1 - w) 
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1.0 
B 
Ab 
• ! 
0 
Fig. 25 Schematic representation of an inverse Scatchard 
plot 
Where L = Concentration ligand bound 
Maxim= ] 
w2 = ( B Ab ) = [souod - Plateu counts 
B counts (Bound counts) 
B = Bound counts 
Ab = Maximum bound counts 
Ab = Maximum binding capacity of receptor 
which changes ordinate limits to 0 and 1 (see full theore-
tical and practical details of how these plots aTe done in 
"An Approach to Immunoassay" by W.H.C.Walker, Clin. Chern. 
Vol.23,No.2, pp.384, 1977, and also see Walker 1977. 
Suffice it to use the final form of inverse Scatchard out-
lined in the above article, as illustrated in Fig. 25. 
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Data from LDR curves was easily converted into the 
format of the inverse Scatchard plot for deriving maximum 
binding capacity (Ab) and affinity constant K, both obtain-
able from values on the abscissa axis. 
Data for LDR Plot and Inverse Scatchard. 
1 pl of labelled IgG-H3 (32224 cpm and 0.458 pg protein) 
was added to approximately 500 ul in a reaction tube made of 
380 ~l of 50mM Tris-HCl buffer pH 7.4, 100 pl of 5% bovine 
serum albumin in the same buffer and varying amounts of 
placental membrane protein ( 1- 1000 pg ). GF/C glass fibre 
rapid filters (Whatman) were used to separate bound from 
free radioactivity. Radioactivity on filters was counted by 
dipping them in 5 ml fisofluor 1 (Fisons) scintillant and 
from specific activities, bound IgG at each StMPM concentra-
tion was calculated. Specific binding was assessed in presence 
of a 200-fold excess of unlabelled IgG. A typical experiment 
is shown in Figure 26 for LDR plot and Figure 27 for the 
inverse Scatchard transformation of data. A number of expe-
riments were performed"to determine these constants as per 
Table 5. In this table also published affinities and bind-
ing sites for Fe 0 -IgG system are also given for making caiparisons. 
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Fig. 26 
Log dose response curve for specific IgG-H 3 binding. 
1 Jll of H3-IgG (32224 cpm) was incubated with increasin.,- a!l'ounts 
of membrane protein in a total reaction volume of 500 pl of 
phosphate buffered saline pH 7.4 (PBS), made up of 100 pl o~ 
5% BSA, 380 pl PBS, and a variable volume of me~brane protein. 
Han-specific binding was subtracted when the experi~ent was 
repeated in presence of 91,2)lg of unla.helled Ir:G. 
AFFINITY • q6 X 108 M"1 
ToTAL NO BINDING SITES • 0.68 X 1014 
• 
• 
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- 500 -400 - 300 -200 -150 -100 -so 
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134 
Jt 
AB 
Fig. 27 - shows an inverse Scatchard of data fran Fig. 26. The horizontal 
axis represents bound membrane protein llv2 where L = rrenbrane bound nrotein .. 
( pg/1 ) , and w2 = ( 1 - AB/B). AB = maximum binding capacity (maximum 
counts), and B = bound H3-IgG (bound counts). The intercept on the 
abscissa = ( AB + r1 ) where K = equilibrium affinity constant and a 
rrolecular weight of IgG = 150,000 daltons was used in its calculation. 
The affinity and total binding sites per Ill?.' merri:>rane protein are shown too. 
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From Experimental Data Published Constants 
Expt. Affinity Cons- Binding site~ Ref Ka Binding site 
tant (Ka) fmg StMPM fmg StMPM 
1 8.56 x 108M-1 0·68 X 1014 Johnson 4 x 107M-1 1.5 X 1014 
et al 1981 
2 1,46 X 10 ~-1 1. 32 X 1014 
3 2,1 X 107M-1 0,30 X 1013 
4 5.86 x 107M-1 2.837 X 1013 Niezgodka 1.04 X 107M-1 2 X 1015 
et a1 1981 
5 0.53 X 10 ~-1 14 5.23x10. 
~-1 l·SOx 1014 
Rees and 5 X 108M-1 
-
_Average 2.2 X 10 Wallace 1979 1 X 10~-1 
-
Balfour and - 3,8 im:>l/ug 
Jones 1978 StMPM 
or 
2,37 X 1015; 
mg StMPM 
McNabb 4 x 106M-1 2 X 1012 
et al 1976 
Table 5 
As will be seen there are close similarities of this 
data to that published. In the experimental system, using 
purified membrane, an average of Ka = 2.2 x 108M- 1 and the 
14 
number of sites ef 3.6 x 10 jmg were obtained. It would 
thus appear that the overall affinity constant,pooling all 
available data,is in the order of 107 - 108M-1 whilst total 
number of binding sites are in the order of 1013 - 1014 
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sitesfmg of membrane. The variation seen for these .constants 
amongst different workers, is a reflection, in part, of 
differences in the system used. for example , Balfour and 
Jones 1978, used whole placental membranes, and so did 
McNabb et al 1976, and Rees and Wallace 1979. Johnson and 
Brown 1981, used Chaotrope washed membrane preparations, 
whilst Niezgodka et al 1981, used purified membranes too, 
but these were subsquently solubilised in lithium iodosali-
cylate. 
The IgG-Fcr -Receptor Kinetics; Association and Dissociation 
Rate Constants. 
(1) Optimisation of aliquoting of reaction mixture for 
kinetic data. 
For both association and dissociation rate constant 
determination, it is not practicable to filter the whole 
reaction volume, for purposes of determining bound ligand 
at specified time intervals. This is not because it is 
impossible but it would be too laborious. Aliquoting is 
necessary and because of rapid time sequences with short 
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Fig. 28. 
In the kinetic experiments rapid aliquots of membrane 
at timed intervals were filtered through GF/C (Whatman) 
discs. It was necessary therefore that aliquots contained 
sufficient membrane to give optimal results for the sampled 
fractions. Data shows log dose response curves (LDRs) for 
incubating 300 )lg of membrane and aliq.uoting 100 pl (e e), 
300 ug of membrane and filtering 50 ul <•-•), and 75 pg of 
membrane and filtering 50 pl <•··•) to assess binding. Frorn 
the LDRs, utilising 300 pg and sanpling 100 pl gave a rrore sensitive 
curve (curve shifted to the left) and this was used for all kinetic 
experiments. 
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intervals, it was therefore necessary to find the optimal 
amounts to aliquot which contained sufficient membrane to 
get decent results. 
Initial experiments were performed using 300 pg of 
membrane in 0,5 ml reaction volume and filtering only 100 pl 
through GF/F filters (Whatman), then using 300 pg membrane 
and filtering 50 pl or 75 pg membrane and filtering 50 pl. 
Data is shown in Fig. 28 where varying amounts of IgG-H3 
were incubated with either of the above membrane amounts 
and then aliquoting in the manner outlined. From counts 
of bound ligand for aliquots an estimate of total binding 
due to whole membrane in each tube was made. From the 
three dose response curves in Fig.28, it will be seen that 
using 300 pg of membrane and filtering 100 pl gave better 
sensitivity on the LDR-curve as judged by this curve shift-
ing more to the left relative to the others. Therefore it 
was decided to use these conditions in the subsquent kine-
tic experiments, with the provision that a fixed amount of 
ligand was used usually 2 pl of H3 -IgG ( 0. 458 pg/ul). 
(ii) Association rate constant (k1 ) 
2 pl of lgG-H3 ( 0. 458 pg/pl and 70358 cpmjug) were 
incubated ~ith membrane at 37°C in a total volume of 0,5 ml, 
This consisted of about 378 pl of 50mM Tris-HCl pH 7,4 
buffer, 100 pl of 5% BSA in same buffer and 20 pl contai-
ning 300 pg of membrane (StMPM). At intervals of 30 seconds, 
1,2,3,5,7,10,15,25,30, and 45 minutes, Aliquots of 100 pl 
were rapidly filtered through GF/F filters, that had 
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previously been pre-soaked in ~ BSA. Radioactivity on 
duplicate assay filters was measured using a Tricarb 
scintillation spectrometer in 5 ml of Fisofluor 1 (Fisons, 
Loughborough). Specific binding was obtained in excess 
cold IgG ( x 200 fold ). Fig. 29 shows the association 
3 
curve for IgG-H binding on Fe~ receptor. The second 
order 
where 
rate 
kl = 
kl = 
t = 
Beq = 
Bo = 
constant, k1 , is given by; 
1 [ Beq ] r· Beq - Bt ] • ln BoLo --t Beq2 - BoLo BoLo - Beq Bt Beq 
Second order rate constant 
Time 
Maximum binding at equilibrium 
Initial targ:et (ReceEtor) concentration 
expressed in terms of IgG bound at maximal 
capacity. This is usually done in Receptor 
kinetic work, since actual receptor molecular 
weight and amount are usually unknown and 
reasonable results are usually obtained when 
receptor concentration is expressed in terms 
of maximal ligand binding capacity, 
Lo = Initial ligand concentration 
Bt = Bound ligand at time t 
By plotting ln ( Beq - Bt)/BoLo - Beq Bt) versus time a 
negative linear regression line is usually obtained. By 
calculating the slope of this line, k1 , the rate constant 
can be derived. 
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Fig. 29 Association of IgG-H3 to Fc'lS' -receptor; 
time course of IgG-H3 binding. 
2 pl of IgG-H3 ( -0.916 )lf<. ) were incubated at 37°C with 
300 ?g of placenta membrane protein in a reaction volume of 
500 pl as described in the text. At various times, 100 pl 
of reaction mixture were rapidly filtered through Whatman 
GF/F filters and bound radioactivity (countsjmg membrane 
protein) was plotted as a function of time. 
A typical saturable hyperbolic curve was obtained (Note -
Non-specific binding was subtracted in 200-fold excess cold 
IgG) 
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Fig. 30 Determination of second order kinetic rate 
constant (k1) 
Data from Fig.29 was plotted in a manner described'in the 
text using a second order rate constant equation whereby 
ln ( Beq - Bt )/( B0 L0 - BeqBt ) is plotted against time. 
This gave a negative linear regression whose gradient yielded 
7 1 . -1 the rate constant k1 = 0.676 x 10 M- m1n In this system 
3 Lo (initial ligand concn) = 6. 0 nM of IgG-H and B0 (initial 
receptor coneD) = 8 nM. 
"" I 
0 
...... 
X 
+J 
., 
' cr 
Q) 
., 
I 
0 
-' 0 
., 
' +J 
., 
I 
cr 
Q) 
., 
Q) 
Ol 
0 
142 
20 
•• 
10 • 
8 
2 
1~---.--------.-------~------~r-------~ 
2 6 10 14 
minutes 
Fig. 31 Determination of rate constant (k1) 
This data from a similar experiment to that in Fig. 29 was 
plotted as shown to determine the second order constant as 
in Fig. 30. In this experiment Lo = 4. 44 nM (initial ligand) 
and B0 = 5.33 nU (initial receptor concn), a 
7 -1 -1 k 1 = 3.91 x 10 M min was obtained. The 
constant from two experiments was k 1 = 2.29 
rate constant 
pooled rate 
7 -1 . -1 
x 10 M m1n . 
16 
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whence 
= slope x Beg 
•••••••• 0 •• . (12) 
2 Beg - BoLo 
For full details of derivation of these second order kinetics 
refer to Maelicke et al 1977. 
Determination of Total Receptor Concentration, Bo, for use 
in kinetic experiments. 
In equations (11) and (12), k 1 , cannot be calculated 
unless Bo is known - A prior determination of the total 
receptor concentration Bo, must be made. One of the funda-
mental difficulties lies in not knowing the molecular weight 
and amount of membrane bound receptors, but whose actual 
concentrations cannot be calculat'ed and so. an. indirect 
-estimate has to be made in terms of their. maximum ligand 
binding capacity. 
This is usually done in two major ways; a) membrane 
is varied with a fixed amount of ligand counts; here the 
amount of membrane protein is varied so as to aesorp 10% 
of total counts. This amount is usually evaluated from 
specific activities of ligand and becomes the receptor 
concentration. b) With membrane fixed the ligand is varied 
till maximum binding takes place and from Scatchard plot 
of bound/free versus free ligand concentration, the maximum 
binding capacity (depicting receptor concentration) can be 
calculated. The latter system (b), was utilised to determine 
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Fig. 32 Determination of total receptor concentration 
(B0 ) for kinetic data experiment. 
For data displayed in Figs. 29 and 30, determination of 
receptor concentration (B0 ) was done in a separate experiment. 
Here increasing ligand lgG-H3 ( 70358 cpmf)lg) was added to a 
reaction mixture of 1ml consisting of 756pl of 50mM Tris-HCl, 
3 200 ~1 5% BSA, IgG-H and 660 .~g of membrane protein, 
till saturation occurred. (Note; 4 ul IgC-H3 = 1,83 pg IgG) 
A Scatchard plot is shown from which the maximum receptor 
concentration (B0 ) = 8.0 nM (intercept) was calculated using 
IgG MW = 150,000. 
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receptor concentration Bo, in the following kinetic assays, 
Fig. 32 shows one such assay to establish, Bo, which was 
equal to 8nM receptor concentration. 
Data to determine k 1 association rate constant. 
Fig. 30 shows a plot of ln ( Beq - Bt /BoLo - Beq Bt) 
versus time for data shown in Fig, 29. A rate association 
constant, k 1 = 0.676 x 10
7 M- 1 min-1 was obtained using 
equations ( 11) and ( 12). In this assay Lo = 6. OnM of H3-
IgG and Bo = 8nM of receptor concentration and 2 pl of 
IgG-H 3 at 0.458 ugful in a reaction volume of 0.5 ml. 
Fig, 31 shows another similar experiment whereby 
Lo = 4.44nM of IgG-H 3 and Bo = 5.33nM, 'receptor concentration'· 
7 
-l - 1 bt . d A The rate constant, k 1 = 3.91 x 10M min . wa$ o allle. n 
7 -1 -1 
average of k 1= 2.29 x 10 M min , was achieved from the 
two types of experiments. 
Dissociation of IgG-FclS' Rate Constant (k2) 
2 pl of 3H-IgG at 0,5 pg/pl was incubated with 20 pl 
of StMPM (membrane) representing 660 pg membrane protein; 
200 pl of 5% BSA in 50mM Tris-HCl pH 7,4 buffer and 756 pl 
of buffer to make up to 1 ml of incubation volume, Reaction 
proceeded at 37°C for 1 hour to attain equilibrium. Then 
1000 pg unlabelled IgG ( x 1000-fold excess) were added, 
and kinetic measurements of dissociation commenced at 0, 
30 seconds, 1,3,5,10,15,25 and 55 minutes, and rapidly 
filtering through GF/F filter discs. 
Fig. 33 shows a dissociation curve plotted as perce-
ntage inhibition of maximum binding at t = 0, versus time 
from first order kinetics. 
k2t = ln Bt/Beq 
k 2 = -(ln Bt/Beq) 1/t 
Therefore a plot of ln Bt/Beq, versus t (time), a negative 
linear regression curve was obtained as shown in Fig. 34 
The gradient (s), gave k 2 (s). The regression in Fig.34 
showed two linear segments, one occurring within the first 
10 minutes of the dissociation and having a half life (t!) 
-1 
= 6! minutes and k 2 = 0,10 min and a slower component 
-1 k 2 = 0.010 min , ten times less than the first, and which 
characterised the rest of the dissociation curve. This 
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experiment seems to suggest two receptor sites, with diffe-
rent dissociation rates, the first with low affinity (high 
k 2 ), and second high affinity (low k 2 ). 
-1 -1 M min (from association data) and k 2 
(k2 /k1 ) of 2.55 x 10-
9M was obtained. 
Using k1= 3,91 x 10
7 
-1 
= 0.100 min a K0 
This extraordinary finding seemed to suggest hetero-
geneity of Fe 'a' -receptor sites, at least on the dissociation 
curve. The association curve did not show this - It is 
possible, as has been shown in other receptor systems that 
the kinetics of receptors is dose dependent and sometimes, 
activation or recruitment of other receptor sites can be 
manifested depending on the activating or inhibitory ligand 
concentration. Thus some sites can be inhibited or activated 
in a dose dependent manner. This allosterism has been shown 
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Fig. 33 Dissociation of IgG-Fc l5 rate constant (k2) 
2 pl of IgG-H3 (1 pg) was incubated with 660 pg of placental 
membrane protein in a reaction volume of 1ml consisting of 
778 pl of 50 mM Tris-HCl pH 7.4 and 200 pl of 5% BSA. The 
reaction was allowed to proceed to equilibrium at 37°C for 
1 hour and then an excess unlabelled IgG (x1000 fold, ie. 
1000 pg) was added and then 100 pl aliquots sampled and 
filtered through GF/F filters. The dissociation curve is 
shown with arrows depicting 50% binding (t! = 6! min). 
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Data in Fig. 33 was subjected to loge (Bt/Beq) against time, 
where Bt is the ligand still bound at time t and Beq is the 
steady state bound IgG prior to displacement. 1000 p.g of 
unlabelled IgG had been used. Data here shows a heterogen-
eous curve with the first linear initial fast component 
(t! = 6! min, (arrowed) with k 2 = 0.10 min-1) and a second 
slower component (k2 = 0.010 min-1). Overall the high dis-
placing dose revealed heterogeneity of binding sites on 
the Fe~ -receptor. 
60 
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to occur, for example, with the acetylcholin·e receptors which 
may exist in different forms. 
It is difficult to draw hard and fast conclusions regard-
ing the Fc 0 -receptor in the light of this apparent hetero-
geniety from the dissociation data. It is noteworthy with 
regard to the deployed unlabelled displacing dose (1000-fold 
excess) that this might affect the kinetics of dissociatioQ 
to expose heterogeniety of receptor sites. On available 
data from literature the inhibiting doses have normally been 
around 200-fold excess against 1 pg of I 125-IgG (Brown and 
125 Johnson 1981), 160 pg against 0.082- 18 pg I -IgG (Niez-
125 godka et al 1981), and 50 pg cold IgG against 1 pg I -IgG 
(Johnson and Brown 1980). In none of many of these experi-
ments was dissociation kinetics specifically measured parti-
cularly with high unlabelled doses. The main concern was 
in inhibiting non-specific binding. 
Heterogeneity of IgG receptor binding has been only 
reported once by Rees and Wallace (1979), who showed a 
biphasic Scatchard plot. At two temperatures of 4°C and 
37°C, they showed Ka of 5 x 108M- 1 and 1 x 108 M-1 (4°C) 
as well as Ka of 4 x 10 7M- 1 and 5 x 106M-1 at 37°C. Thus 
the second lower affinity component varied 5 to 8 times 
less than its higher affinity counterpart at both 4 and 37°C 
respectively. In the present study, the lower affinity 
component was 10-times less than the high affinity one, 
which agrees closely to Rees and Wallace's findings. 
To summarise, it appears there is a need to investigate 
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as to whether the Fe'( -receptor can exist in different states. 
The more reported homogeneous population of receptor sites 
is only a limited view particularly when high ligand or 
displacing doses have not been sufficiently used to this end. 
Thermodynamics of lgG and Fey· receptor Interaction. 
Introduction. 
Temperature effects on binding of IgG to placental 
receptors have been studied by Balfour and Jones (1976), 
who found greater binding at 37°C than at 4°C, Niezgodka 
et al (~981), using isolated membranes found no differences 
at all in specific binding at 4°C to 45°C. Ockleford and 
Clint (1980) however, used incubated placental tissue and 
found depressed lgG uptake at 4°c in contrast to enhanced 
uptake at 37°C, 
These workers differentiated between mere binding of 
lgG to its receptor and subsquent uptake which is modulated 
by endocytosis (Ockleford and Clint 1980, Arend and Mannik 
1973), Thus temperature might exert different effects on· 
'· 
these two interrelated but independent processes of binding 
and uptake.Ockleford and Clint stated that lower temperature 
principally inhibited uptake and not binding, whilst higher 
temperatures enhanced both binding and uptake, They found 
uptake at 4°C to be 20% of that found at 37°C, Therefore 
temperature studies have generated both conflicting and at 
times complimentary results. 
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In the present study temperature effects were re-appraised 
with respect to binding of lgG on isolated placental membranes. 
A choice of 0,20, and 45°C temperatures was made. Any diffe-
rences in binding were used to calculate some thermodynamic 
parameters such as the activation enthalpy and entropy energy 
changes. These would give sane clues as to the molecular 
nature of the IgG-receptor interaction. 
0 Assay and Assessment of lgG Binding at 0,20, and 45 C. 
0 - 1400 pg of placental membrane protein were incubated 
with 2 pl of 3H-IgG (138258 cpm and specific activity 27651 
cpm/pg), in a total volume of 0.5 ml per tube made up of 
350 pl of 50 mM Tris-HCl pH 7,4 buffer, 100 pl of 5% BSA in 
same buffer, and a variable volume of membrane (0 - 35 pl 
at 40 pg/pl). One set of duplicate assays was incubated at 
0°C for 3 hours, another at 20°C for 2 hours and the last 
at 45°C for 1 hour. 
At the end of incubation the duplicate reaction mixtures 
were filtered through GF/C glass fibre filters (Whatman) to 
assess bound radioactivity which was subsquently plotted 
against membrane concentration as shown in Fig, 36. From 
the log dose response curves, it would appear that there is 
more binding at 0°C than at 20°C and than at 45°C. However, 
the reason for increased binding with respect to lowered 
temperature can be due to either a change in affinity or 
total binding capacity (number of sites). To find out,data 
from Fig. 36 were transformed into inverse Scatchard plots 
to check on affinities and binding capacities as shown in 
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temperatures. Conditions of the assay are as described in 
the text. 
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Fig. 37 Scatchard plot of saturation data. 
Binding data in Fig. 36 depicting the effect of temperature 
on IgG-H3 were subjected to the inverse form of the Scatchard 
plot to find out whether temperature affects the equilibrium 
constant (Ka) and the total number of binding sites (AB) for 
the Fe "'6 -receptor, Results are given and discussed in the text. 
L =amount of IgG bound in pg per 50 pl of.reaction volume 
containing a specific amount of mE.mbrane. 
A = amount or number of counts of I~G bound. 
AB = maximum number of counts or amount of IgG bound. 
W = ( 1 - AB/A ) 
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Fig.37 
There were slight changes in affinity as per; 
8 -1 0 8 -1 0 Ka = 2.66 x 10M at 0 C, Ka = 1.77 x 10M at 20 C, and 
Ka = 1.45 x 108M- 1 at 45°C. Clearly the affinity went up 
with respect to lowering the temperature. It increased by 
1.8 times at 0°C, which was almost twice the value at 45°C. 
Likewise, the binding capacities were 0.118 x 10-7M at 
-7 0 7 0 0 .107 x 10 M at 20 C, and :::.OC!."..:::1~0~8.....!.:x.....:o.10:::..-_M:::.._:a:::.;t::.....;4~5~C. 
There was a slight increase in binding capacity at 0°C 
although by 20°C,right through to 45°C similar binding capa-
cities were obtained. The slight increase in capacity at 
lower temperatures could be significant for the placenta 
taken as a whole. 
The changes are small and little wonder that Niezgodka 
et al (1981), who did not look for any possible alterations 
in affinity or binding capacity concluded that there were 
no differences in specific binding between 4°C and 45°C. 
Nonetheless,. the slight increases in both affinity and 
binding capacity at low temperatures make sense in terms 
of the fluid mosaic model of plasma membrane proposed by 
Singer and Nicholson (1972). The lower temperature leads 
to diminished membrane fluidity and this restricts lateral 
movements of receptor molecules which increases the apparent 
nett binding capacity. At higher temperatures, the overall 
affinity drops as there is more kinetic movements leading 
to dissociation of ligand and increased fluidity and so 
both the affinity and to a much lesser extent, the capacity 
may drop. 
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Discussion of effect of Temperature on Binding 
In essence this data could be interpreted that the 
primary change is in the affinity rather than the capacity. 
In fact one could go further to add that the capacity over 
this temperature range is presumably not significantly 
altered. A very comparable situation has been observed in 
a very recent study, by Ciaraldi and Olefsky (1983), who 
specifically examined the effect of temperature on the coup-
ling of insulin receptors to stimulation of glucose trans-
port in the isolated rat adipocytes. Their temperatur.e 
range included 16°C, 24°C and 37°C. 
They found that both total and cell surface binding 
varied in an inverse linear manner over this temperature 
range. Scatchard analysis of their data suggested that 
diminished binding was caused by altered affinity as tempe-
rature rose with no concormitant change in the overall 
receptor numbers. They added that the drop in affinity was 
caused by an increase in the dissociation rate as tempera-
ture rose but with no change in the associ at ion rate. In 
these two respects there seems to be close similarities 
between the insulin receptor behaviour with respect to 
temperature and the Fey -receptor data in the present study, 
where the lgG binding capacity. was slightly. greater at 0°C 
than say at 20°C and 45°C. This was judged from the log dose 
response curves; the half-maximal binding (at 50% or the 
IC50 ) is for example, greater at 0°C than at 45°C. It must 
therefore be assumed, as in the insulin receptor study that 
the dissociation rate fGr IgG from its receptor increases 
with rising temperature, and hence the fall in binding. 
This is evidenced by corresponding association constant (Ka) 
to drop by 1.8 times between 0 and 45°C as has been demonst-
rated. 
This data contrasts that of Watabe et al (1980), who 
showed IgG binding to 60,000g placental pellet to be less 
0 0 
at 4 C than at 37 C. 
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Other receptor systems have been studied with respect to 
temperature. Maes et a1 (1981), who studied the Warfarin-
albumin binding system also noted the decrease in binding 
affinity with the rise of temperature,although these workers 
did not investigate on what happens to total binding capacity 
as has been done for the IgG-Fc~ receptor system in the 
present study, where temperature causes measurable changes 
to the affinity and total number of binding sites. Niezgodka 
et al (1981) denied any effects of temperature on binding 
between 0 and 45°C, although in their paper no data is given 
for either the effect on affinity or binding capacity. 
Ockleford and Clint (1980) tried to speculate on dimi-
nished uptake at 4°C as opposed to 37°C to be due to possible 
depression of function of cytoskeletal elements presumably 
actin filaments which mediate endocytic vesicle formation 
and hence uptake. These workers too stated that there was 
no temperature effect on binding althrugh in the same paper 
they proceeded to speculate that both uptake and binding were 
enhanced at higher temperatures. As for binding per se, 
they did not produce any data to prove that there was no 
effect on binding with respect to temperature, particularly 
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as they utilised placental tissues to measure uptake rather 
than isolated membranes which measure birlding. 
Thermodynamic Activation Enthalpy and Entropy changes. 
The changes in affinities between 0 and 45°C were 
submitted to aVant-Hoff plot as shown in Fig.35 where 
loge K (where K is the association equilibrium constant) 
is plotted against the reciprocal of temperature (1/T) as 
deduced from the following relationships; 
6G = RT ln K .................. (13) 
or 
But 
Therefore 
ln K = AG 
RT 
A G = AH - T A S ••• 0 • 0 • 0 •• 0 ••••• 
ln K. = -(AH-TAS) 
RT 
(14) 
or ln K. - - AH + AS (Vant-Hoff equation) .... (15) 
RT R 
Therefore a plot of ln K (loge of equilibrium association 
constant ,K) against 1/T (degrees Kelvin - 1 ) is linear IVant-
Hoff plot), with gradient of -t::.H/R, 
where 
K = EquilibrilJ!ll association constant at a particular 
temperature. 
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G = Gibb's free energy 
H = Activation enthalpy 
s = Activation entropy 
T = Temperature in degrees Kelvin 
R = Gas constant = 1.987CaljMolejdegree 
Fig. 35 shows results of a Vant-Hoff plot far: three specific 
temperatures, namely, 0.20 and 45°C. 
Table 6 summarises all the thermodynamic parameters obtained 
with use of equations 13,14, and 15 in addition to the affi-
nity and total number of binding sites, with respect to 
different temperatures. 
Discussion of Thermodynamics results. 
Thus the binding of IgG to its Fe~ receptor is exother-
mic with ~H = -2.51 Kcal/Mole as well as associated with 
favourable b.G of -10.52 to -11.87 Kcal/Mole. Even more 
important is the associated large positive entropy changes 
-1 -1 0 0 
of +29.4 Cal.Mole degree K between 0 and 45 C. Thus 
the binding ·has unfavourable enthalpy change but a very 
favourable large entropy changes which are typical of hydro-
phobic interactions. 
Therefore at a molecular level the binding IgG area 
includes or extends to the hydrophobic region of the receptor 
and the reaction is entropy driven. Furthermore, the marked 
exothermy of ~H -1 = -2.51 Kcal.Mole is also typical of 
reactions ascribed to involvement of hydrogen bonding. 
0' Rielly et al ( 1967 ) studied the anticoagulant Warfarin's 
1.0 
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Fig. 35 - shows a Vant-Hoff plot. For calculation of activation 
enthalpy (~H) from the gradient of logeKa against 1/T0 (per 
degree Kelvin), where Ka is the equilibrium constant at 0°, 20°, 
and 45°C. _From the gradient ( 6 H/R) and gas constant, 
R = 1. 987 Cal. Mole-1 deg-1, ~H = -2.51 KCal. Mole~l was obtained 
for IgG-H 3 - Fe 0 receptor interaction. 
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Ka ~tal No. of. AH 6s Gibb's Free 
RATURI binding sites (Kcal/M:ile) (Cal.Mole-1K-1 energy (Affinity) /1G (Kcal/ 
(Capacity) (Enthalpy (Entropy} Mole) 
0°C' 2,66-X 10 ~-1 0.118 X 10-7M -2.51 +29,4 -10,52 
20°C 1. 77 x 101\r-1 0,107 X 10-7M -2.51 +29.3 -11.21 
45°C 1,45 X 101\r-1 -7 0,108 x 10 M -2.51 +29.4 -11.87 
Table 6 - shows various thennodynamic parameters for interactioo between 
the IgG and its Fey -receptor at various t~ratures. The changes in 
equilibrium constant and total nllllbers of binding sites are also given. The 
reactioo is associated with high negative enthalpy ( 6 H = -2. 51 KCal/V.Ole) 
A . -1 -1 
which is exothennic and is entropy driven ( -uS = + 29. 3 Cal. J.ble K ) due 
to hydrophobic binding. 
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A -1 binding on albumin and noted wH of -3.14 Kcal.Mole which was a very 
pronounced exothermy and they ascribed it to hydrogen bonding. 
Still on similar studies, many workers have also noted the 
A -1 -1 high entropy changes of ~S = +21 Cals.Mole deg (Maes 
et al 1982) and -1 -1 = +16 Cals.Mole deg (Oester et al 
1976) which they too ascribed to hydrophobic interactions. 
Thus the IgG-Fcr system has close similarities to other 
binding systems. 
Dumphy et al (1981), also studied specific binding of 
3H-phorbol, 12, 13-dibutyrate by mouse brain at 4°, 13°, 
23° and 37°C. They found slight increase in endothermy 
( 8 H = +0. 4 Kcal/Mole ) associated with large entropy changes 
of ~S = +38 Cal/Molefdeg, which they too attributed to 
hydrophobic nature of binding. 
Modulation of IgG-Fc ¥-receptor Binding by Monovalent and 
Divalent Cations. 
Various workers have studied effects of pH, ionic 
strength, and even temperature on binding of IgG to its 
receptor (Balfour and Jones 1976, Brown and Johnson 1981, 
Watabe and Gitlin 1979, Niezgodka et a1 1981), In these 
experiments, ranges of pH (6,6- 8.8), 0°C- 45°C for 
temperature and ionic strength 0.05 - 0.5M NaCl from Niez-
godka et al were studied whilst Brown and Johnson investigated 
pH (5.4- 9.4), ionic strength 1- 200mM Tris-HCl pH 7.4. 
Others have used 4 °C - 37°C tempera.ture gradients, 
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It must be emphasised that whilst'drastic changes in 
binding or even uptake have been noted, these pH, ionic 
strength and temperature gradients are non-physiological, 
and more of mere in-vitro laboratory assays. This is the 
the major criticism of all these experiments in that these 
drastic changes in these variables are harrtly encountered 
in vivo-physiological milieu, Body temperature is constantly 
kept at 37°C, and the drastic temperature differences at say 
4°C for which altered binding and uptake have been obser-
ved, are not applicable to in vivo situations. Therefore in-
vivo modulators of binding or even uptake must be sought. 
Possible in-v.ivn modul.atorR nf h.inding have beAn exaltlined 
with respect to oestrogen receptor, having also shown that 
in vitro activators such as temperature, ammonium sulphate 
precipitation, addition of salts for the oestrogen receptor 
are not operative in vivo. The search for others resulted 
in discovery that phosphorylation (addition of ATP to the 
system), induced increased nuclear ( King et al,1971,) 
or DNA ( Nawata et al 1981 ) binding to the oestrogen 
receptor. Also it increased binding of glucocorticoid rece-
ptor (John and Mondgil 1979). Proteases also have stimu-
latory effects on oestrogen receptor-DNA binding, therefore 
it emerged that phosphorylation and/or proteolysis led to 
in vivo activation of oestrogen and glucocorticoid receptors. 
There is a need to study these factors with respect .to the 
IgG receptor. 
In the present study univalent and divalent cations 
were selected for their modulation of IgG binding. These 
included cations normally found in vivo such as sodium, 
calcium, and magnesium, others of interest included lithium 
(this cation is not physiological except in therapeutic 
doses) and manganese, Physiological doses were in some insta-
nces exceeded to observe their effects on IgG-receptor bind-
ing. 
Materials and. Methods. 
Membrane (StMPM) was prepared as described before and 
had protein content 33 mgjml. Therefore 20 pl of StMPM 
which was used in incubations delivered 0.66 mg StMPM. How-
ever, in cases of Ca, Mg, and Mn incubations membranes were 
first treated with ethylene glycol tetraacetic acid (EGTA) 
or ethylenediamine tetraacetic acid (EDTA), as follows to 
get rid of endogenous Ca, Mn, and Mg; 
Suspend membrane pellet in 50mM EGTA in 
50mM Tris-HCl pH 7.4 
Stir 30 min 
Centrifuge x lOO,OOOg for 35 min 
J, 
resuspend pellet in 50mM EGTA 
jsomM Tris-HCl pH 7. 4 and I homogenise in Dounce HOMOGENIZER 
Centrifuge x lOO,OOOg for 30 min J ~ Pour off supernatant 
PELLET 
FREE Pellet of EGI'A by washing 'IWICE in 50ml' Tris-HCl pH 7. 4 in Ibunce 
Homogeniser and centrifuge at lOO,OOOg. for 20 minutes. 
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The membrane is now ready for use in the experiments with 
cations. 
Table 7 shows the details of relative concentration ranges 
prepared for each cation for incubation with placental 
membranes. 
Assay of Binding with respect to Cations. 
20 pl of non-EGTA treated StMPM (0,66 mg protein) was 
incubated with 2 ul of IgG-H3 (5pg) in a series of reaction 
volumes of 0.5 ml per tube made of the above membrane and 
ligand plus 369 to 299 ul of 50mM Tris-HCl pH 7,4 buffer 
corresponding to 10 to 80 pl of added univalent cations 
+ .+ (Na and L1 ), The dispensed volumes were made up such that 
concentrations in a reaction volumes of 0.5 ml spanned the 
range of 10- 160mM as per table 7. Each tube also 
contained 100 pl of 5% bovine serum albumin to minimise non-
specific binding. 
For other cations such as high dose of Li+(l- 4M), or 
C 2+ a ' 
2+ 2+ Mg , Mn (1 - 15mM each) appropriate volumes of these 
were dispensed as per table 7, and added to adjusted buffer 
volumes, plus 100 ul of 5% BSA, to 
volume of 0.5 ml. For Ca2 +, Mg2+ 
' 
give a total reaction 
and Mn2 + incubations, 
20 pl of EGTA treated membrane were used in each case, 
At the end of 1 hour at 37°C and at constant mixing, 
each of the duplicate assay tubes of 0.5 ml were rapidly 
filtered through GF/C glass fibre filters (Whatman), and the 
radioactivity retained on filters was measured in vials of 
5 ml Fisoflour 1 (Fisons) scintillant with a Tricarb 
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Monovalent Cations Note. Con en. are based on a Total Reaction Voli.IIIE = 0. 5 ml 
-
NaCl Voli.IIIE dispensed 10 20 30 40 50 60 -70 80 
( ).11) 
( 5.84g/100ml ) Concentration 20 40 60 80 100 120 140 160 
( mM ) 
(Lcm) LiCl Vol. dispensed 10 20 30 40 50 60 70 80 
( ,ul ) 
( 4.24g/100ml ) n Cone (mM) 20 40 60 80 100 120 140 160 
(High) LiCl Vol. dispensed 10 20 30 40 
( pl ) 
( 21. 2g/10ml ) Concn ( M ) 1 2 3 4 
Divalent Cations 
CaCl2 Vol. dispensed 10 20 30 50 90 120 150 
( ).11 ) 
( 1. 095g/100ml ) Concn ( mM ) 1 2 3 5 9 12 15 
MgCl2 Vol. dispensed 10 20 30 50 90 120 150 ( )ll ) 
( 1. 016g/100ml ) Concn ( mM) 1 2 3 5 9 12 15 
MnCl2 Vol. dispensed 10 20 30 50 90 120 150 ( }ll) 
( 0.989g/100ml ) Concn ( mM) 1 2 3 5 9 12 15 
Table 7 
scintillation spectrometer. 
Specific binding was assessed in a third tube at each 
concentration where lmg excess unlabelled 'cold' IgG was 
added. Specific binding in tubes incubated with cations 
was then related to the 'zero' tubes where no cations were 
added and percentage change in binding was plotted as. a 
function of concentration of added cations. 
Results 
Fig. 38 shows the results for Na +, and Li + ( 0 - 160mM) 
and high dose Li+ (1 - 4M) whilst Fig, 39 shows data for 
2+ 2+ 2+ + + Mg , Ca and Mn (1 - 15mM). For both Na and Li (0 -
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160mM) there is a steady but marked drop in specific binding 
at lOOmM concentration for both cations; there was a 35% 
drop for Na+ and a 36% drop for Li+ which were practically 
identical depressions for both at this concentration, 
At 2mM Li+ no depression occurs, this is important 
because Li+ is not a physiological cation and patients 
receiving Li+ for treatment, the therapeutic range should 
not exceed 2rnM otherwise toxicity occurs. If therefore 
less than 2mM were to be given in pregnant women, no effect 
should be observed in vivo for lgG binding. High in-vitro 
Li+ concentration (1 - 4M) resulted in severe depression of 
IgG binding and by 1M and right up to 4M, a plateau of depre-
ssion of 50% binding was achieved. 
Na+ ion has a normal physiological range of (135 - 145 
mMoles/litre). This ion showed significant modulating effect 
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Fig. 38 - shows inhibition of binding of IgG to its receptor by monovalent 
cations. Physiological concentrations of sodium caused rna!Xed reduction 
in binding. Similar depression was caused by an equivalent concentration 
of U +. For higher doses of U + inhibition plateued off and any further 
U + did not cause inhibition in excess of 50%. 
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Fig. 39 - shows the effect of divalent cations on IgG-binding. 
. 2+ 2+ 2+ All cat1ons O~g , Ca , and Mn ) caused marked inhibition 
of binding as described in the text. 
on IgG-binding since between this reference range some 45 -
50% inhibition of binding was observed. 
2+ 2+ 2+ Mg , Ca , and Mn , also resulted in marked inhibit-
ion of binding as the dose of ions was increased in each 
incubating medium. Mg2 + reference physiological range is 
0.7- 0.95rnMoles/litre. However, at 1- 2mM, there was some 
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increase of 8.4% in binding. Beyond 2mM, increasing inhibit-
ion of binding was observed and by 10mM there was a 30% drop 
in IgG binding. 
Ca2 + reference normal range is 2 - 2.6mMolesjlitre. 
At 2.6mM there was 13% inhibition, and by 10mM there was 
33,3% depression in binding similar to that of Mg2 + 
Mn2 + is an essential trace metal and present in serum 
at 10.7 ± 2.2nmolesflitre (0,0107 z 0.0022mM). There are 
very small quantities and for purposes of the experiment 
millimolar quantities were used. There was a steady dose 
dependent inhibition of binding, of 1.7% by 1mM and 45% at 
10mM, and which continued to fall to 68% by 15mM Mn 2+. 
Of the three divalent cations Mn 2+ seemed to have more 
inhibitory potential, and it is just possible that at the 
receptor level normal physiological levels could still regu-
late IgG binding. 
Discussion 
Niezgodka et al 1981, studied ionic strength 0,05 - 0.5M 
NaCl and claimed no effect on r 125-IgG binding for 0.1- 0.5 
range whilst a decrease to 0.05 increased binding by 40%. 
Watabe et al 1980, in contrast to Niezgodka et al, found 
+ 
significantly marked inhibition of binding. For both Na 
2+ 
and Ca at 0.1M more than 50% inhibition was attained and 
by 0.2M for either cation, binding was reduced to 20% of 
control value. 
The above papers are practically the only specific 
references to IgG binding and the effect of cations. The 
present study was an attempt to delve a.bit further and 
also expand the range to include Li+, Mn 2+, and Mg2 + from 
N + 2+ . d . h b . a and Ca ment1one 1n t e a ove stud1es. Results are 
unequivocal in terms of showing marked effects of these 
cations in depressing IgG binding and more or less in line 
with what Watabe et al ·1979, observed for Na+ and ca2+. 
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Cations have been extensively studied in some receptor 
systems and a brief mention of a few will be made. Shiu and 
Friesen (1974) studied Na+, ca2+, and Mg2+ ions with respect 
to r 125-labelled Ovine prolactin binding on mammary gland 
prolactin receptors. NaCl at 50mM enhanced binding of 
prolactin·whilst 10- 25mM CaC1 2 increased binding three-
fold. Higher concentrations of ~11 salts started to inhibit 
binding. MgC12 (1 - 10mM) increased binding by 1.5 - 2.6 
fold over the concentration range. 
Roscher et al (1983) have studied bradykinin receptors 
in cultured human fibroblasts. + Na at physiological conce-
ntrations and ca2 + or Mg2+ at 3 - 10mM reduced bradykinin 
binding by 25% 
ACTH hormone binding to its receptor is likewise very 
sensitive to ca2 + ions as has been shown by Lefkowitz et al 
(1970). Here even within the physiological ranges of ca2 + 
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marked fall in binding was noted. However, by lOmM binding 
was totally inhibited. Summers (1980), studied 3H-clonidine 
binding to the o( 1-adrenergic receptors in kidney membranes 
+ + 2+ 2+ + + 
as affected by Na , K , Mg and Mn . Both Na and K 
produced concentration dependent decreases and 50% reductions 
respectively. Mn 2+ ( 0. 1mM) were achieved by 25mM and 37mM 
2+ 
and Mg ( 1mM) produced marked enhancement of binding follo-
wed by dose dependent inhibition at higher concentrations. 
Summers was able to show from Scatchard plots that Na+ 
inhibited binding by reducing the apparent affinity and not 
th · t b f t "t Mg2+ and Mn 2 + at low e agon1s num er o ·Tecep or s1 es. 
concentrations increased the apparent affinity. He also 
speculated on cations acting.as physiological modulators with 
respect to o( -adrenergic receptors. 
It is tempting to formulate a unified theory to explain 
these ionic effects on receptor function, since many simi-
larities and sometimes identical effects have been observed 
on receptors of different types. Summers, for example, spe-
+ 
culated on the possible link of a receptor to Na transport 
system and since Na+/K+ ATP'ase pump system exists ubiqui-
tously local concentration of these ions at membrane surfaces 
+ + 
or through Na JK channels could indeed have significant 
controlling effects on contiguous receptor molecules. 
In the present study profound inhibiting effects of 
IgG and Fe'(- receptor binding lend support to a possible but 
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significant local control or regulation, particularly when 
physiological levels exhibited marked alterations in binding 
of IgG, All cations investigated inhibited IgG binding 
+ 2+ . 2+ 
at physiological levels for Na , Ca and h1gh dose for Mg , 
Li + and Mn2+. 
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CHAPTER 5 
PLACENTAL SELECTIVITY AND TRANSFER OF PLASMA PROTEINS; 
STUDIED BY IN-VITRO PERFUSION SYSTEM. 
5.1 Introduction 
The placenta is a remarkable organ in that it can perform 
multiple complex functions condensed into a single organ but 
which would normally require several separate organs. Amongst 
its prime functions are gaseous exchange, endocrine function, 
selective transfer of amino acids, antibodies, monosaccha-
rides, lipids and proteins. Salt and water transfer are also 
of major importance. The placenta can perform all these 
functions and yet remain an effective 'barrier'. 
There are general principles governing placental exchange. 
These include concentration gradients, exchange area, thick 
ness, and permeability, molecular size, lipid solubility, 
degree of ionisation and the molecular conformation of trans 
ported material (Hill and Longo 1980). These are a formidable 
array of variables and whilst the placenta in-vivo manages 
to modulate them, it imposes an almost impossible task for 
in-vitro or indeed in-vivo experimental design to study 
transfer. 
The placenta also transfers red blood cells from maternal 
to the foetal circulation during pregnancy and at delivery 
(Lewi et al 1961). Likewise foetal red cells are 
' 
evidenced by HbF (Foetal haemoglobin), have also been detected 
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in maternal circulation (Cohen et al 1964). Clint, Wakely 
and Ockleford (1979), have shown that there are depressions 
or pits on the syncytiotrophoblast with correct size to 
engulf red blood cells or several of them and these workers 
have proposed that these 'pits' are differentiated regions 
with receptors for red cells. It could be that these enclo-
sures transfer red cells eventually to foetal circulation. 
The importance of these tiny red cell leakages into the 
foetus and vice-versa, is not clear. 
The placenta also transfers maternal lymphocytes, 
although the potential dangers of exposing maternal anti-
gens expressed on these cells to the foetus are evident. 
The problem and tolerance to these cells has been reviewed 
by Adinolfi (1970). 
5.2 Transcellular and Paracellular Placental Transfer 
Pathways and the Selectivity of Uptake. 
The transfer of macromolecules across the placenta 
poses some problems. Two pathways have been proposed, the 
transcellular and paracellular pathways. There is little 
morphological evidence as a basis for assessment for presence 
or absence .of paracellular form of transport.,~n contrast, 
the syncytiotrophoblast is in direct contact with 
maternal blood, any uptake is mostly, if not all, by trans-
cellular route (Stevens and Samuel 1979). For transcellular 
route to be more effective, areas of the surface epithelium 
have differentiated to subserve a function of molecular 
recognition by specific adherence or adsorption, as a 
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prelude to membrane invagination and formation of transport 
vesicles. 
These are of two types, the smooth and coated endocy-
tic vesicles. These organelles are thought to mediate 
transcellular transfer of materials for both local needs 
(for placental use and synthesis) and foetal uptake. The 
coated vesicle route is the basis of selective and protec-
ted transport across cells by which proteins normally required 
intact, must be transported. 
In the pictorial words of Hemming and Williams (1976), 
"The protein enters the cell; some is passed on 
through and some is degraded. But the fascinating 
thing is that in those cells there dwells a 
·Maxwell's demon or perhaps a troop of slightly 
specialised demons , which picks over the molecules 
as they enter, deciding what is acceptable and may 
be passed on and what is not and must be degraded; 
that is selection". 
In a nutshell this entails the whole concept of selective 
transfer of molecules particularly macromolecules, as first 
proposed by the Late F.W. Rogers Brambell (1966, 1970). 
Brambell, accepted that primary entry into the micropino-
cytic vesicles was random, and that was non-selective, but 
from thereon, the walls of these vesicles contained specific 
receptors. which recognised the Fc-portion- of the homologous 
IgG. 
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On fusing with lysosomes, the encapsulated lgG was 
protected against proteolysis by steric hindrance, so that 
the vacuole at last contains only the receptor-selected 
protein.. What is true of lgG could be true for many other 
proteins or peptides and hormones with respect to receptor 
selected uptake. 
Brambell's ideas have since been refined, and instead 
of one vesicle containing both non-selected and selected 
protein at first, the existence of smooth and coated 
vesicles has simplified matters; it is now thought that 
the coated vesicles rather than the smooth vesicles are the 
ones with receptors and transfer protein molecules protected 
against proteolysis, whilst smooth ones are for stuff 
destined for placental digestion (Wild 1973, Wild 1979, 
Hemming and Williams 1976, Gitlin and Gitlin 1976). 
5.3 Receptor Recycling after Transfer. 
L 
i 
L + R.~ RL 
L = ligand 
R = receptor L R 
Membrane 
R 
recycling 
Coated vesicles have received vigorous study to chara-
cterise their structure and particularly as they are the major 
vehicles of endocytically protected transcellular uptake. 
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Their ilmer periphery is thought to have the specific receptors 
to various molecules including proteins, polysaccharides, 
fats, certain vitamins and inorganic ions (Llewellyn-Jones 
1969, Ockleford and Whyte 1977). 
The mechanics of vesicle formation involve transforma-
tion of particular hexagons existing as hexagonal lattice 
under the cytoplasm surface of the membrane into pentagons 
with the same length of side; this produces curvature in 
the membrane and eventually causes the vesicle to pinch off. 
Numbers of coated vesicles at the membrane surface do 
not seem to diminish with time although they are continually 
being internalised and carry membrane, From cell economy 
considerations, it follows that re-cycling (depicted in the 
above diagram) of membrane and hence receptors must be taking 
place (Ockleford and Whyte 1977), or else new receptors are 
continually being re-synthesised. 
Theoretical Models of Membrane Transfer; possible application 
to Placental Uptake. 
5,4.1 Diffusion Model. 
The general flux across membrane by diffusion forces 
is given by; 
J = -c A w ou 
DX 
(Leaf 1981) 
where, J = flux of solute across unit area of membrane, is 
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proportional to force du/dx exerted on solute, concentration, 
c, of solute, to fraction A of membrane area available to 
penetration by the solute in question and the mobility, w, of 
solute in membrane, 
This equation gives linear uptake fluxes, Many substa-
nces cannot fit this model and sometimes permeation is faster 
than is predictable by diffusional uptake, and is inhibited 
by excess of substrate. The curves of uptake for such sub-
stances are not linear, and more usually are hyperbolas. 
This is true of uptake by placenta for macromolecules and 
certain sugars, which imply a carrier or receptor mediated 
uptake which warrants the use of Michaelis-Menten kinetics, 
for models such as the simple zero-trans-uptake procedure, 
infinite Cis-and infinite Trans-uptake 
5,4,2 Zero Trans Uptake Procedure. 
Consider two sides of the membrane, the Cis and Trans, (the 
CIS TRANS 
starting uptake ZERO 
Membrane 
uptake side) when uptake is initially zero, the system becomes 
the zero-trans procedure. At variable substrate imputs on 
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the Cis side one monitors the trans side uptake. The rate 
of uptake reaches a maximum limiting velocity, Vzt, as subs-
trate concentration is increased. The substrate concentrat-
ion at half-maximal velocity, is Km, then the uptake hyper-
bola is described by; 
where zt = zero trans and 1-+2, denotes uptake from face 1 
(Cis) to face 2 (Trans), an s1 = substrate concentration in 
face 1. This equation has the form of Michaelis-Menten 
kinetics (Stein 1981). The zero-Trans uptake model has 
been used extensively to study carrier mediated uptake,for 
example, galactose uptake by human red blood cells (Ginsburg 
and Stein 1975), to characterise kinetics of glucose efflux 
from red blood cells (Karlish et al 1972). 
5.4.3 Infinite Cis-procedure. 
Here one sets the substrate concentration on the Cis-
face at limitingly high level and then measure the nett Cis 
to trans flow of substrate, when the substrate concentrations 
at the trans face are set at various levels. In absence of 
substrate on the trans side, uptake is at maximal, initial 
rate velocity, but as trans substrate levels build up, uptake 
slows down and reaches saturation once again. It can be shown 
that flux velocity 1 ~2 face, vic 
1-+2; 
= 
Km + 
ic = infinite Cis, Km is the half-saturation concentration 
of substrate at the trans face which is just sufficient to 
reduce the net flow of substrate (S 2 ) in the Cis to trans 
direction to one half of the maximal value. 
5.4.4 Infinite Trans-procedure. 
The procedure here is infinite Cis in reverse. The 
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substrate concentration at the trans face is set at a limi-
tingly high level. Concentrations of substrate (S 1 ) at the 
Cis face are set at various levels, usually labelled, and 
the unidirectional flux( Cis-trans (1~2) ) is measured; 
the flux has the form; 
= v w.ax 
it = infinite trans, Vmax is the maximum velocity and Km is 
the concentration at which half maximal flux is obtained. 
Each of these models are capable of describing rece-
ptor or carrier mediated fluxes across membranes. As will 
be seen later, the first model of zero trans procedure, was 
slightly modified for application to uptake of radiolabelled 
proteins in an in-vitro isolated placental perfusion system. 
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5,5 Aims of Transfer Studies. 
In vivo-studies of placental uptake particularly when 
radioligands are used are for ethical considerations, 
difficult to perform, let alone the large body compartments 
which would dilute the label before even the placenta 
begins to take it up. Quite satisfactory results can be 
obtained by using an in-vitro perfusion system, whereby 
controlled imputs of labelled ligand to mimick maternal 
conditions can be utilised and uptake via the foetal aspect 
of the placenta is measured. 
In-vitro perfusion have been studied with respect to 
placental amino acid transfer (Young 1981), oxygen consu-
mption (Challier et al 1976), glucose and lactate transfer 
and metabolism (Schneider et al 1972). 
However, this technique has not been widely applied 
to the study of transfer of serum proteins. Therefore it 
was felt that the system is well suited to this sort of 
study particularly when uptake of radiolabelled proteins 
is easy to measure. Quite apart from application of this 
technique to study of IgG-H3 uptake (Ockleford, personal 
communication), other plasma proteins have not yet been 
subjected to this useful assay. 
The primary aim was to see if uptake was saturable 
in the first instance and subsquently whether it was 
relatable to an assymetrical carrier system for each protein 
and thus raising the possibility of this carrier being a 
receptor. Testing for the carrier, involved utilisation of 
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the Zero-trans model of uptake. Uptake curves were then 
subsquently tested with Ginsburg and Stein's (1975) equation 
for assymetric carriers in an attempt to see if this equat-
ion could linearise the uptake curves. If it did, then 
placental protein uptake is most probably a receptor mediated 
transfer process. The other supportive evidence from these 
curves would be any appearance of saturability. 
Materials and Methods. 
Proteins; Nine· proteins were studied: IgG, D( 1 anti-
trypsin, o( 1 acid glycoprotein, haptoglobin, 
C( 2HS-glycoprotein, transferrin, prealbumin, fibrinogen, 
and Gc-glycoprotein, These proteins were radiolabelled 
with tritium in a similar manner to that outlined on page 77. 
Table 8 gives a summary of the doses infused on the mater-
nal aspect of the isolated perfusion system and the specific 
activities of the radioligands. 
5.6 The In-vitro Placental Perfusion System 
The apparatus: 
The apparatus was designed such that it had two major 
components; the maternal and foetal compartments. Fig,40 
shows the overall plan of all the major components; the 
whole assembly is also shown in the photograph in Fig.41. 
The Foetal Circuit. 
This consisted of a reservoir, an inverted conical 
flask, in which a hole was artificially bored in the 
middle of its bottom-end (now facing upwards), for intro-
ducing solutions and additives. The exit glass piece was 
connected to a flow meter by a rubber tubing which _then 
connected to a 'heat exchanger' (Trevanol miniprime heat 
exchanger unit)). Water at 37°C was pumped in and out of 
the heat exchanger from a water tank reservoir. The coni-
cal flask reservoir was also partially submerged in the 
water tank to keep it at 37°C A peristaltic pump (set to 
pump 3 - 5mlsfmin) was usually either an LKB 2120 va.rio-
perpex peristaltic pump or a Vater-Marlow infusion pump. 
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The tubing from the pump was finally connected to a nylon 
portex microcannula (diameter 1.3 mm), via a three-way 
sampling tap to the foetal artery. This had previously been 
identified by stripping or peeling the chorionic membranes 
off the placenta. Usually a small peripheral cotyledon 
was selected for perfusion as this was usually small and 
gave good flow characteristics. 
A return circuit was completed by first letting fluid 
perfuse the foetal vein for about 5 minutes so as to identify 
the cotyledonous vein through which the return was flowing. 
This was likewise cannulated with a similar Portex 1.3mm 
nylon microcannula and connected via another three-way-
sampling tap to a mercury manometer and back to the reser-
voir, The foetal ·reservoir was gassed with 4~% oxygen, 
5% carbon dioxide, and 55% nitrogen. 
The Maternal 'Circuit' 
This was an 'open' system in that whilst it is called 
a circuit, it really is a one way system and no return was 
needed. Once again like the foetal side, a conical flask 
reservoir containing buffer with addittves and for intro-
ducing maternal radiolabelled protein, was partially sub-
merged in a water tank bath kept at 37°C. This reservoir 
was also gassed with 40% 0 2 , 5% co2 and 55% N2 . The flow 
rate was kept between 2 - 5mls/min and the pressure kept 
at 10 - 20mmHg as shown in the line diagram in Fig. 40. 
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The flow through the pump tubes was effected by a Water-
Marlow automatic infusion pump connected to a flow meter 
and at the end was attached a glass microcannula with a 
very thin end, for insertion into the maternal decidual 
cotyledon as shown in the diagram. The photograph in Fig.41 
shows the laboratory arrangement of the various components. 
Reservoirs. 
Hartman's solutions (Trevanol, Thetford, East Anglia) 
were used for both foetal and maternal reservoirs and 
contained lOOinM glucose, 4% dextran 70 (mV = 70000) as 
additives. Appropriate volumes (usually lml) of radio-
labelled proteins were added to the maternal reservoir 
as shown in Table 8, and allowed to warm to 37°C prior to 
the start of maternal perfusion. 
5.7 The Placenta and Perfusion experiments. 
Placentae were obtained from the Department of Obste-
trics and Gynaecology at the Leicester Royal Infirmary 
(Labour Ward), soon after full term normal deliveries. 
The placentae were rapidly washed with cold Hartman's solut-
ion and rushed to the laboratory but carried on ice. 
MATERNAL CIRCUIT 
TEMPERATURE 37"c 
FLOW RATE 2-5 ML/MIN 
PRESSURE OPEN CIRCUIT/ 
10-20 MMIJG 
Fig. 40 
40% 
5% 
PROPORTIONAL 
THERMOSTAT 
RESERVOIR 
BUFFERED 
SALINE 37"c 
I 
FETAL CIRCUIT 
TEMPERATURE 37°C 
FLOW RATE 5 MLIMI N 
PRESSURE 60-80 MMHG 
HG MANOMETER 
WATER JACKET 37°C 
200 p M 01 AMETER 
MICROCANNULA PENETRATING PERFUSED COTYLEDON 
The diagrammatic arrangerrent of the in-vitro placental oerfusion system. 
Fig. 41 
This shows the laboratory set up of the main comnonents of 
the in-vitro nlacental perfusion system outlined in Fi~.40. 
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The two tanks on either side kept the perfusates (in inverted 
conical flasks) on maternal and foetal sides at 37°C, then the 
peristaltic pumps, tubings and microcannulae inserted into the 
placenta on the tray. Detailed description is given in the text. 
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Fig. 42 
This shows a closer view of the in-vitro oerfusion in progress. 
The foetal side is being perfused with 'inlet' and 'outlet' micro-
cannulae in place. Sampling taos are clearly visible; the exit 
one for monitoring radioligand uptake. 
On the left is a maternal microcannula entering the underside 
(the maternal decidua) to perfuse a corresPonding selected cotyledon 
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Chorionic membranes were stripped off and cannulation 
of the foetal artery and veins was done. Fig.42 shows 
the foetal circuit completed, with microcannulae in place 
and preliminary perfusion to 'flush out' blood, in progress. 
At the end of about 20 minutes, the reverse side correspond-
ing to the perfused cotyledon, when the placenta was turned 
on its back, became pale and swollen (see Fig, 43 ). 
The paleness implied near or completed flushing out of blood 
and blood clots as well as a good flow circuit had been 
attained. 
In most instances, no anticoagulant was found necessary. 
Some workers usually add 50 - 60ugjml of heparin in the 
perfusion fluids. The placenta was kept moist throughout 
the experiment by dripping of warm buffer at 37°C from an 
overhead reservoir (Fig. 40 ). The maternal microcannula 
was then gently inserted into the pale area (Fig. 43 ) 
and secured into place. Radioligand was then perfused into 
the maternal aspect at a rate of 2 - 5mlsjmin. Monitoring 
of uptake was immediately started by drawing 0,5 -·1ml 
aliquots through the exit three-way tap on the foetal aspect 
at 0,1,2,3,5,7,10,15,25,30,45,60,70 and 80 minutes. These 
aliquots were added to 5 - 10ml Fisofluor 1 scintillant and 
counted for 4 minutes each. Counts were expressed per ml 
of aliquot. 
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Fig. 43 
After about 30 minutes of perfusing the foetal side, the 
placenta was turned on its back (maternal side up) to see which 
cotyledon was being perfused as judged by the paleness. The 
photograph shows such a pale swollen area in which the maternal 
microcannula was inserted and then timin~ of the exoeriment 
commenced. 
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5.8 Modifications introduced into the perfusion system 
a) Maternal circuit 
After several experiments, it was found that the mater-
nal circuit could be modified, without loss of experimental 
detail. Since ligand qunatities administered were usually 
small, there was a big dilutional effect caused by long 
tubings between the maternal reservoir and the microcannula. 
It was decided that the radiolabel after equilibrating at 
37°C in the maternal water-bath, a lml syringe attached 
to the microcannula would be used to aspirate and deliver 
the radioligand directly into the perfused pale area shown 
in Fig. 44, 
b) Foetal circuit. 
Once again, it was found that the foetal return line to 
the reservoir was too long and if circulation of foetal 
uptake were allowed to flow back to the. reservoir and then 
back into the placenta, it would take a very long time for 
equilibration to occur. In any case, equilibration was 
not important for the short period of perfusion 0 - 30min 
or up to 1 hour. Secondly, it was found that the exit 
fluid line from a single and usually small cotyledon, very 
often stagnated with poor flow because of a long fluid 
column to push along and often causing significant back 
pressure between the exit and the reservoir. 
Therefore the extensive tubings leading back to the 
reservoir were removed and the exit cannula was allowed to 
drain directly into a collecting flask. This improved the 
Perfused 
cotyledon 
Fig. 44: 
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Syringe for introduction 
of maternal radioligand 
' Exit' Foetal sampli1 
of uptake. 
Placenta. 
3-way taps 
collecting 
flask 
Modifications in the original perfusion system 
for effective delivery of maternal radioligand and 
relief of column back pressure on the foetal circuit 
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flow characteristics substantially since the dumping down 
of flow due to the fluid column ahead was no longer present. 
This arrangement converted the foetal circuit into an 'open' 
one, just as the maternal circuit was. These modifications 
are diagramatically depicted in Fig. 44. Satisfactory 
results were achieved by these changes. Consequently, there 
was no need to monitor back pressure as in the closed system 
where pressures in excess of 60mmHg led to rupture of 
placental capillaries, 
Results 
Countsjml of uptake were plotted against time for each 
protein. Fig, 45 shows one graph reproduced by kind permi-
ssion (Dr. C.D. Ockleford of University of Leicester) aimed 
at showing 3 . the uptake of IgG-H when both 'inlet' and exit 
lines were sampled when a completed foetai circuit was 
used. Saturable uptake is evident. Radioactivity in the 
inlet samples signifies uptake mixing in the reservoir and 
then returning to the cotyledon. In the present study 
interest was only in the uptake exit line which was 'open' 
so that no radioactivity in the inlet was encountered. 
Data for uptake of radiolabelled proteins over the period 
of 60 - 80 minutes is presented in Figs. 46 to 50. 
Without exception all uptake curves showed high initial 
rate of uptake, which reached equilibrium as saturation 
was reached. Times at which maximum uptake commenced are 
given in Table 8. The curves have the characteristic 
rectangular hyperbolas, typical of Michaelis-Menten kinetics, 
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Fig. 45 
This shows uptake when both the input and output of foetal 
microcannulae were sampled at various times. This was in a 
closed foetal circuit when the uptake equilibrated with the 
reservoir and returned to the placenta. Other perfusion condi-
tions are shown in the diagram (Reproduced with kind permission 
of Dr. C.D.Ockleford, University of Leicester). 
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Foetal uptake of fibrinogen, Gc-glycoprotein and IgG. 
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Fig. 48: In-vitro foetal uptake of o(2HS-glycoprotein 
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Fig. 50: In-vitro foetal uptake of PreAlbumin. 
This signifies or points to these protein ligands binding 
on to carriers of some sort which have saturable characte-
ristics. It is therefore implicitly proposed that this 
putative carrier is a specific receptor for each of the 
test-proteins. 
However, certain other characteristics of a receptor 
quite apart from saturability, must be fulfilled such as 
possession of high affinity sites or constants. In the 
following sections, attempts will be made to use equations 
for asymmetric carriers that is to say for unidirectional 
nett fluxes, to see if these uptake curves could be linea-
rised; and if so, do they have the form of Lineweaver-Burk 
like plots (mentioned earlier on page 122 ) from which 
affinity constants can be calculated ? 
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Zero-trans model of uptake applied to placental uptake curves. 
Of the membrane models discussed in this chapter, the 
zero-trans model was thou~ht to be the most appropriate 
for placental work, although in-vivo transport could be 
more complex. A diagramatic representation is shown in 
Fig. 51. Here the maternal side is regarded as the Cis 
(side 1) whilst the uptake foetal side is the trans (side 2). 
So,is the maternal imput substrate or ligand concentration. 
Ct, is the uptake with respect to time (t), R1. is recipro--
cal of maximum velocity of transfer from 1 ~ 2 direction, 
R2 , is the corresponding quantity in 2--')- 1 direction. 
K = half saturation concentration. 
MATERNAL 
CIS 
So 
Rl 
'\ 
SIDE FOETAL SIDE 
TRANS 
UPTAKE 
Cr 
~ 'ACTIVE 
UPTAKE UPTAKE 
Ct 
' R2 
K1-+2 
Fig. 51: The Zero-Trans uptake procedure. 
r--
T 
TIME. 
1\) 
0 
1\) 
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Eilam and Stein (1974) have produced such an integrated 
kinetic equation, taking into account all these parameters 
for an asymmetric carrier and it is applicable to the pla-
centa where uptake is generally in favour of the foetal 
side (asymmetrical) and here regarded as the Trans side of 
maternal input. 
Ginsburg and Stein (1979), with minor modifications, 
re-stated the integrated time course equation as; 
( A + BS0 ) 1n ( S - C) + B 
So 
= -t ....... (16) 
where,A and B are constants, which take into account K, 
R1 , R2 and K, constants (see Ginsburg and Stein 1979). 
These workers have transformed algebraically the above 
equation into a better usable form, namely; 
( A + BS0 ) [ '" ( 1 -
where, in this context, 
C = uptake 
S0 = maternal input 
t = time 
C/80 ) • C/80 ] 
c 
- A = t 
c 
.... (17) 
Uptake (cpm/ml) was converted to (cpm/min) by multi-
plying with the foetal flow rate shown in Table 8 for 
each protein. From specific activities (cpm/ug protein), 
the perfused counts were converted into molar units, S0 , 
all shown in Table B 
Plots as per Ginsburg and Stein's integrated equation 
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( 17), are sho.vn in Figs. 52(a) and 52(b) for all proteins. There 
is a striking similarity to the well known Lineweaver-Burk 
double reciprocal plot as discussed on page 122. Thus 
this equation for asymmetric carriers, predicts placental 
protein uptake. 
Calculation of affinity constants 
From equation 16, the intercepts are therefore 
Y-cept = A/S 0 
X-cept = A S 0/( A + BS 0 ) 
under conditions, where S0 is reasonably high 
2 S X-cept ~ A/B 
Therefore, 
n;s • K 
0 
K (affinity constant) = 
(details as per Ginsburg 
and Stein, 1979). 
2 S0 • X-cept x s0 
n 
where, n = equivalent concentration of an impermeable solute, 
and S0 , the perfused concentration. Assumption is made that 
S0 / 11 = 1, that is to say, the theoretical con cent rat ion of 
an impermeable solute, n , and S
0 
'.are set the same then, 
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Table 8 
This table summarises some of the in-vitro placental 
perfusion conditions, such as the maternal input of radi6-
labelled proteins, the corresponding specific activities, the 
maximum rate of foetal uptake (C) and the time(T ) required 
max 
for this at a given foetal perfusion flow rate. 
Furthermore, the affinity of each perfused protein expre-
ssed as (KD) for membrane carrier is shown in the last column, 
as estimated by the use of Ginsburg and Stein's integrated 
equation for assyrnrnetric carriers for flux across plasma 
membranes. 
LIGAND CPMljJL CPMI)JG MOLAR FOETAL CMAX TMAX CALCULATED 
PROTEIN INPUT <SPECIFIC CONCN FLOW (NM/MIN) <MIN) AFFINITY 
VOL ACTIVITY) so RATE ( KD ) 
(MLs) (NM) (MLs/MIN) NM 
FIBRINOGEN 0.9 5401 10718 1677 3 23.33 40 28,12 
TRANSFERRIN 1 19273 24558 8718 3 4.74 50 .3.00 
PRE ALB 1 36140 87272 6788 2 2.63 85 4.34 
IGG 1 9801 43344 1215 2 1.39 60 0.22 
HAPTOGLOBIN 1 13900 48165 2886 . 5 2.75 60 0.19 
0( 1 AT 0.6 6260 121370 573 3 0.688 65 a'. 65 
o( 1 AG 0.9 9515 174930 1113 3 0.623 65 a'. 06 
Gc 1 18150 52606 6757 3 13.42 55 L23 
o( 2HS-GLY- 1 6559 49942 2680 3 10.99 70 1.58 
COPROTEIN 
Table 8 
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X-cept 
Affinities (K0 values) have been calculated as displayed in 
Table 8, bearing in mind that by the very nature of perfusion 
experiment, non-specific binding cannot be eliminated. 
Therefore any estimate of the affinity constants will be 
affected by this inherent problem. In the case of disso-
ciation constants the true values must be less than those 
in Table 8. Nonetheless, K0 ts obtained were very reasonable 
approximation and in chapter 8 better values will be derived 
via radioreceptor assays. 
Conclusion 
It must be appreciated that there were many uptake 
factors to consider in a perfusion study in terms of those 
of theoretical interest and those which are practicable in 
order to obtain good estimates of uptake parameters. Good 
data was obtained in this study and pointed to possibilities 
of receptor mediated mechanism for protein uptake in the 
human placenta since uptake profiles showed similarities to Michaelis-
Menten kinetics. 
In conclusion, placental uptake of proteins was clearly 
a saturable entity and when a zero-trans model of uptake was 
considered, particularly the use of Ginsburg and Stein's 
integrated equation, which when applied to uptake data linear-
ised :these curves. The linear graphs were strikingly similar 
in shape to the classical Lineweaver-Burk plots. This has 
been observed also for receptor mediated glucose and galactose 
influx and efflux in erythrocytes (Eilam and Stein 1974; and 
Ginsburg and Stein 1979). 
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Figs. 52(a) to (i) - show linearisation of uptake curves 
shown in Figs. 47 and 50. This was done by use of Ginsburg 
and Stein's equation for assymetric carriers (1979) as 
applied in this instance to foetal uptake of various radio-
labelled plasma proteins in an in-vitro placental perfusion. 
Here t/C (where tis time and the corresponding C, uptake), 
plotted against ln ( 1 - C/S + C/S )/C where S is the 
0 0 0 
.maternal or Cis input. The fact that curves are linearised 
proves that a Zero-trans uptake model and hence equation (17) 
describe placental transfer well. Furthermore, the saturable 
character of uptake curves coupled to this subsquent linear 
transformation is strongly suggestive of a receptor mediated 
uptake. The intercept on the horizontal axis (X-cept) and 
the initial maternal input are shown for each graph. 
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CHAPTER 6 
COLLOIDAL GOLD - PROTEIN CONJUGATES FOR ULTRASTRUCTURAL 
ELECTRON MICROSCOPIC STUDY OF PLACENTAL RECEPTORS. 
Gold particles in a colloidal form are very electron 
dense, and can be conjugated to various protein ligands 
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for electron microscopic study. Colloidal gold protein 
conjugates are thus well suited to receptor binding investi-
gations since the position of the protein adsorbant can be 
accurately located. Colloidal gold adsorbed immunoglobulins 
and lectins have been widely studied to localise surface 
antigens (Geoghagen 1977) and(Dickson et al 1981), have used 
the technique to visualise c< 2macroglobulin-gold uptake by 
endocytic vesicles. 
Since colloidal gold is easily conjugated to immuno-
globulins, the conjugation can be done directly or indirectly 
in a manner analogous, for example, to indirect and direct 
fluorescence or peroxidase immunocytochemistry. Furthermore, 
colloidal gold is non-cytotoxic and is a stable cytochemical 
marker, readily prepared and is fit for various modes of 
microscopy (review by Horisberger 1979, Goodman et al 1980). 
Multiple labelling experiments can be performed by use of 
different particle sizes, which are· easily prepared and reco-
gnised (Horisberger and Vonlanthen 1979). Gold markers can 
be prepared in the size range of 5 - 150 nm with size depe-
ndent characteristics and absorption spectra (Goodman et 
al 1981). 
Colloidal gold is a negatively charged hydrophobic sol 
maintained in solution by electrostatic repulsion. Its 
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negative charge can be put to use when a positively charged 
ligand is reacted with the gold sol. Proteins being ampho-
teric macromolecules with polarity, they can be made to 
acquire net positive charge if the buffer pH in which they 
are dissolved falls below or near to the protein's isoele-
ctric point (pi). The electrostatic bonding that results, 
can be stabilised using polyethylene glycol (PEG). This 
interaction is therefore dependent on pH, protein concentrat-
ion, as well as ionic concentration (Goodman et al 1980). 
In a detailed study, Goodman et al 1981, have investi-
gated the optimal conditions for these various factors which 
influence gold-protein interaction. They further elucidated 
on bioviability of these conjugates, absorption spectra, 
stability as influenced by pH, dialysis, and suitability 
of various buffers in the process of conjugation. They were 
also able to measure by radioimmunoassay the total amount 
of ligand bound on gold particles. These radioimmunoassays 
also permit the calculation of the numbers of molecules of 
label per gold particle. Dickson et al (1981), using 
o< 2macroglobulin-gold probe found -v400 molecules bound 
to each gold particle. 
Aims of this Study. 
The colloidal gold probe because of its simplicity to 
prepare as well as easy attachment to proteins if the right 
conditions are set, particularly extensive dialysis of protein 
solution, knowledge of pi values and titration of amounts 
that can be conjugated, then a very useful marker is in hand 
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and can be used to probe receptors on the placenta. This 
particular technique, unfortunately has not yet been applied 
extensively to the study of plasma proteins with respect to 
possible existence of receptors, particularly on the placenta. 
It was therefore felt that some proteins be labelled 
with this marker and then the conjugates subjected to isolated 
placental membranes where receptors are suspected, since this 
is the layer normally in direct contact with the maternal 
circulation. 
Materials and Methods. 
Reagents 
Chloroauric acid (HAuC12 ) (H. Lamb, London), trisodium 
citrate (BDH Poole Dorset) polyethylene glycol (PEG) (MW 
20,000), 0.2 pm membrane filters, dialysis membranes. 
Dialysis of protein ligands 
A visking tubing (32/32) was soaked in distilled water 
overnight prior to dialysis. It was checked for any leaks. 
Proteins in PBS and at 3mgjml were placed in the bisking 
tubing, both ends tied, but one end left with sufficient 
string to hang in a beaker containing 0.005M sodium chloride 
like a 'tea-bag'. Dialysis continued for 48 hours under 
constant stirring and several changes of dialysis fluid. 
The solutions were left in a fridge to avoid moulds growin~ 
on the tubing. 
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Solutions 
All solutions were centrifuged at 3000 rpn and filtered throu¢1 
0.22 pm filter after being prepared. All glassware was kept thoroughly 
clean as any dusts or improper cleaning would cause flocculation of 
gold sols. 
The following solutions were needed: 
( 1) 200 mls of distilled water in a 250 ml round bottomed flask 
(2) 4% chloroauric acid 
(3) 1% sodium citrate 
(4) 1%PEG 
(5) 0.2 M JS003 or 0.2 M HCl 
(6) Phosphate buffered saline or Hanks buffer with PEG. 
Relationship between colloidal gold particle size and fonnative factors; 
Different gold particle sizes can be prepared depending on what 
is required, by the use of various carhinations of sodium citrate, PEG, 
and total sol. volume as per the following schedule: 
Particle size 
Factor 18 nm 35 nm 50 nm 100 nm 
Total No. of 200 X 1012 40 X 1012 1 X 10l3 1,5 X 1012 
particles 
1% sodium cit- 5 3 2 1.5 
rate ( mls ) 
1% PEG ( mls ) 6 3 2.4 1.2 
Hanks buffer or 0.6mg/ml 0.3mg/ml 0. 24rql:/ml 0.1~/ml 
PBS with (1% 
PEG) 
This table is formulated on the basis of total volume of 200 ml of sol. 
initially prepared. 
. 
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Preparation of Gold Sol. 
200 mls of distilled water were added to a round botto-
med flask. For 18 nm particles, used in this study, 0.5 ml 
of 4% chloroauric acid (HAuC1 4 ) was added with mixing, then 
the solution was boiled under constant reflux till the yellow 
colour turned black and then wine red or dark red, as shown 
in Fig. 53. 
The solution was cooled, and filtered. The pH of this 
solution was adjusted to below or near enough to the pi of 
the protein to be conjugated. This will result into adsorp-
tion of protein by electrostatic forces. Care was taken not 
to coat the pH meter electrode with gold, by taking 1ml ali-
quots.to which drops of 1% PEG were added and then the elect-
rode directly immersed into this to record the pH. Adjust-
ments of pH wither way of the pi value were made by titra-
tion of the gold sol. with 0.2 M K2 co3 or 0.2 M HCl. 
Preoaration of protein gold conjugates 
This was a trial and'error process; the aim was to find 
the optimal level of protein that can be added to the pH 
adjusted gold sol. such that no flocculation occurred. 
In order to do this, a series of 1ml aliquots of gold sols. 
in LP 3 tubes was prepared. Increasing microlitre volumes of 
the protein standards of each protein were added to each 1ml 
of the colloid till flocculation occurred. The volume of 
protein just before flucculation occurred, was taken as the 
titration point. Table 9 shows the various titration volumes 
which were used to work out how much of protein should be 
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Fig. 53: Preparation of Colloidal Gold Sol . 
Reflux condensing apoaratus was required to preoare colloidal 
gold. 0 , 5ml of H4AuC1 4 was added to 200mls of distilled water. 
For 18nM colloidal gold particles, 5mls of 1~ sodium citrate 
were added and the solution boiled with refluxin~ till it 
assumed a red wine-like colour as shown here, and then cooled . 
Subsquent steps are discussed in the text. 
added to a standard 200 mls of the originally pre~ared 
colloidal gold solution. 
After adding the protein, the colloidal solution was 
stabilised by addition of PBS containing 0.6 mgfml of PEG 
(for the 18 nm particles which were used in this study). 
224 
The pH was then adjusted to neutrality for all gold protein 
solut·ions. The labelled colloid was concentrated by spinning 
at 28,000g (17000 rpm) for 30 minutes at 4°C in a Sorvall 
OTD-65 refrigerated ultracentrifuge (Du Pont Instruments) 
and using 35 ml polycarbamate tubes and an AH 625 rotor. 
The unlabelled colloid is discarded in the supernatant. 
The resultant pellet was re-suspended in a suitable 
buffer (PBS at pH 7.4 and containing PEG at 0.6 mgjml). 
The colloidal protein conjugate is now ready for incubating 
in placental tissue to assess receptor binding. 
Incubation of Au (18 nm) - protein conjugates with nlacental 
villi. 
Tiny villi were dissected (5mg pieces) from the placenta 
and then incubated in 1ml of Au-protein conjugates at 37°C 
for 1 hour and gassed with 5% C02 , 40% 0 2 , and 55o/o N2 . 
Control samples containing 1mg of unlabelled protein were 
pre-incubated with placental membranes for 30 minutes before 
protein ligands were subsquently introduced for 1 hour 
incubation. Here, the idea was to competitively inhibit 
binding and thereby obtain controls for each protein. 
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Ti trations; max. vol-, Total vol. Equivalen1 
Conjugat- (ul) of protein to lml (p.l) of in ()lg) 
PF.OTEIN pi ing pH of colloid without protein protein/ 
flocculation per 200ml 200ml 
of gold sol gold sol. 
Hp 4.5 3.6 1 )ll at 0.33ugful 200 66 
Tf 5.9 5.0 3 )ll at 0. 33u"ful 600 198 
Fg 5.8 4.6 10 )ll at 1.5ugful 2000 3000 
Pre Alb 4.7 3.6 0.5 )ll at 0.066ug/ul 100 6.6 
Gc Unknown Tried pH 1 )ll at 0,22 ugful 200 44 
3.8 
o(2HS Unknown Tried pH 25 }ll at 0. 33 ug/ul 5000 1650 
3.8 
0( 1AT 4.0 3.6 1 pl at 0,066ugful 200 13 
IgG 5,8 4.7 1 pl at 0.33 ugful 200 66 
Thrcni:lin Unknown Tried pH 2 )ll at 0.25 ugful 400 100 
4.0 
o( 1AG 2.7 3.0 5 }ll at 0.05 ugful 1000 50 
·ncx; Unknown Tried pH 4 }ll at 0.33 ugful 400 132 
3.6 
Table 9 
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At the end of the incubations, unbound Au-protein 
were rapidly washed off by two rapid washings of placental 
tissues in PBS or Hanks buffer and then fixed the tissue 
in 3% gluteraldelyde for 2 hours. Post-fixation of tissue 
was done in Karnovsky's fixative for 4 hours at 4°C and 
thereafter the tissue was washed in two changes of cacody-
late buffer for ·10 minutes each. The tissue was fixed also 
in 1% osmium tetroxide in cacodylate buffer at 4°C for 1 hour. 
Thereafter the tissue was washed in two changes of cocody-
late for 10 minutes each, and then block stained in fresh 
1% uranyl acetate in distilled water for 30 - 45 minutes. 
Tissue was dehydrated through 50,70, and 90% alcohols 
10 minutes each, and thereafter for two changes, 10 minutes 
each. Further treatment in 50:50 mixture of ethanol/propy-
lene oxide for 10 minutes and then two changes of prooylene 
oxide, for 10 minutes each. 
The tissue was then transferred in fresh mixture of 
propylene oxide/~ resin (50:50), and then placed in 
an incubator with lids removed from pots for 30 minutes. 
The tissue was placed in fresh spurrsresin at 37°C 
for 1 hour, then embedded in fresh resin in capsules or moulds 
and allowed to polymerise at 60°C for at least 16 hours or 
overnight. 
Then sections were cut and then picked up on formvar/ 
carbon coated 200 mesh grids and then subsquently counter-
stained with Reynolds lead acetate and uranyl acetate and 
then examined thereafter using a Jeol 100CX or Phillins 
electron microscope. 
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. RESULTS 
Figs. 54 to 58 show some of the proteins with Au-speci-
fic protein binding to the microvillar plasma membrane and 
some with particles endocytosed into specialised transport 
vesicles. For proteins to bind on to the surface of the 
gold particles, there are many variables to consider, such 
as pi, the configuration of the protein concerned, particle 
size of the gold sol, and the optimal binding conditions have 
to be right. In this study results are shown for transferrin, 
haptoglobin, beG and o(1acid glycoprotein as shown in the 
photographs. Other proteins did not show colloidal gold 
adsorption. 
It is possible also that during the processing for 
electron microscopy some of the conjugated protein or gold 
became desorbed and as stated above, there are critical 
conditions that have to be met for gold particles to adsorb 
on proteins. For some of the proteins it· was a trial and 
error procedure to get optimal pH for purposes of conjugat-
ing gold to the protein since pi's for some proteins could 
not be found in the reference texts consulted, One signifi-
cant point about this technique is that it provides a direct 
visualisation of the process of surface events from binding, 
formation of coated vesicles and inclusion of ligand, and 
then the vesicle dynamically transfers itself across the 
syncytio and cytotrophoblastic layers to exocytose its 
contents into a foetal capillary and thus effect a complete 
transfer of protein ligand. 
This process has been observed for lgG antibodies in 
particular, and Huxham and Beck (1981) studied receptor 
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mediated transport of rat lgG across the 11.5 day in-vitro-
rat york sac endoderm and demonstrated well the whole pathway 
from binding to extrusion of the gold-IgG in the york sac. 
Dickson et al (1981) adsorbed o( 2macroglobulin to colloidal 
gold particles. Binding was demonstrated in rat kidney 
(NRK-2T) and swiss mouse 3T3 cells at 0°C. On warming the 
cells for 30 minutes, gold was rapidly internalised into 
uncoated vesicles previously called receptosomes and with 
longer incubations the particles were visualised in lysosomes. 
This technique offers a useful new tool in the study of 
receptor mediated uptake. 
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Fig. 54(a) - sho.vs colloidal gold-labelled transferrin ( Au-Tf) , 
18 nm particles bound to the surface of the trophoblastic 
membrane. The picture also shows the binding· process of 
three gold particles (arrowed) leading to curving in of the 
membrane to form a caveola, which will eventually seal off as 
a c6ated·vesicle. Coated vesicles are the specialised moda-
lities of transcellular protein transport, protected against 
proteolysis, to the foetus. 
\ 
Fig. 54(b) - shows microvillus membrane. The arrow shows the 
process of coated vesicle formation with the caveola sealing 
off to enclose the gold-protein conjugate (Au-Tf), for uptake 
(arrowed). 
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Fig. 54(b) 
Legend for Figures 55(a) and (b) 
Fig. 55(a) 
Competitive inhibition of Au-Tf (gold-transferrin ) by 
unlabelled transferrin, lmg in lml colloidal gold sol by a 
preincubation with membranes before Au-Tf was added. 
The picture shows complete inhibition of binding as 
evidenced by absence of any gold particle on the microvillous 
placental membrane. This is suggestive of existence of 
transferrin receptors. 
Fig. 55{b) 
In another similar competitive inhibition experiment 
using unlabelled transferrin there is no Au-Tf binding any-
where on the surface or in the syncytio and cytotrophobla-
stic areas. 
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Fig. 55(a) 
Fig. 55(b) 
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Fig. 56 
Fig. 56(a) - Colloidal gold - haptoglobin conjugate, adsorp-
tion to the surface of syncytiotrophoblastic microvilli. 
One particle is in closed vesicle, (arrowed). (35 nm particles 
were prepared) 
Fig. 56(b) - Microvilli surface in the left half of the pict-
ure. A colloidal gold (Au-Hp) particle appears taken up in 
a coated vesicle, (arrowed). (35 nm particles were orepared) 
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Fig. 56(a) 
Fig~ 56(b) 
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Fig, 57 shows adsorbed Au-a(1aaid glycoprotein adsorption 
to the surface of the olacental microvillar membrane. 
Fig. 58 - shows some gold particles conjugated to human 
chorionic gonadotrophin (beG) binding to the 
apical surface of the trophoblastic membrane. 
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CHAPTER 7 
AFFINITY CHROMATOGRAPHY OF TRITON-X100 SOLUBI LISED TROPHO-
BLASTIC MICROVILLAR MEMBRANE IN AN ATTEMPT TO ISOLATE 
RECEPTOR STRUCTURES FOR SOME SPECIFIC PLASMA PROTEINS. 
Introduction 
The plasma membrane of the placental trophoblastic is 
particularly unique in that multiple functions normally 
requiring separate specialised organs are all carried out 
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by the same membrane. These functions include phagocytosis, 
transfer of gases, excretion of foetal waste products, 
absorption of nutrients by either simple or facilitated 
diffusion or indeed by active transport. (Steven and Samuel, 
and Fox 1967). 
Active transport is of great interest since macromole-
cules such as plasma proteins are too large to be effectively 
transported across the placenta by simple diffusion. (Reynolds 
1979). ~uently the existence of specialised membrane 
receptors plays a vital role in recognition and active trans-
fer of these macromolecular proteins to the growing foetus. 
(Brambell 1970, Wild 1976, Fox 1979). Therefore attempts 
must be made to identify human syncytiotrophoblastic plasma 
membrane (StMPM) associated components which are central to 
our concepts regarding successful maternal acceptance of 
the foetus as a homograft during pregnancy. These components 
normally form the interface between the maternal blood's. 
immune system and the foetus. 
Previous work has shown existence of numerous proteins 
associated with the St~~M (Carlson et al 1976, Smith et al 1977, 
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Johnson and Faulk 1978). These proteins include transferrin, 
o< 2macroglobulin, alkaline phosphatase, HLA determinants and 
~ 2microglobulin (Ogbimi et al 1979). Cytoskeletal micro-
villar core proteins such as actin of (Mr 38,000); fimbrin 
(Mr 68,000) and villin (Mr 95,000) have also been identified 
(Brown and Johnson 1981; Bretscher and Weber 1979; Matsudaira 
and Burgess 1979). More important are those proteins which 
act as recepients of others for purposes of selective uptake 
and transfer; namely receptors. With regards to the placenta, 
IgG-Fc¥ receptor, it has been successfully isolated from 
solubilised placental membrane extracts (Brown and Johnson, 
1981; Ogbimi et al, 1979; Balfour and Jones 1978), although 
controversy still exists as to the actual structual make up 
of the receptor area. This will be discussed in chaoter 8. 
Transferrin receptors on the placenta have also been 
successfully identified as having ·Mr 70,000 using gel filtra-
tion and Mr 65,000 by SDS-PAGE (Brown and Johnson, 1981). 
Trans cobalamin II, a vi t arnin B12 transport·ing protein in 
plasma has been shown to have a specific high affinity rece-
ptor on the human placenta by which the vitamin B12 is 
transferred to the foetus. (Seligman and Allen, 1978). It 
has a molecular weight, Mr of 50,000. Apart from these three 
types of receptors, very little else is known as to whether 
other plasma proteins possess specific receptors on the 
human placenta. As already mentioned, a choice of proteins 
were studied in the preceeding chapters with respect to 
immunofluorescence and peroxidase, placental perfusion of 
radiolabelled ligands, colloidal gold, and in the case of 
lgG, by kinetics and saturation analysis; all these separate 
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studies jointly gave strong evidence as to the existence of 
specific saturable receptors. 
In this chapter another step has been taken to try to 
isolate the actual receptor structure using affinity chroma-
tography as the major purification step. This technique 
combined with SDS-PAGE provide a powerful tool for identi-
fying receptors using cyanogen bromide sepharose 4B linked 
to a specific purified plasma protein as the adsorbent to 
extract the receptor from solubilised placental membrane. 
In the articles quoted above with reference to IgG, trans-
ferrin and transcobalamin II recP.ptors, these two techniques 
were the major steps in isolation of the receptors, although 
gel filtration was also used in molecular weight calculation 
of the receptor protein or in saturation analysis to find 
out other binding data such as receptor homogeneity and 
affinity constants. The following plasma proteins were 
conjugated to the cyanogen bromide Sepharose 4B and then used 
to try to isolate receptors from the soluble fraction of 
the StMPM; IgG, 0( 1 acid-glycoprotein, pre albumin, haptoglobin, 
thrombin, 0( 1 anti trypsin, Gc-glycoprotein and 0( 2HS-glyco-
protein. 
Methods 
Step 1: Preparation of placental homogenate 
Four placentae, each weighing about 600g were stripped 
of chorionic membrane and cut into small pieces. These were 
homogenised at top speed in an MSE-blendor (Fisons) for 45 
seconds in 2.0 volumes of 10mM Tris-HCl pH 8.2 buffer 
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containing 150mM of NaCl, At times a food homogeniser; a 
MUltichef (Curry's electric store) proved to be the best to 
use since a whole placenta could be minced in about 2 minutes, 
The mince was filtered through cheesecloth and the homoge-
nate of about 1.5 litre was centrifuged at 800g for 10 minutes, 
then at 10,000g for 10 minutes, each time discarding the 
pellet. The supernatant was then spun at 100,000g for 30 
minutes and discarding the supernatant. The pellet was homo-
genised in 50 mls of a 10mM mannitol in 2mM Tris/HCl pH 7.1 
with a loose fitting Dounce homogeniser and the rest of the 
purification steps are outlined in Fig. 7 on page 52 . The 
final purified membrane was adjusted. to 5mg/ml concentration. 
Step 2: Membrane solubi1isation 
The membrane prepared above was solubilised in 10mM 
Tris/HCl pH 8.2 buffer containing 1% Triton-x100 and 150mM 
NaCl. Solubilisation was continued overnight·with homoge-
nate constantly stirred, then sonicated on ice for 5-8 minutes. 
After stirring for 45 minutes, the mixture was re-homogenised 
using a Potter-Elveljeim homogeniser and then spun at 36,000g 
for 30 minutes and the supernatant removed. 
Step 3: Ammonium Sulphate precipitation: 
31.5gms of solid ammonium sulphate,was added ·to every 
100mls of supernatant from the previous step, stirred for 
10 minutes on ice and centrifuged in portions of 400mls using 
50ml x 8 polycarbamate centrifuge tubes, and spinning at 
36,000gfor 20 minutes. The pellet was resuspended in 100mls 
of 10mM Tris/HCl pH 8,2 containing 150mM NaCl and 0.15% 
Triton-x100 and then dialysed for 24 hours. The dialysate 
was changed at 6 and 20 hours. The solubilised membrane 
was stored at -20°C till required. 
Step 4:- Coupling of specific protein to CN Br-activated 
Sepharose4B for affinity.chromatography. 
3gms of freeze dried CN~activated Sepharose (for a 
0.9 x 15cm column) were swollen from 15 minutes to 1 hour 
or at times overnight in a beaker with lmM HCl, and washed 
on sintered glass or Whatman filter paper (Whatman ) 
with 600mls of lmM HCl (200mls per lgm of gel). 
240 
The protein to be coupled was then dissolved in a coupl-
ing buffer of O.lM NaHC03 containing 0.5M NaCl. About 5-lOmg 
protein per ml of gel can be coupled. Depending on the 
amounts of protein available the following quantities of 
protein were coupled to the 3g gel: 30mg for IgG, 44mg for 
0(1 acid-glycoprotein, 10.5mg for ~ 1antitrypsin, lOmg for 
prealbumin, 7mg of Gc-glycoprotein, lOmg of o( 2HS-glycopro-
tein, 3.4mg of haptoglobin, and 15mg of thrombin. Proteins 
were mixed with gel suspension in a 250ml beaker on a rock-
ing mixer for 2 hours at room temperature. 
After coupling unbound protein was washed away twice 
using coupling buffer and then any remaining active groups 
on the gel were blocked by reacting the gel suspension with 
0.2M glycine pH 8.0. Excess adsorbed protein was washed 
away using a cycle of coupling buffer followed by acetate 
buffer (O.lM, pH 4.0) each containing 0.5M NaCl and repeated 
four to five times. Each Sepharose protein conjugate was 
then ready for use and was stored at 4°C till required. 
Step 5: Affinity isolation of receptors using protein-eN 
Br-activated Sepharose 4B adsorbents. 
Each gel adsorbent was poured on a 0.9 x 12cm column 
(Pharmacia Uppsala, Sweden). The dialysed solubi1ised 
receptor preparation was spun at 16,000g for 20 minutes and 
then applied to the column at flow rate of 12mls/hr. The 
system was linked to a Cecil 2010 UV-spectrophotometer, 
(Cecil Instruments, Cambridge) with scanning attachment for 
monitoring absorbance at 280nm. 
The following washing and elution sequence was applied 
at 12mlsjhr: 
1) Wash wit~ lOOmls of equilibration buffer 
(lOmM Tris-HCl pH 8.2 + 0.5M NaCl) 
2) Wash with 50mls equilibration buffer + lOmM EDTA. 
3) Wash with 30mls equilibration buffer. 
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4) Wash with 40mls of O.lM glycine/HCl pH 2.3 and collection 
of 6ml fractions. 
Stage 4 gave single peaks in each case of varying sizes. 
I ) 
The absorbance range was set at 0.2. It is important to note 
that the placental homogenate contained Triton-~00 which 
itself absorbs at 280nm thus interfering with monitoring of 
elution protein peaks. Therefore thorough washing was done 
till the recorder set back to the base of the chart before 
the desorbing 0.2M glycine/HCl pH 2.3 was applied. The recep-
tor eluate was immediately buffered to pH 7.4 by 1M Tris 
~H 11.0 and then dialysed against lOmM Tris-HCl pH 8.2 contain-
ing 0.15M NaCl and 0.15% Triton before freeze drying the 
receptor material. 
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SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
The receptor preparation in each case was applied to 
SDS-PAGE which was carried out on a 9% polyacrylamide running 
gel incorporating a 3% stacking gel. The whole gel was cast 
as a slab of 0.75mm x 10cm x 14cm using Laemmli's buffer 
system (Laemmli 1970) which required stock solutions of 
acrylamide: N'N'-Bis methylene acrylamide (30:0:8), 1.5M 
Tris-HCl pH 8.8, and a 0.5M Tris-HCl pH 6.8. A running gel 
of 9% was cast in 0.375M Tris-HCl pH 8.8 containing 0.1% SDS. 
After polymerisation a 3% stacking gel was cast on top of 
the running gel in 0.125M Tris-HCl pH 6.8 containing 0.1% SDS. 
(See below for details of reagents and preparation of solut-
ions for the Laemmli's system). 
Samples were prepared in 0.0625WTris-HCl pH 6.8 contai-
ning 2% SDS and 10% glycerol. 5% mercaptoethanol was added 
to the sample and the mixture immersed far 3 minutes in a 
boiling water bath. Bromophenol Blue (0.001%) was then 
added and electrophoresed using Protean Cell electrophoretic 
apparatus with a cooling facility (Fig, 59 shows the 
apparatus supplied by Bio-Rad Laboratories, Watford, U,K). 
The Protean Cell is a vertical slab cell instrument that 
virtually eliminates instrument variability with sharp separat-
ions and eliminates edge effects due to uneven cooling, 
Elecvrnphoresis was performed at 30-40mA constant current 
till the dye front was nearly reaching the bottom edge and 
gels were stained with 0.05% Coomassie Blue R-250 in acetic 
acid/isopropanol/water (1:1:8) overnight and destained with 
methanol, water and acetic acid (4:4:1). 
Fig. 59 
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Bio-Rad Protean Cell for slab SDS-Polyacrylamide 
gel electrophoresis. 
Molecular weight standards were purchased from Sigma 
(Sigma Chemical Co., London) for calibration purposes. 
Log Mr was plotted against relative mobility of bands which 
included myosin, Mr 205,000, ~-galactosidase, Mr 116,000, 
phosphorylase B, Mr 97,400, albumin bovine, Mr 66,000, and 
albumin egg, Mr 45,000. 
Reagents and gels for SDS electrophoresis (Laemmli's buf~er 
System). 
Stock solutions: 
A. Acrylamide:BIS (30:0:8) 
30g acrylamide 
0.8g N'N' BIS methylene acrylamide 
q.s. 100ml with distilled water 
Filter and store at 4°C in the dark 
B. 1.5M Tris-HCl,pH 8.8 
18.15g Tris base 
50ml distilled water 
Adjust to pH 8.8 with 1 N HCl 
q.s 100ml with distilled water 
C. 0.5M Tris-HCl, pH 6,8 
3.0g Tris base 
50ml distilled water 
Adjust to pH 6.8 with 1 N HCl 
Separating gel preparation - 9% gel, 0.375M Tris, pH 8.8 
(Sufficient for two 0.75mm x 10cm x 14cm slabs) 
Distilled water 13.1ml 
1.5M Tris-HCl, pH 8.8 7.5ml 
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10% (wfv) SDS 0,3ml 
Acrylamide: BIS (30:0:8) 9,0ml 
10% ammonium persulfate (fresh) 0.1ml 
TEMED 0.0075ml 
30,0ml 
Stacking gel preparation - 3% gel, 0,125M Tris, pH 6.8 
(Sufficient for two 0.75mm thick stacking gels) 
Distilled water 6.3ml 
0.5M Tris-HCl, pH 6.8 2.5ml 
10% (w/v) SDS 0.1ml 
Acrylamide: BIS (30:0:8) 1.0ml 
10% ammonium persulfate (fresh) 0.1ml 
TEMED 0.005ml 
10,0ml 
1. ,prepare the gel solutions on ice. Add all reagents, 
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except the TEMED, in order and deaerate under vacuum for 
15 minutes (while in an ice bucket). To initiate polyme-
risation, add TEMED and swirl gently to mix, 
2. Dilute the sample 1:5 with sample buffer and heat on a 
ooiling water bath for 2 minutes. 
Sample Buffer 
Distilled water 
0.5M Tris-HCl, pH 6.8 
Glycerol 
10% (w/v) SDS 
2-Mercaptoethanol 
0.05% (wfv) Bromophenol Blue 
4.7ml 
1.0ml 
1.0ml 
1.0ml 
0,1ml 
0.2ml 
Electrode Buffer, pH 8,3 
Tris base 
Glycine 
10% (w/v) SDS 
q,s, to 1 litre with distilled water 
-RESULTS 
6.0g 
28.8g 
10.0ml 
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Fig, 60 shows the calibration curve for molecular weight 
standards used in molecular weight assessment of receptor 
extract bands. Fig,61 shows sample wells 1 to 14. The band 
running at the centre of gel in all wells was albumin at 
Mr 66,000 and regarded as contaminant during the extraction 
of receptor. It is a well documented fact that albumin is 
usually a problem in affinity chromatography even when 
thorough washing of the column is done. Bio-Rad's Cibacron 
Blue ·F .3G-A affinity gel can be used to adsorb the albumin 
(Travis et al 1976), and thus remove it from contaminating 
affinity purification of proteins (Bio-Rad Technical Bulletin, 
No.36E), Also Blue Sepharose CL~6B has been used to remove 
albumin. Since the albumin band could be identified on the 
gels, it caused no confusion at all with regard to identi-
fying receptor bands. 
From the calibration plot for molecular weight markers, 
receptor bands were assigned molecular weights according to 
their relative mobility, Lanes 0 and 1 in Fig.61 corres-
ponded to low and high molecular weight markers respectively. 
Fig, 60 
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195K 
140K 
78l{ 
74K 
66K 
62K 
=:::::::::;::;:;;:.r-_ ~~~ 
--,__ 46K 
Lane 0 is low mol ecul ar weight marker with (Bovine albumin 
and egg albumin). Lane 1, is high molecular weights and 
lanes 2 and 3 are solubilised membranes. 
Figure 61: SDS- oolyacrylamide slab gel for Triton-X100 
solubilised placental membrane and affinity 
isolated receptor structures to specific 
plasma proteins. 
0 1 2 3 
Figure 62 
195K 
105K 
95K 
78K 
74K 
66K 
49K 
46K 
SDS-polyacrylamide slab gel electrophoresis of a 10-fold 
concentrated membrane extr act initially solubilised with 
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Triton-x100 in lanes 2 and 3. Eight protein bands can be seen. 
Lanes 0 and 1 represent low and high molecular weight markers 
respectively. 
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Lanes 2 and 3 were duplicate runs of the solubilised membrane 
extract. Lane 5 for-haptoglobin receptor gave a band of Mr 
48,000, lane 6 for 0( 1acid glycoprotein gave Mr of 46,000, whilst 
lane 9 for prealbumin gave Mr of 49,000. Lanes 13 and 14 for 
o(i antitrypsin receptor gave Mr of 62,000. The 0( 1 anti trypsin 
band showed a reasonably concentrated receptor extract. Whilst 
protein quantities conjugated to the CN Br-activated Sepharose 4B 
differed, the actual amount of receptor adsorbed was also a 
function of receptor density in the first place and so the amounts 
of receptor extracted differs greatly. 
The solubilised receptor material in lanes 2 and 3 had bands 
of Mr 54,000, 66,000, 74,000, 78,000, 140,000 and 195,000, and 
there were no co-migrating bands to correspond to haptoglobin, 
0( 1 acid glycoprotein and prealbumin receptor bands. Demarcat-
ion of bands:on SDS-PAGE is usually difficult due to presence of 
Triton in the solubilised fraction, added to the fact that the 
receptor material was relatively dilute in comparison to the 
affinity isolated receptors. When the solubilised material was 
concentrated ten times in the Amicon chambers, some previously 
invisible bands appeared-as-shown in Fig.62 although the staining 
was still weak. There were now eight visible bands as compared 
to~ in Fig. 61 and had molecular weights of 46,000, 48,000, 
66,000, 74,000, 78,000, 95,000, 105,000 and 195,000, some of 
which co-migrated with 0( 1acid glycoprotein, haptoglobin and 
IgG receptor bands (:see below). Ogbimi et al (1979) showed 
molecular weights of 114,000, 108,000, 95,000, 81,000, 62,000, 
61,000,4S:5o0,40,000,30,000,27.500, and 18.000. Those underlined 
corresponding closely either to those in lanes 1 and 2 in fig 61 
for the putative receptor bands. 
Lane 12 for the IgG receptor gave four bands with M of; 
r 
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(from top to bottom), band 1 (Mr 195,000) band 2 CMr 78,000), 
band 3 (Mr 74,000) and band 4 (Mr 66,000). Band 4 was the albumin 
contaminant. The other 1 to 3, IgG receptor bands in lane 12 
had co-migrating bands of Mr 74,000, 78,000 and 195,000 in the 
solubilised receptor preparation in lanes 2 and 3. It would 
therefore appear that IgG receptor could be heterogeneous as will 
be pointed out in the discussion. 
DISCUSSION 
In the SDS-PAGE analysis of affinity isolated receptors 
positive results were obtained for haptoglobin, 0( 1acid glyco-
protein, prealbumin and o( 1antitrypsin with molecular weights 
of 48,000, 46,000, 49,000 and 62,000 respectively. For reasons 
not quite clear, there were no receptor bands in the 0( 2HS-glyco-
protein, Gc-glycoprotein and thrombin lanes. This is not to 
suggest that they have no receptors since there are a number of 
factors which affect the appearance of a band in SDS-PAGE; for 
example, the prevalence or density of a particular membrane 
protein or receptor in the purified preparation. It is also well 
known that Coomassie Blue R-250 is insensitive in staining clearly 
low concentrations of some proteins, for which reason Bio-Rad 
Laboratories (Watford, U.K) have developed a silver stain with 
a 10 to 50-fold increase in sensitivity (Technical Bulletin 
No, 39EG). There could also have been insufficient extraction 
of the receptor itself. 
It should be noted that for some of the proteins studied 
there was only a small supply of lOmg per vial and either the 
whole amount or even less than this was conjugated to the affinity 
gel. Here manufactures recommend at best, 5-lOmgjml of gel and 
9.5mls of gel were used for the 0.9 x 15cm affinity column. 
Some workers go round these problems by radiolabelling 
the extract itself and thereafter try to isolate membrane 
antigens or receptors. By autoradiographing the SDS-PAGE 
gel, receptor bands could be identified, Alternately when 
gel-filtration is performed on the desorbed receptor from 
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the affinity column .amd which had previously been incubated 
with radiolabelled protein, .the monitoring of eluted radio-
activity helps to identify the free or bound receptor fraction. 
(Seligman et al, 1979, Seligman et al, 1978, Brown and John-
son, 1981). In the present study, financial constraints 
limited the exploration of these alternatives due to shortage 
of highly purified proteins particularly as each lOmg vial 
for some of these proteins costs around £200, 
The three molecular forms of IgG of Mr 195,000, 78,000, 
and 74,000 obtained in this study are reminiscent of other 
reports that the IgG receptor has molecular heterogeneity. 
Balfour and Jones (1978) were the first to attempt the isolat-
ion and characterisation of IgG placental receptor. They 
applied a Triton-x100 solubilised extract on to IgG-Sepharose 
4B ·oolumn and the eluted receptor analysed on SDS-PAGE. They 
found three major bands with molecular weights of 37,000, 
45,000 and 60,000 and six minor bands with higher molecular 
weights which they did not state. 
Niezgodka et al (1981) also noted this heterogen~ity when 
they isolated the IgG receptor using lithium dicodosalicylate 
to solubilise the placental membrane and found two major bands 
on SDS-PAGE with Mr 74,000 and 104,000 and three minor peaks 
with Mr 56,000, 144,000 and 163,000. They also commented on 
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the weak binding of Coomassie Blue to receptor glycoproteins 
which limits proper visualisation. In the present study only 
higher molecular weights of 74,000, 78,000 and 195,000 were 
seen for IgG receptor. It is quite possible that low ones were 
present but not discernible due to weak binding of Coomassie 
Blue. More significantly, most of the membrane antigens appear 
as very small bands and at times barely visible. 
The IgG bands of Mr 74,000 and 195,000 are in the same order 
of magnitude with those of Mr 74,000 and 163,000 seen by Niez~ 
godka et al (1981). The explanation for IgG's heterogen~ity 
has not been conclusively worked out. Balfour and Jones (1978) 
suggested that the solubilised membrane inevitably contained 
membranes of other subcellular organelles or cell types that 
make up the placenta but which could conceivably possess IgG 
receptors. Also erythrocytes and white cell membranes which 
have IgG receptors (Balfour and Jones 1977, Abrahamson et al 
1970), always contaminate placental membrane isolation. 
Balfour and Jones continued to assert that their three major 
IgG receptor bands could represent three subtypes; one being 
found on the epithelial syncytiotrophoblastic membrane which is 
in direct contact with maternal blood, and is inhibitable or 
by monomeric IgG (Elson et al 1975). The other two are found 
on the endothelium of foetal stem vessels which take up IgG 
picked up from the maternal serum by the first receptor subtype. 
The endothelial IgG receptor is not blocked by monomeric IgG. 
This differential sensitivity to IgG itself by the receptor 
subtypes ensures delivery of IgG to the foetus and demonstrates 
a complicated control mechanism, Furthermore one endothelial 
receptor subtype aan bind immunocomplexes containing IgG, 
whilst the other binds aggregruted IgG which is blocked 
·by IgM-pretreatment (Johnson et al 1973). 
254 
Johnson and Brown (1981) have comprehensively reviewed 
the IgG-Fcr rece~tor and seem to acknowledge the diverse 
molecular weights that have been obtained in detergent 
solubilised Fer -receptor. They point out strong evidence 
implicating a Mr 115,000 globular protein with five globular 
units linked loosely and that other molecular weights could 
be proteolysis products of this molecule. The controversy 
is still unresolved. Nonetheless in the present study, there 
were bands in the solubilised membrane fraction co-migrating 
with the IgG-receptor fraction and agreeing with Niezgodka 
et al's (1981) findings. Information regarding other plasma 
protein receptors is rather novel as there is no reference 
to any other study that has attempted to identify receptors 
for haptoglobin, pre albumin, o( 1 acid glycoprotein and 
o( 1 antitrypsin on human placenta. Insufficient receptor 
material disallowed identification of the Gc-glycoprotein, 
o( 2HS-glycoprotein and thrombin receptors. 
Thrombin receptors on.other cell systems such as fibro-
blasts have demonstrated clearly that thrombin has a cell 
surface receptor of about Mr 35,000 and fibroblasts possess 
about 2 x 105 thrombin receptors/cell and a high affinity of 
1 x 1o-9M. Human foreskin also possesses these receptors. 
(Baker et al 1979). Glenn and Cunningham (1979) have also 
identified a thrombin cell receptor of Mr 43,000 to which 
thrombin attaches and cleaves it before its mitogenic 
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stimulation of cells is expressed. This was consistently 
shown in chick embryo cells and mouse-embryo dividing cells. 
Platelets also have thrombin receptor but Scatchard analysis 
has revealed high affinity (Kd 1.8-2nM) and low affinity 
sites (Kd = 200nM) on the receptor. 
Prealbumin, as the main vehicle for transporting 
retinol (Vitamin A) bound to retinol-binding globulin has 
been shown by Vahlquist et al (1975) to be present in foetal 
cord blood but which is immunologically indistinguishable 
from that of the paired maternal blood. Evidence from their 
study suggested that prealbumin and retinol-binding globulin 
must be transferred across the placenta, the principle route 
by which Vitamin A reaches the foetus, A prealbumin receptor 
of Mr 49,000 has been identified in this study in conjunction 
with other previous supportive evidence. Gc-glycoprotein 
has also been shown to cross the placenta readily (Johnson 
et al, 1974) although no receptor band was identified in the 
preparation used for SDS-PAGE. 
Finally Carlson et al (1976) analysed the placental 
plasma membrane and obtained sixteen bands with~ of 330,000 
295,000, 240,000, 215,000, 102,000, 89,000, 77,000, 73,000, 
67,000, 51,000, 49,000, 45,000, 33,000, 31,000, 26,000 and 
21,500. The underlined molecular weights are close to those 
obtained in Fig. 62 . Ogbimi et al (1979) also obtained 
twenty one bands. Of these, only six stained strongly,the 
rest stained very weakly, 
CHAPTER 8 
RECEPTOR-PRCYI'EIN BINDING ISOTHERMS USING PURIFIED SYNCYTIQ-
TROPHOOLASTlC MEMBRANE OR RECEPTOR DESORBATES FROM AFFINITY 
CHROMATOORAPHY. 
Introduction 
256 
Once receptor molecules are isolated or while still 
intact on the plasma membrane, it becomes imperative to 
explore their functional and physical characteristics. It 
is these which impart iniqueness to these molecules and thus 
enable them to mediate cellular and extra-cellular functions 
with unparalled precision. 
One of the problems of studying isolated receptors is 
the fact that their natural environment on the plasma membrane 
is disrupted. This may render the receptor inactive or even 
lose its natural conformation. The interaction between the 
agent and its receptor by which an effect is achieved must 
be thought of as a dynamic event more than the static 
classical picture of lock and key. The receptor causes an 
effect by a series of biochemical and biophysical events 
(Ariens 1964, Ariens and Simonis 1976). The chemical nature 
of the agent also affects the nature of the receptor - certain 
protein molecules (the ligand) have been shown to have struc-
tural similarities to the receptor molecule; for example, the 
transcobalamin II molecule has complimentary structural 
similarity to the transcobalamin II receptor on the placenta, 
(Seligman and Allen, 1978). This implies that the agent and 
its receptor must have evolved from the same ancestral molecule. 
Enzyme-substrate interaction has parallels in agent-
receptor binding - the differentiation between an active 
site on the enzyme molecule and the enzyme molecule as a 
whole. Under certain circumstances the receptor site might 
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be constituted from an interface between different molecules. 
Furthermore, there are accessory binding sites, not located 
on the receptor molecule itself, as in the cases of agonist and 
competitive antagonists for cholinergic-anticholinergic, 
histaminefantihistaminic, adrenergic and antiadrenergic 
relationships to the receptor. For these systems the agonist 
binds on the polar area of the receptor, whilst its antagonist 
binds on the sorrounding hydrophobic area made up of the 
lipid membrane (Ariens 1967, 1974, Ariens and Simonis 1960). 
These points all emphasise the problem encountered in study-
ing isolated receptors removed from the plasma membrane. 
These other structural relationships pertinent to the function-
ing of the receptor molecule 'M:mld be renoved in the isolated receptor. 
Nonetheless, binding studies using radiolabelled ligands 
have permitted useful information to be obtained on isolated 
receptors, which is in fact more accurate than when studied 
on intact membranes. This presupposes that during isolation 
gentle methods have to be used to avoid destruction of the 
receptor molecule, which is usually a protein. Equally useful 
information can be derived by incubating radiolabelled ligands 
with purified membrane preparations so long as other contami-
nating membranes of subcellular organelles are removed. 
Effective solubilising agents for extraction of receptor 
molecule are usually detergents which disperse the lipid 
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bilayer and thus cause release of embedded protein molecules. 
These range from strong ionic detergents such as sodium 
deoxycholate (NaDOC) and sodium dodecyl sulphate (SDS) to 
non-ionic ones like Triton-x100 and Nonidet-P40. These non-
ionic detergents are both polyoxoethylene-octyl phenols and 
are extremely effective in solubilising membrane antigens, 
added to their non-disruptive nature with respect to the 
receptor molecule, (Miller 1970, Duchon and Collier 1971). 
NaDOC and SDS, whilst useful too, can degrade the protein 
molecule. 
In the following study Triton-x100 solubilised membrane 
extracts were subjected to affinity chromatography using 
CN Br-activated Sepharose 4B coupled to a specific protein. 
The receptor desorbed from the affinity column was utilised 
as substrate for radio1abelled protein binding studies. It 
was seen in the previous chapter that when the receptor 
desorbates were analysed on SDS-polyacrylamide gels, some of 
the bands stain with varying intensity when Coomassie Blue 
is used, whilst others were not visualisable at all due to 
very low protein concentration amongst other factors, 
The problem of eliciting good bands on SDS-PAGE can be 
resolved if radiolabelled proteins are used to locate the 
receptor-protein conjugate by autoradiography or if the 
desorbed receptor from the affinity chromatography is 
incubated with the respective radiolabelled ligand. In this 
chapter, these incubations have been performed and from 
binding isotherms, it was possible to analyse the data using 
Scatchard plots (Scatchard, 1949) to assess some properties 
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of these receptors. These included affinity constants, total 
binding capacity, and from the shape of the Scatchard plot, 
heterogeneity or homogeneity of binding sites could be 
assessed. In some instances intact purified plasma membrane 
instead of the receptor fraction was used. 
Materials and Methods. 
a) Isolation and Solubilisation of Syncytiotrophoblastic 
Membrane· ( StMPM) . 
This was done essentially as outlined on page 52 and 
following steps in Fig.7 for isolation of purified StMPM 
using the method of Booth et al 1981 by a combination of 
differential ultracentrifugation and precipitation of non-
trophoblastic membrane with Mg2+ ions. Once prepared, the 
StMPM was assayed for protein using Micro-Lowry protein assay 
(Lowry et al 1951) or the Bio-Rad protein assay kit using 
Bradford's method based on the use of acidified Coomassie 
Blue G250 (Bradford 1976). The membrane was solubilised using 
1% Triton-x100 as outlined in chapter 7, pages 238-239. 
b) Affinity Isolation of Receptors. 
The solubilised fraction was then passed over a column 
of CN Br-activated Sepharose 4B linked to a specific protein 
( eg. thrombin, Gc-glycoprotein, o{ 2HS-glycoprotein, prealbumin, 
I'( 1 acid glycoprot·ein and' haptoglobin) , as out lined in det ai 1 
in chapter 7, pages 240-241. Receptors were desorbed using 
O.lM glycine/HCl pH 2.3 which was immediately buffered to 
pH 7.4 using 1M Tris pH 11.0. Those receptor fractions were 
then freeze-dried and stored till required. 
C) <Radi.olabelling of Plasma .Proteins, 
125 ul of N-Succinimidyl 2,3,H3 propionate (NSP), 
(Amersham International,Product Code TRK 556 1mCi/ml), was 
placed into a 10ml conical glass test tube, Toluene was 
blown off by a gentle N2 stream. The dry NSP was reacted 
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on ice with appropriate amounts of protein (see Table 10), 
dissolved in 0.2M Borate buffer pH 8,0, The mixture was 
chromatographed on Sephadex G50 column (0.9 x 15cm Pharmacia 
Fine Chemicals, London) and eluted with 50mM Tris/HCl pH 7.4. 
Fractions were monitored for radioactivity and protein label-
led ·.peaks identified. Percentage incorporation of label 
was calculated in each case and from counts incorporated 
amounts of protein used,and efficiency of the Scintillation 
counter, the specific activities were calculated, (see Table 
10 ). 
d) Radio Receptor-Ligand Binding. 
Table 11 shows incubation conditions for reacting 
receptor preparations or intact StMPM, with radiolabelled 
proteins in order to construct binding isotherms. Incubat-
ions were carried out in 50mM Tris/HCl pH 7.4 containing 
1% Bovine serum albumin (BSA). BSA minimises non-specific 
binding. Incubations were carried out for 1 hour at 37°C, 
shaking the tubes every 15 minutes, Separation of bound from 
free radioactivity was done by filtering the total test tube 
contents through GF/C glass fibre discs (Whatman) using the 
Amicon filtering chamber capable of taking twelve discs at 
a time and attached to a vacuum pump (Amicon.Stoneygate, 
Gloucs). For solubilised receptor fraction, Sepbacryl S 200 
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NSP /Protein Molecular AIIDunt of Specific 
Protein ratio weight protein activity 
labelled (cpm/ug) 
( ug ) 
Prealbtunin 2:1 61,000 72.65 1.2 X 106 
Gc-glycoprotein 1:1 50,000 59.55 6.43 X 105 
~ 2HS~glycoprotein 1:1 49,000 58.35 ' 4 3.'13 X 10 
Haptoglobin 1:1 '' 100,000 119.00 5.55 X 104 
Thrarbin 2:1 39,000 100.00 6.53 X 10 4 
~ 1 acid glycoprotein 1:1 44,000 52.40 3.24 X 10
4 
Radiolabelling of Plasma Proteins. 
0(1Acid glycoprotein Gc-glycoprotein Pre Albumin o(~-glycoprotein Haptoglobin 'Ill :raiD in 
. 
1',{, BSA per 100 100 100 100 100 100 
(JJl)' tt .. ' 
· 50rrM Tris 340, 300' 340' 340' 340, 300, 379, 378, 374, 
buffer pH 340, 300, 250, 350 250, 350 250, 350 340' 300' 250' 350 250, 350 368, 362 
7. 4 (pl) tt (1 - 4) tt (1-4) tt (1-4) tt (1 - 4) tt . (1~4) . .. tt .(1.~ 5_} . 
~-Protein 10, 50, 100, 500 10, 50, 10, 50, 10, 50, 100, 500 10' 50' 20 pl of~-
( pl ) 100, 500 100, 500 100, 500 thralbin, 
(6043 cpn) 
StMPM (pl) 
- - -
- - 1 ' 2' 6' 12' 18 
. 
Or 
Solubili-
sed Rece- 200 200 200 200 200 ' 
ptor (,ul) -
Preparat-
ion. ' 
Total 650, 650, 650, 850 650, 650, 650, 650, 650, 650, 650, 850 650, 650, 500 
: volUIJE ' 650, 850 650, 850 650, 850 
<)It) 
Table'll Assay Procedure for Receptor-radioligand Incubations. tt = iest tube 
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gel filtration was used on a 1, 5 x 30cm column to separate 
bound from free radiolabel. Non-specific binding was always 
subtracted when experiments were repeated in 100-fold excess 
unlabelled protein. 
It should be noted that for thrombin, purified membrane 
(StMPM) was used; fixed number of counts were placed in each 
tube plus buffer and 1% BSA, and membrane was varied. 
( t{embrane protein was 54 pg/pl StMPM). To evaluate binding 
parameters the inverse form of the Scatchard plot must be 
used as explained previously (Walker 1977) on pages 130-132. 
When solubilised receptor fraction was used (200 pl), the 
variable was the 3H-labelled protein. There was one persi-
stent problem with regards to quantitating receptor protein 
which was at the lower end of sensitivity for the Lowry assay 
method and even more difficult was the fact that 0.15% 
Triton~x100 which is necessary to add to the buffer to keep 
receptors (generally hydrophobic) in solution, is well known 
to absorb at 280nm and thus interferes grossly with protein 
quantitation. It was therefore. a difficult problem to sort 
out but by adding constant amounts of receptor fraction, 
whatever protein was there, was assessed indirectly by being 
able to absorb sufficient counts of the radiolabel, C>S% 
was sufficient although protei~with high receptor density 
such as IgG distribution can absorb up to 10% of added counts 
quite easily). 
Results 
Data from binding isotherms was appropriately transformed 
to ordinary Scatchard plots with the exception of thrombin, 
where the inverse Scatchard was used, Figures 63 to 69 
display these results, In all these plots, the bound/free 
radioactivity was plotted against bound counts, (Y and X-
axes respectively) as per Scatchard equation; 
B/F = KA ( n B ) 
where B = number of moles of ligand bound per 
mole of protein (receptor) 
F = molar concentration of free ligand 
KA = association constant 
n = total number of binding sites (in moles) 
per mole of receptor protein, 
The intercept on X-axis gives the maximum binding capacity 
(number of sites), whilst the gradient or slope gives tbe 
affinity constant Ka. 
Table 12 summarises these results in terms of affinity 
constants, binding capacity and existence of homogeneity or 
264 -1 
heterogeneity of binding sites, Scatchard plots for 0( 1 acid 
glycoprotein, Gc-glycoprotein, prealbumin, and thrombin were 
linear, whilst those of o( 2HS-glycoprotein and haptoglobin 
were non-linear. This implied non-homogeneity of receptor 
sites for these two sets of receptor proteins. 
Consequently, c< 2HS-glycoprotein exhibited a high 
-8 -1 . 
affinity (Ka = 1.23 x 10 M ) , low capacity (capacity = 
8,15 x 10-11M) and low affinity (Ka = 0,46 x 107M-1 ), high 
capacity (capacity = 4,68 x lo-10M) receptor sites, Likewise 
haptoglobin possesses a high affinity (Ka = 8.89 x l0 7M-1 ), 
5 
PREAL.BUMIN 
8 -1 Ka = 2.47 x 10M 
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-11 Binding capacity = 1. 736 x 10 ~1 
4 
3 
2 
1 
400 800 1200 1600 2000 2400 
Bound (cpm) 
Fig. 63 Prea1bumin 
Specific binding of H3-prealbumin was transformed into 
Scatchard plot as per incubation conditions described in the 
. 8 -1 
text. The affinity of Ka = 2,47 x 10 M , with a total binding 
-11 capacity of 1,736 x 10 M was obtained, The receptor sites 
were homogeneous due to linear plot, 
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Fig. 64 - D( 2HS-Glycoprotein. 
Scatcbard plot of 3H- 0( 2HS-glycoprotein binding on its 
isolated receptor fraction as described in the methods. The 
The curvilinear shape implied two binding sites on the D( 2HS-
glycoprotein receptor and exhibited co-operative effects. 
One site bad high 
capacity= 8.15 x 
and high capacity 
8 -1 
affinity, low capacity (Ka = 1.23 x 10M ; 
1o-11M) whilst the other bad low affinity 
7 -1 -10 (Ka = 0.46 x 10 M , capacity = 4.68 x 10 M). 
Fig. 65 Haptoglobin 
A Scatcbard plot of 3H-baptoglobin interacting with its 
put·ative receptor. Non-linearity of the plot suggests betero-
geneity of receptor sites on the receptor molecule; one site 
with high affinity, low capacity (Ka = 8.89 x 107M- 1 , 
capacity = 3.71 x 1o-11M), whilst the other site had low affinity 
and high capacity (Ka = 0,55 x 107M-1 , capacity= 1,44 x 1o-10M). 
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• 
600 
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Fig. 66 Gc-glycoprotein 
Specific binding of 3H-Gc-glycoprotein to its receptor 
was linear on 
receptor site 
Scatchard plotting with 
8 -1 (Ka = 8,95 x 10 M ). 
Fig. 67 - o( 1 Acid glycoprotein 
a high affinity homogeneous 
Specific binding of 3H- 0( 1 acid glycoprotein interacting 
with its receptor also produced linear Scatchard plot, implying 
a moderately high affinity a homogeneous receptor population with 
constant of 0.76 x 10 7M- 1 and capacity of -10 5,90 x 10 M. 
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Eig. 68 Thrombin 
This- shows· an interaction of ~-thrarbin with purified trophoblastic 
membrane (StMPM);6043 cpm in 20 pl of 3H-thrombin was placed 
in each tube (six in all), in presence of 100 pl of 1% bovine 
serum albumin, varying amounts of 50mM Tris-HCl pH 7.4 buffer 
as shown in Table 11 and varying amounts of membrane, 
(54 ~g/pl StMPM). After 1 hour at 37°C separation of bound 
from free counts was achieved by vacuum filtration through 
glass fibre GF/C discs (Whatman). Non-specific binding was 
subtracted when the experiments were repeated in presence of 100-fold 
unlabelled thranbin. Saturation was reached at 648 of StMPM. 
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Fig. 69 
Data from Fig.68 on specific binding of 3H-thrombin was 
transformed according to the inverse Scatchard plot, in order 
to assess the affinity binding sites on the putative thrombin 
receptor. A linear relationship implied homogeneous receptor 
sites with high affinity of 3.0 x 1010M-1 and capacity of 
3.05 x 1011 sitesjmg of syncytiotrophoblast was calculated. 
This was equivalent to a binding capacity of Z4. 7 )lg/1 per 
1.296 mg of membrane. 
B/AB 
Inverse Scatchard Plot for Thrombin/Receotor interaction 
•"'" . 
l.O 
0.8 
0.6 
( AB + K- 1 ) = . 26 pg/1 
AB (Binding capacity)= 24.7 pg/1 0.4 
per 1. 296mg of lrenbrane 
0.2 
0 
-26 -24 -22 -20 -18 -16 -14 -12 -10 -8 -6 -4 -2 
LW2 (ug/1) 
"' 
""' Fig. 69 
"' 
I 
~1Acid glyCO'- Gc-glyooprotein Haptoglobin o<:tJS-glycopro- PreAlbmrl.n 
protein tein . 
. 
0.76 X 107M-l ~-1 
8.89 X 107M-l 1. 23 x 1ol\r-1 ~-1 Affinity (Ka) 8.95 X 10 and and 2.47 X 10. 
0.55 x 107M-l 0.46 X 107M-l 
Binding Capacity 5 -10 . 90 X 10 ·p,4J. -11 1,6 x 10 M 3. 71 x 10-llM 8,15 X 10 
-1~ 
-lly 1. 73 X 10 . 
and and ( "Bmax ) 1.44 X 10-lOM 4.68 X 10-lOM 
Heterogen~ity 
-of sites - + + -
• 
H(lll)gen eity 
of sites + + - - + 
Table 12 Binding Parameters for Placental Receptors to Specific Plasma Proteins. 
Key: + present 
absent 
-
Thrrni:>in 
1~-1 3.0 X 10 . 
3.05 X 1011 
Sitesfng StMPM 
-
... ' .. 
+ 
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low capacity (3.71 x 10-11M) site as well as low affinity 
(K = 0,55 x 107M- 1 ), high capacity (capacity= 1.44 x 1o-10M) 
a 
site, 
Thrombin on the other hand showed a homogeneous high 
affinity site with Ka = 3 x 1010M- 1 with 3,05 x lo11sitesfmg 
StMPM. Thrombin was the only protein studied using unsolubi-
lised intact membrane and was studied by the varying membrane 
amount at a fixed radioligand concentration. Fig. 68 shows 
the binding curve which reaches equilibrium or saturation and 
its inverse Scatchard plot in Fig, 69 for assessment of the 
affinity and total number of binding sitesfmg of membrane. 
Discussion 
For the proteins chosen, this thesis reports for the 
first time on the binding characteristics of these receptors 
other than that of IgG which was separately studied in 
chapter 4, All along in this thesis evidence has been 
accumulated through immunochemical,in vitro perfusion of 
the placenta, colloidal gold study, the affinity chromato-
graphy for isolation of solubilised receptors, and now the 
saturation analysis which all point to existence of receptor 
molecules on the placental membrane for selective transfer 
of these plasma proteins from mother to the foetus. 
From literature survey, it appears that there has been 
little interest in the subject of placental receptors and 
this explains why there is a paucity of information with 
regards to mechanisms of protein transport across the placenta. 
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On the other hand, there has been a number of studies which 
have established that some plasma proteins with genetic and 
immunochemical characteristics are indistinguishable from 
those of the mother and thus confirming their maternal origin 
(Sutcliffe 1981, Adinolfi 1970, Johnson et al 1974) and the 
wide spread belief that they somehow cross the placenta. 
Data presented in this chapter takes the story a little 
further and isolates the receptor structures to perform 
radioligand/receptor incubations so as to establish existence 
of high affinity receptor sites. 
. h 1 7 - 1 1 1n t e order of x 10 M to x 
High affinity constants 
1o10r.c 1 im!)licate a 
receptor site as it is impossible for non-specific binding 
to have constants of this magnitude. The heterogeneity of 
haptoglobin and o( 2HS-glycoprotein receptors is quite 
interesting although its implication in terms of binding 
of these proteins is far from clear as yet. 
Thrombin, a proteolytic enzyme, when added to cultures 
of non-proliferating cells, leads to rapid cell division. 
Carney and Cunningham (1978) have studied thrombin induced 
cell division in chick and mouse embryo cells and human 
foreskin cells and have shown that thrombin possesses a 
specific receptor on these cells. By binding to it, it splits 
a 43,000 dalton receptor and then initiate mitogenesis 
(Glenn and Cunningham 1979). I 125-labelled thrombin incubat-
ions with these cells yielded linear Scatchard plots over 
a wide range of 1125-thrombin concentrations. This implies 
a single class of thrombin receptor sites with a high affinity 
9 -1 5 
constant of 1 x 10 M and 2 x 10 receptor sites/cell, 
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(Carney and Cunningham 1978). 
Platelets also possess thrombin receptors but their non-
linear plots suggest multiple classes of receptors with 
co-operative interactions (De Meyts, 1976). Martinet al, 
1976, have also confirmed two thrombin receptor sites on 
platelets,-with non-linear Scatchard plots; one low capacity 
390 sites/platelet and high affinity (Kd = 1.9nM) and a high 
capacity 2500 sites/platelet and low affinity (Kd = 200nM). 
Macrophages are chemotactically attracted to thrombin 
(a useful role in the clotting process) by their 9ossession 
of thrombin receptors. Bar-Shavit et al, 1983, have demons-
trated (using a macrophage cell line J 774 cells) that a 
saturable receptor exists on these cells, and has a Kd = 
-9 7.51 x 10 M. Thrombin concentrations eliciting chemataxis 
-10 -6 -8 
range from 10 to 10 M with optimum of 10 M which is 
very near to its Kd value. Existence of the thrombin receptor 
on the human placenta might be of an important role in coagula-
tion control or indeed initiating mitogenesis; -mitogenetic 
role on the syncytiotrophoblast is of obscure importance 
since this layer does not divide except the layer below it, 
the cytotrophoblast. The existence of the receptor is there-
fore of as yet unclear significance. The high affinity 
obtained in other studies is of the order of 109M-1 and it 
compares well with a Ka of 3 x 1010M-1 obtained for the 
placental receptor. 
CONCLUSION 
A choice was made of a few plasma proteins so as to 
explore the mechanism by which they cross the placenta with 
receptor mediated uptake as the major modality. These 
included 0(1antitrypsin, 0( 1acid glycoprotein, haptoglobin, 
thrombin, fibrinogen, 0( 2HS-glycoprotein, Gc-glycoprotein 
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and prealbumin. IgG has also been studied with regards to 
re-establishing binding characteristics as well as the effect 
of temperature and cations on modulation of binding. In the 
following paragraphs a brief mention of each protein will be 
made and the conclusion made in the light of evidence 
accumulated in this study. 
Q(_1 antitrypsin is responsible for the bulk of (90%) 
antiprotease action in addition to other inhibitors such as 
0( 2macroglobulin. This protein might therefore be required 
to protect the foetus against excessive proteolytic enzymes. 
Its mode of transport across the placenta was not clear, but 
from experiments in this study, there was strong adsorption 
on the syncytiotrophoblastic membrane as shown by both pero-
xidase and fluorescence experiments, Furthermore, placental 
in-vitro perfusion showed an active uptake profile. In 
addition, colloidal gold 0( 1antitrypsin conjugate showed 
some adsorption on the StMPM. This data would seem to indicate 
receptor mediated binding and possibly transport. When affinity 
chromatography of solubilised receptor fraction was performed 
using CN Br-activated Sepharose 4B linked too( 1antitrypsin, 
a band of Mr 60,000 was desorbed. This was assumed to be the 
solubilised o<1antitrypsin receptor. Receptor-radiolabelled 
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0( 1antitrypsin interaction demonstrated a homogeneus receptor 
site with the affinity of Ka = 0,76 x 107M-1 . 
It is therefore not unexpected that by 26 weeks to 
birth, up to 175% of adult maternal level exists in the 
foetal circulation, an extremely high gradient, The placenta 
must therefore be responsible for maintaining this gradient, 
of course only active transport can explain this. The 
finding of o(iantitrypsin of maternal origin in foetal 
circulation by Biasucci and Gitlin (1969) lends support to 
placental transfer. It must be remembered that de-novo 
synthesis also takes place to some extent. 
Q( 1 acid glycoprotein is another acute phase protein, 
with no clear-cut function although there is some evidence 
that it is involved in inactivation of progesterone. If 
this is its major role, then it is reasonable to suppose 
that it would have a vital role to play in a milieu of 
foetal-maternal progesterone exchange, particularly as this 
hormone exerts an anabolic role as well as a precursor of 
other steroid hormones, and therefore requires a carefully 
controlled balance. The present study shows evidence that 
this protein too is actively transferred from in-vitro 
placental perfusion. Fluorescence, peroxidase and colloidal 
gold experiments also showed marked membrane binding, 
Furthermore, Triton-X100 solubilised placental membrane 
was subjected to the affinity isolation of o( 1 acid glyco-
protein receptor using CN Br-activated Sepharose 4B coupled 
to o( 1 acid glycoprotein. This adsorbent extracted a receptor 
of Mr 47,000 on SDS-PAGE. Radioligand/receptor binding 
studies also gave a homogeneus receptor site with high 
affinity of Ka = 0.76 x 107M-1 , 
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Gc-glycoprotein was chosen because of current evidence 
which shows that it is a major carrier of vitamin D and 
presumably its metabolites (Constans et al 1983). Vitamin D 
is crucial to the rapid skeletal development of the foetus, 
and therefore its plasma carrier, the Gc-glycoprotein was 
of interest from this point of view. Both immunocytochemi-
stry and the perfusion experiments showed binding as well 
as a saturable uptake profile. 
Due to insufficient quantities of purified Gc-glyco-
protein, it was not possible to prepare a sufficiently strong 
CN Br-activated Swpharose 4B-Gc adsorbent in order to visibly 
see the Gc-receptor band on SDS-PAGE. However, the same 
receptor fraction was used in receptor-radioligand binding 
studies and due to the high sensitivity of radiolabelled 
protein, saturable binding enabled calculation of affinity 
constant of the receptor/Gc interaction (Ka = 8.95 x 108M- 1 ), 
saturable binding and high affinity are strong evidence for 
existence of Gc-receptor;~ Gc proteins have been found in 
foetal cord blood and phenotypic studies have indicated 
maternal origin of this protein, although foetal de-novo 
synthesis is known to take place (Johnson et al 1974, 
Adnolfi, 1970). 
Transferrin carries iron in plasma which would otherwise 
be toxic in free state. There is much evidence to show 
equilibrium between this mobile binder of iron and ferritin, 
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another iron storage protein, both in plasma and in the liver, 
where both proteins are synthesised. The placenta has specific 
receptors to bind and subsquently transfer this protein across 
the placenta and from work of Brown and Johnson (1980), it 
has been shown from co-migration experiments of deoxycholate 
solubilised membrane preparation that there are no coincident 
protein bands between transferrin and this preparation, This 
led Ogbimi and Johnson (1980) to show from immunoelectropho-
resis, using an anti-transferrin antibody that most of 
transferrin in this soluble fraction migrates as a complex 
with its receptor. 
Brown and Johnson (1981) have isolated the transferrin 
receptor structure from StMPM and from affinity chromatography 
and gel filtration they found that the receptor is a 65,000 
dalton protein with a 1:1 binding with transferrin. In the 
present study, immunohistological placental uptake and 
colloidal gold studies seem to support a receptor mediated 
transferrin transplacental transport, 
The IgG receptor has been extensively studied (Mat-re and 
Johnson 1979, Brown and Johnson 1980, Johnson et al 1976, 
Balfour and Jones 1978), although the homogeneity of the 
receptor molecule is still a subject of some controversy. 
In this report, some effort was made tore-measure binding 
affinity and dissociation constants as various workers in 
the past have obtained different values because of differing 
radio-receptor assay systems, 
8 -1 For the association an average Ka = 2.2 x 10M was 
obtained and total number of binding sites on the Fe 
receptor of •·50 x 1014 were also observed. Furthermore, a 
rate constant of 2.29 x 107M- 1 min-1 was obtained, Both 
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being in close agreement with what some workers have obtained, 
On the dissociation aspect, high displacing dose ( x1000 fold) 
was used and this seemed to indicate some heterogeniety on 
the dissociation curve, with one fast component with 0,10 min- 1 
and another slow one ten times smaller, at 0,010 min-1 . 
From the dissociation rate data, a parallel has been shown 
from work of Rees and Wallace (1978), who showed a high and 
low affinity equilibrium constants for IgG-Fcl receutor. 
Furthermore, this work has differed from previous reports 
in that the IgG-Fc~ interaction may not be a 1:1 as stated 
before, but a 4:1 as data in this report suggests. The main 
criticism being that previous work does not specifically 
show reasonable data to prove a 1:1 relation, Thermodynamic 
activation energies for this system have also been presented 
for the first time as no previous work has reported on this 
aspect. In this report it is shown that the interaction is 
associated with a AH = -2,56 KCalfMole, a markedly exothermic 
reaction and typical of hydrogen bonding interactions, as 
well as a large positive entropy change of ~S = +29 Cal 
-1 -1 . 
Mol deg ,typical of hydrophobic associations. 
The effect of monovalent and divalent cations were 
investigated and it was of interest to notice that Na+ ions 
in physiological range markedly inhibits binding by as much 
as 36% which might imply a fine physiological regulator as 
discussed before. Ca++ ions also inhibited binding in physio-
logical range. Li+, Mn2 + and Mg2+ also showed marked 
inhibitory modulating effects although in unphysiological 
concentrations. 
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Affinity chromatographic isolation of IgG receptor using 
CN-Br-activated Sepharose 4B-IgG adsorbent showed three bands 
on SDS-PAGE of (Mr 72,000, 78,000 and 165,000), This implied 
that the IgG receptor is heterogeneus, presumably due to 
multiple number of antigenically similar molecules, but which 
differ in molecular weight. Work in this study has demons-
trated this multiplicity of IgG-receptor subtypes and agrees 
with other investigators who have also showed multiple IgG-
Fe~ receptors (Balfour and Jones 1978, Niezgodka et al, 
1981, Johnson and Brown, 1981), 
For fibrinogen, an existence of a receptor for it, quite 
apart from crossing the placenta, might have·marked local 
clotting regulatory consequencies. Both in-vitro uptake and 
immunohistological studies seemed to indicate binding to the 
trophoblastic membrane. The saturable uptake seen in the 
in-vitro perfusion experiment seemsto suggest that this protein 
crosses the placenta; presumably by a specific receptor, 
Thrombin that was radiolabelled showed marked membrane 
absorption in the region of 16% of added counts. This avid 
binding is too high to be due to non-specific binding, only 
a specific receptor to thrombin can explain this, From 
incubations of purified placental membrane with 3H-labelled 
thrombin, saturable uptake was shown and the inverse Scatchard 
plots showed a homogeneus receptor site with a high affinity 
10 -1 
constant of 3 x 10 M . Other workers have demonstrated 
existence of thrombin receptor on mouse and chick embryo 
cells, and platelets (Carney and Cunningham 1978, Glenn and 
CUnningham 1979, Bar-Shavit 1983). 
In the present study existence of placental thrombin 
receptor could be of vital importance. If one speculates 
that fibrinogen has receptor on the placenta (it could be 
locally immobilised by its receptor)and this acts as a 
substrate for thrombin (also immobilised by its receptor) 
to initiate clotting at a particular site in the placenta. 
This could be a very fine regulatory mechanism in clotting 
control. 
c( 2HS-glycoprotein has little subscribed function to 
it,although recent studies have implicated it as a major 
bone matrix protein. It is produced in the liver but settles 
in bone matrix. If it has a receptor mediated uptake, it 
then becomes obviously vital for the foetus with a rapidly 
growing skeletal system that requires this protein, as 
its own synthetic capacity is low in early gestation. In 
this study saturable uptake in the placental perfusion 
experiment has been shown as well as binding from immuno-
cytological studies. 
From receptor-radiolabelled 3H- o( 2HS-glycoprotein 
biriding, Scat chard transformation of the data showed hetero-
geneity of receptor sites. There were two sites; one with 
high affinity, low capacity and the other with tow affinity, 
high capacity. Co-operative effects were therefore present 
for the 0( 2HS-glycoprotein receptor. 
Haptoglobin is the major binder of free haemoglobin 
and haptoglobin levels drop sharply in presence of increased 
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haemolysis. However, very little haptoglobin is detectable 
in foetal cord blood (the level is 1% of adult concentration) 
and only in 10% of cord bloods. The percentage rapidly rises 
to 46.5% with detectable levels by the age of 2 months. This 
suggests that the foetal liver has the capacity to synthesise 
this protein at birth (Adinolfi 1970, Gitlin and Gitlin 1975). 
lnspite of lack of evidence that this protein is trans-
ferred across the placenta, the present study has clearly 
showed marked membrane binding by immunocytochemical methods. 
Furthermore, there was saturable uptake in the placenta 
perfusion. Affinity chromatography of solubilised membrane 
gave a band with Mr 46,000,presumed to be a haptoglobin 
receptor. In addition there wereco-operative receptor sites 
when isolated receptor fraction was incubated with 3H-hapto-
globin. Both receptor sites exhibited high and low affinity 
7 -1 7 -1 
constants (Ka = 8.89 x 10M , 0.55 x 10M ). All this 
data is very suggestive of a haptoglobin receptor capable 
of transferring haptoglobin. As to whether it is detectable 
subsquently in cord blood, is a different argument. Gitlin 
and Gitlin, 1975, seem to think that this lack of detection 
of haptoglobin might be due to increased haemolysis in the 
conceptus .but hastily add that this is not yet proven. 
Receptor characteristics have been observed for prealbumin. 
Prealbumin is a major transporter of retinol, a vitamin A 
carotenoid which is required by the foetus. Also prealbumin 
is one of the transporters of thyroxine in addition to 
thyroxine binding globulin. Both these different but vital 
285 
functions of prealbumin might become very important if indeed 
a receptor exists on the placenta to transfer this protein 
to the foetus with its load of vitamin A and thyroxine, akin 
to transferrin and iron, 
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